id	sid	tid	token	lemma	pos
bam-10622	1	1	magnesium	magnesium	NOUN
bam-10622	1	2	supplementation	supplementation	NOUN
bam-10622	1	3	in	in	ADP
bam-10622	1	4	rheumatoid	rheumatoid	NOUN
bam-10622	1	5	arthritis	arthritis	NOUN
bam-10622	1	6	eur	eur	PROPN
bam-10622	1	7	j	j	PROPN
bam-10622	1	8	transl	transl	PROPN
bam-10622	1	9	myol	myol	ADV
bam-10622	1	10	32	32	NUM
bam-10622	1	11	(	(	PUNCT
bam-10622	1	12	3	3	NUM
bam-10622	1	13	):	):	PUNCT
bam-10622	1	14	10622	10622	NUM
bam-10622	1	15	,	,	PUNCT
bam-10622	1	16	2022	2022	NUM
bam-10622	1	17	doi	doi	NOUN
bam-10622	1	18	:	:	PUNCT
bam-10622	1	19	10.4081	10.4081	NUM
bam-10622	1	20	/	/	SYM
bam-10622	1	21	ejtm.2022.10622	ejtm.2022.10622	NUM
bam-10622	1	22	1	1	NUM
bam-10622	1	23	magnesium	magnesium	NOUN
bam-10622	1	24	supplementation	supplementation	NOUN
bam-10622	1	25	and	and	CCONJ
bam-10622	1	26	insulin	insulin	NOUN
bam-10622	1	27	resistance	resistance	NOUN
bam-10622	1	28	in	in	ADP
bam-10622	1	29	patients	patient	NOUN
bam-10622	1	30	with	with	ADP
bam-10622	1	31	rheumatoid	rheumatoid	NOUN
bam-10622	1	32	arthritis	arthritis	NOUN
bam-10622	1	33	mohsen	mohsen	PROPN
bam-10622	2	1	norouzi	norouzi	INTJ
bam-10622	2	2	(	(	PUNCT
bam-10622	2	3	1	1	NUM
bam-10622	2	4	)	)	PUNCT
bam-10622	2	5	,	,	PUNCT
bam-10622	2	6	boshra	boshra	ADJ
bam-10622	2	7	rezvankhah	rezvankhah	NOUN
bam-10622	2	8	(	(	PUNCT
bam-10622	2	9	2	2	NUM
bam-10622	2	10	)	)	PUNCT
bam-10622	2	11	,	,	PUNCT
bam-10622	2	12	mohammad	mohammad	PROPN
bam-10622	2	13	reza	reza	PROPN
bam-10622	2	14	haeri	haeri	PROPN
bam-10622	2	15	(	(	PUNCT
bam-10622	2	16	3	3	NUM
bam-10622	2	17	)	)	PUNCT
bam-10622	2	18	,	,	PUNCT
bam-10622	2	19	hosein	hosein	PROPN
bam-10622	2	20	heydari	heydari	PROPN
bam-10622	2	21	(	(	PUNCT
bam-10622	2	22	4	4	NUM
bam-10622	2	23	)	)	PUNCT
bam-10622	2	24	,	,	PUNCT
bam-10622	2	25	javad	javad	PROPN
bam-10622	2	26	tafaroji	tafaroji	PROPN
bam-10622	2	27	(	(	PUNCT
bam-10622	2	28	4	4	NUM
bam-10622	2	29	)	)	PUNCT
bam-10622	2	30	,	,	PUNCT
bam-10622	2	31	navid	navid	PROPN
bam-10622	2	32	shafigh	shafigh	PROPN
bam-10622	2	33	(	(	PUNCT
bam-10622	2	34	5	5	NUM
bam-10622	2	35	)	)	PUNCT
bam-10622	2	36	,	,	PUNCT
bam-10622	2	37	jamshid	jamshid	PROPN
bam-10622	2	38	ordoni	ordoni	PROPN
bam-10622	2	39	avval	avval	PROPN
bam-10622	2	40	(	(	PUNCT
bam-10622	2	41	6	6	NUM
bam-10622	2	42	)	)	PUNCT
bam-10622	2	43	,	,	PUNCT
bam-10622	2	44	alireza	alireza	PROPN
bam-10622	2	45	rahat	rahat	PROPN
bam-10622	2	46	dahmardeh	dahmardeh	PROPN
bam-10622	2	47	(	(	PUNCT
bam-10622	2	48	6	6	NUM
bam-10622	2	49	)	)	PUNCT
bam-10622	2	50	,	,	PUNCT
bam-10622	2	51	niyoosha	niyoosha	PROPN
bam-10622	2	52	masoumzadeh	masoumzadeh	NOUN
bam-10622	2	53	(	(	PUNCT
bam-10622	2	54	7,8	7,8	NUM
bam-10622	2	55	)	)	PUNCT
bam-10622	2	56	,	,	PUNCT
bam-10622	2	57	mohammad	mohammad	PROPN
bam-10622	2	58	gharehbeglou	gharehbeglou	PROPN
bam-10622	2	59	(	(	PUNCT
bam-10622	2	60	5,6	5,6	NUM
bam-10622	2	61	)	)	PUNCT
bam-10622	2	62	(	(	PUNCT
bam-10622	2	63	1	1	X
bam-10622	2	64	)	)	PUNCT
bam-10622	2	65	department	department	NOUN
bam-10622	2	66	of	of	ADP
bam-10622	2	67	internal	internal	ADJ
bam-10622	2	68	medicine	medicine	NOUN
bam-10622	2	69	,	,	PUNCT
bam-10622	2	70	school	school	NOUN
bam-10622	2	71	of	of	ADP
bam-10622	2	72	medicine	medicine	NOUN
bam-10622	2	73	,	,	PUNCT
bam-10622	2	74	qom	qom	PROPN
bam-10622	2	75	branch	branch	PROPN
bam-10622	2	76	,	,	PUNCT
bam-10622	2	77	islamic	islamic	PROPN
bam-10622	2	78	azad	azad	PROPN
bam-10622	2	79	university	university	PROPN
bam-10622	2	80	,	,	PUNCT
bam-10622	2	81	qom	qom	PROPN
bam-10622	2	82	,	,	PUNCT
bam-10622	2	83	iran	iran	PROPN
bam-10622	2	84	;	;	PUNCT
bam-10622	2	85	(	(	PUNCT
bam-10622	2	86	2	2	X
bam-10622	2	87	)	)	PUNCT
bam-10622	2	88	research	research	NOUN
bam-10622	2	89	institute	institute	NOUN
bam-10622	2	90	for	for	ADP
bam-10622	2	91	endocrine	endocrine	NOUN
bam-10622	2	92	sciences	science	NOUN
bam-10622	2	93	,	,	PUNCT
bam-10622	2	94	shahid	shahid	PROPN
bam-10622	2	95	beheshti	beheshti	VERB
bam-10622	2	96	university	university	NOUN
bam-10622	2	97	of	of	ADP
bam-10622	2	98	medical	medical	ADJ
bam-10622	2	99	science	science	NOUN
bam-10622	2	100	,	,	PUNCT
bam-10622	2	101	tehran	tehran	PROPN
bam-10622	2	102	,	,	PUNCT
bam-10622	2	103	iran	iran	PROPN
bam-10622	2	104	;	;	PUNCT
bam-10622	2	105	(	(	PUNCT
bam-10622	2	106	3	3	X
bam-10622	2	107	)	)	PUNCT
bam-10622	2	108	department	department	NOUN
bam-10622	2	109	of	of	ADP
bam-10622	2	110	biochemistry	biochemistry	NOUN
bam-10622	2	111	,	,	PUNCT
bam-10622	2	112	school	school	NOUN
bam-10622	2	113	of	of	ADP
bam-10622	2	114	medicine	medicine	NOUN
bam-10622	2	115	,	,	PUNCT
bam-10622	2	116	qom	qom	PROPN
bam-10622	2	117	university	university	PROPN
bam-10622	2	118	of	of	ADP
bam-10622	2	119	medical	medical	ADJ
bam-10622	2	120	science	science	PROPN
bam-10622	2	121	,	,	PUNCT
bam-10622	2	122	qom	qom	PROPN
bam-10622	2	123	,	,	PUNCT
bam-10622	2	124	iran	iran	PROPN
bam-10622	2	125	;	;	PUNCT
bam-10622	2	126	(	(	PUNCT
bam-10622	2	127	4	4	X
bam-10622	2	128	)	)	PUNCT
bam-10622	2	129	department	department	NOUN
bam-10622	2	130	of	of	ADP
bam-10622	2	131	pediatrics	pediatric	NOUN
bam-10622	2	132	,	,	PUNCT
bam-10622	2	133	school	school	NOUN
bam-10622	2	134	of	of	ADP
bam-10622	2	135	medicine	medicine	NOUN
bam-10622	2	136	,	,	PUNCT
bam-10622	2	137	qom	qom	PROPN
bam-10622	2	138	university	university	PROPN
bam-10622	2	139	of	of	ADP
bam-10622	2	140	medical	medical	ADJ
bam-10622	2	141	science	science	PROPN
bam-10622	2	142	,	,	PUNCT
bam-10622	2	143	qom	qom	PROPN
bam-10622	2	144	,	,	PUNCT
bam-10622	2	145	iran	iran	PROPN
bam-10622	2	146	;	;	PUNCT
bam-10622	2	147	(	(	PUNCT
bam-10622	2	148	5	5	X
bam-10622	2	149	)	)	PUNCT
bam-10622	2	150	department	department	NOUN
bam-10622	2	151	of	of	ADP
bam-10622	2	152	anesthesiology	anesthesiology	NOUN
bam-10622	2	153	and	and	CCONJ
bam-10622	2	154	critical	critical	ADJ
bam-10622	2	155	care	care	NOUN
bam-10622	2	156	medicine	medicine	NOUN
bam-10622	2	157	,	,	PUNCT
bam-10622	2	158	school	school	NOUN
bam-10622	2	159	of	of	ADP
bam-10622	2	160	medicine	medicine	NOUN
bam-10622	2	161	,	,	PUNCT
bam-10622	2	162	shahid	shahid	PROPN
bam-10622	2	163	beheshti	beheshti	VERB
bam-10622	2	164	university	university	NOUN
bam-10622	2	165	of	of	ADP
bam-10622	2	166	medical	medical	ADJ
bam-10622	2	167	science	science	NOUN
bam-10622	2	168	,	,	PUNCT
bam-10622	2	169	tehran	tehran	PROPN
bam-10622	2	170	,	,	PUNCT
bam-10622	2	171	iran	iran	PROPN
bam-10622	2	172	;	;	PUNCT
bam-10622	2	173	(	(	PUNCT
bam-10622	2	174	6	6	X
bam-10622	2	175	)	)	PUNCT
bam-10622	2	176	department	department	NOUN
bam-10622	2	177	of	of	ADP
bam-10622	2	178	anesthesiology	anesthesiology	NOUN
bam-10622	2	179	and	and	CCONJ
bam-10622	2	180	critical	critical	ADJ
bam-10622	2	181	care	care	NOUN
bam-10622	2	182	medicine	medicine	NOUN
bam-10622	2	183	,	,	PUNCT
bam-10622	2	184	school	school	NOUN
bam-10622	2	185	of	of	ADP
bam-10622	2	186	medicine	medicine	NOUN
bam-10622	2	187	,	,	PUNCT
bam-10622	2	188	zahedan	zahedan	PROPN
bam-10622	2	189	university	university	PROPN
bam-10622	2	190	of	of	ADP
bam-10622	2	191	medical	medical	ADJ
bam-10622	2	192	science	science	NOUN
bam-10622	2	193	,	,	PUNCT
bam-10622	2	194	zahedan	zahedan	PROPN
bam-10622	2	195	,	,	PUNCT
bam-10622	2	196	iran	iran	PROPN
bam-10622	2	197	;	;	PUNCT
bam-10622	2	198	(	(	PUNCT
bam-10622	2	199	7	7	X
bam-10622	2	200	)	)	PUNCT
bam-10622	2	201	department	department	NOUN
bam-10622	2	202	of	of	ADP
bam-10622	2	203	infectious	infectious	ADJ
bam-10622	2	204	disease	disease	NOUN
bam-10622	2	205	and	and	CCONJ
bam-10622	2	206	tropical	tropical	ADJ
bam-10622	2	207	medicine	medicine	NOUN
bam-10622	2	208	,	,	PUNCT
bam-10622	2	209	school	school	NOUN
bam-10622	2	210	of	of	ADP
bam-10622	2	211	medicine	medicine	NOUN
bam-10622	2	212	,	,	PUNCT
bam-10622	2	213	zahedan	zahedan	PROPN
bam-10622	2	214	university	university	PROPN
bam-10622	2	215	of	of	ADP
bam-10622	2	216	medical	medical	ADJ
bam-10622	2	217	science	science	NOUN
bam-10622	2	218	,	,	PUNCT
bam-10622	2	219	zahedan	zahedan	PROPN
bam-10622	2	220	,	,	PUNCT
bam-10622	2	221	iran	iran	PROPN
bam-10622	2	222	;	;	PUNCT
bam-10622	2	223	(	(	PUNCT
bam-10622	2	224	8)	8)	NUM
bam-10622	2	225	department	department	NOUN
bam-10622	2	226	of	of	ADP
bam-10622	2	227	infectious	infectious	ADJ
bam-10622	2	228	disease	disease	NOUN
bam-10622	2	229	and	and	CCONJ
bam-10622	2	230	tropical	tropical	ADJ
bam-10622	2	231	medicine	medicine	NOUN
bam-10622	2	232	,	,	PUNCT
bam-10622	2	233	imam	imam	PROPN
bam-10622	2	234	khomeini	khomeini	PROPN
bam-10622	2	235	hospital	hospital	PROPN
bam-10622	2	236	complex	complex	NOUN
bam-10622	2	237	,	,	PUNCT
bam-10622	2	238	tehran	tehran	PROPN
bam-10622	2	239	university	university	PROPN
bam-10622	2	240	of	of	ADP
bam-10622	2	241	medical	medical	ADJ
bam-10622	2	242	science	science	NOUN
bam-10622	2	243	,	,	PUNCT
bam-10622	2	244	tehran	tehran	PROPN
bam-10622	2	245	,	,	PUNCT
bam-10622	2	246	iran	iran	PROPN
bam-10622	2	247	.	.	PUNCT
bam-10622	3	1	this	this	DET
bam-10622	3	2	article	article	NOUN
bam-10622	3	3	is	be	AUX
bam-10622	3	4	distributed	distribute	VERB
bam-10622	3	5	under	under	ADP
bam-10622	3	6	the	the	DET
bam-10622	3	7	terms	term	NOUN
bam-10622	3	8	of	of	ADP
bam-10622	3	9	the	the	DET
bam-10622	3	10	creative	creative	ADJ
bam-10622	3	11	commons	common	NOUN
bam-10622	3	12	attribution	attribution	NOUN
bam-10622	3	13	noncommercial	noncommercial	ADJ
bam-10622	3	14	license	license	NOUN
bam-10622	3	15	(	(	PUNCT
bam-10622	3	16	cc	cc	NOUN
bam-10622	3	17	by	by	ADP
bam-10622	3	18	-	-	PUNCT
bam-10622	3	19	nc	nc	PROPN
bam-10622	3	20	4.0	4.0	NUM
bam-10622	3	21	)	)	PUNCT
bam-10622	3	22	which	which	PRON
bam-10622	3	23	permits	permit	VERB
bam-10622	3	24	any	any	DET
bam-10622	3	25	noncommercial	noncommercial	ADJ
bam-10622	3	26	use	use	NOUN
bam-10622	3	27	,	,	PUNCT
bam-10622	3	28	distribution	distribution	NOUN
bam-10622	3	29	,	,	PUNCT
bam-10622	3	30	and	and	CCONJ
bam-10622	3	31	reproduction	reproduction	NOUN
bam-10622	3	32	in	in	ADP
bam-10622	3	33	any	any	DET
bam-10622	3	34	medium	medium	NOUN
bam-10622	3	35	,	,	PUNCT
bam-10622	3	36	provided	provide	VERB
bam-10622	3	37	the	the	DET
bam-10622	3	38	original	original	ADJ
bam-10622	3	39	author(s	author(s	NOUN
bam-10622	3	40	)	)	PUNCT
bam-10622	3	41	and	and	CCONJ
bam-10622	3	42	source	source	NOUN
bam-10622	3	43	are	be	AUX
bam-10622	3	44	credited	credit	VERB
bam-10622	3	45	.	.	PUNCT
bam-10622	4	1	abstract	abstract	ADJ
bam-10622	4	2	rheumatoid	rheumatoid	VERB
bam-10622	4	3	arthritis	arthritis	NOUN
bam-10622	4	4	(	(	PUNCT
bam-10622	4	5	ra	ra	NOUN
bam-10622	4	6	)	)	PUNCT
bam-10622	4	7	is	be	AUX
bam-10622	4	8	a	a	DET
bam-10622	4	9	multifactorial	multifactorial	ADJ
bam-10622	4	10	disease	disease	NOUN
bam-10622	4	11	affecting	affect	VERB
bam-10622	4	12	the	the	DET
bam-10622	4	13	immune	immune	ADJ
bam-10622	4	14	system	system	NOUN
bam-10622	4	15	and	and	CCONJ
bam-10622	4	16	many	many	ADJ
bam-10622	4	17	tissues	tissue	NOUN
bam-10622	4	18	in	in	ADP
bam-10622	4	19	the	the	DET
bam-10622	4	20	body	body	NOUN
bam-10622	4	21	.	.	PUNCT
bam-10622	5	1	this	this	DET
bam-10622	5	2	study	study	NOUN
bam-10622	5	3	aimed	aim	VERB
bam-10622	5	4	to	to	PART
bam-10622	5	5	evaluate	evaluate	VERB
bam-10622	5	6	the	the	DET
bam-10622	5	7	effect	effect	NOUN
bam-10622	5	8	of	of	ADP
bam-10622	5	9	magnesium	magnesium	NOUN
bam-10622	5	10	supplementation	supplementation	NOUN
bam-10622	5	11	on	on	ADP
bam-10622	5	12	insulin	insulin	NOUN
bam-10622	5	13	resistance	resistance	NOUN
bam-10622	5	14	and	and	CCONJ
bam-10622	5	15	fasting	fast	VERB
bam-10622	5	16	blood	blood	NOUN
bam-10622	5	17	sugar	sugar	NOUN
bam-10622	5	18	(	(	PUNCT
bam-10622	5	19	fbs	fbs	PROPN
bam-10622	5	20	)	)	PUNCT
bam-10622	5	21	of	of	ADP
bam-10622	5	22	patients	patient	NOUN
bam-10622	5	23	with	with	ADP
bam-10622	5	24	ra	ra	PROPN
bam-10622	5	25	.	.	PUNCT
bam-10622	6	1	in	in	ADP
bam-10622	6	2	this	this	DET
bam-10622	6	3	prospective	prospective	ADJ
bam-10622	6	4	uncontrolled	uncontrolled	ADJ
bam-10622	6	5	before	before	ADP
bam-10622	6	6	-	-	PUNCT
bam-10622	6	7	after	after	ADP
bam-10622	6	8	study	study	NOUN
bam-10622	6	9	,	,	PUNCT
bam-10622	6	10	ra	ra	PROPN
bam-10622	6	11	patients	patient	NOUN
bam-10622	6	12	referring	refer	VERB
bam-10622	6	13	to	to	ADP
bam-10622	6	14	rheumatology	rheumatology	NOUN
bam-10622	6	15	clinics	clinic	NOUN
bam-10622	6	16	of	of	ADP
bam-10622	6	17	qom	qom	PROPN
bam-10622	6	18	city	city	PROPN
bam-10622	6	19	from	from	ADP
bam-10622	6	20	january	january	PROPN
bam-10622	6	21	2020	2020	NUM
bam-10622	6	22	to	to	ADP
bam-10622	6	23	january	january	PROPN
bam-10622	6	24	2021	2021	NUM
bam-10622	6	25	were	be	AUX
bam-10622	6	26	evaluated	evaluate	VERB
bam-10622	6	27	.	.	PUNCT
bam-10622	7	1	first	first	ADV
bam-10622	7	2	,	,	PUNCT
bam-10622	7	3	the	the	DET
bam-10622	7	4	patients	patient	NOUN
bam-10622	7	5	received	receive	VERB
bam-10622	7	6	the	the	DET
bam-10622	7	7	routine	routine	ADJ
bam-10622	7	8	rheumatoid	rheumatoid	NOUN
bam-10622	7	9	arthritis	arthritis	NOUN
bam-10622	7	10	treatment	treatment	NOUN
bam-10622	7	11	including	include	VERB
bam-10622	7	12	5	5	NUM
bam-10622	7	13	mg	mg	NOUN
bam-10622	7	14	prednisolone	prednisolone	PROPN
bam-10622	7	15	and	and	CCONJ
bam-10622	7	16	200	200	NUM
bam-10622	7	17	mg	mg	PROPN
bam-10622	7	18	hydroxychloroquine	hydroxychloroquine	PROPN
bam-10622	7	19	daily	daily	ADV
bam-10622	7	20	for	for	ADP
bam-10622	7	21	6	6	NUM
bam-10622	7	22	months	month	NOUN
bam-10622	7	23	and	and	CCONJ
bam-10622	7	24	fbs	fbs	PROPN
bam-10622	7	25	and	and	CCONJ
bam-10622	7	26	insulin	insulin	NOUN
bam-10622	7	27	levels	level	NOUN
bam-10622	7	28	were	be	AUX
bam-10622	7	29	measured	measure	VERB
bam-10622	7	30	after	after	ADP
bam-10622	7	31	.	.	PUNCT
bam-10622	8	1	then	then	ADV
bam-10622	8	2	,	,	PUNCT
bam-10622	8	3	they	they	PRON
bam-10622	8	4	received	receive	VERB
bam-10622	8	5	the	the	DET
bam-10622	8	6	routine	routine	ADJ
bam-10622	8	7	arthritis	arthritis	NOUN
bam-10622	8	8	rheumatoid	rheumatoid	NOUN
bam-10622	8	9	treatment	treatment	NOUN
bam-10622	8	10	in	in	ADP
bam-10622	8	11	addition	addition	NOUN
bam-10622	8	12	to	to	ADP
bam-10622	8	13	300	300	NUM
bam-10622	8	14	mg	mg	NUM
bam-10622	8	15	/	/	SYM
bam-10622	8	16	day	day	NOUN
bam-10622	8	17	oral	oral	ADJ
bam-10622	8	18	magnesium	magnesium	NOUN
bam-10622	8	19	sulfate	sulfate	NOUN
bam-10622	8	20	for	for	ADP
bam-10622	8	21	6	6	NUM
bam-10622	8	22	months	month	NOUN
bam-10622	8	23	and	and	CCONJ
bam-10622	8	24	then	then	ADV
bam-10622	8	25	,	,	PUNCT
bam-10622	8	26	fbs	fbs	PROPN
bam-10622	8	27	and	and	CCONJ
bam-10622	8	28	insulin	insulin	NOUN
bam-10622	8	29	levels	level	NOUN
bam-10622	8	30	were	be	AUX
bam-10622	8	31	measured	measure	VERB
bam-10622	8	32	.	.	PUNCT
bam-10622	9	1	the	the	DET
bam-10622	9	2	homeostasis	homeostasis	NOUN
bam-10622	9	3	model	model	NOUN
bam-10622	9	4	assessment	assessment	NOUN
bam-10622	9	5	of	of	ADP
bam-10622	9	6	insulin	insulin	NOUN
bam-10622	9	7	resistance	resistance	NOUN
bam-10622	9	8	(	(	PUNCT
bam-10622	9	9	homa	homa	NOUN
bam-10622	9	10	-	-	PUNCT
bam-10622	9	11	ir	ir	NOUN
bam-10622	9	12	)	)	PUNCT
bam-10622	9	13	was	be	AUX
bam-10622	9	14	used	use	VERB
bam-10622	9	15	for	for	ADP
bam-10622	9	16	determining	determine	VERB
bam-10622	9	17	insulin	insulin	NOUN
bam-10622	9	18	resistance	resistance	NOUN
bam-10622	9	19	.	.	PUNCT
bam-10622	10	1	thirty	thirty	NUM
bam-10622	10	2	five	five	NUM
bam-10622	10	3	patients	patient	NOUN
bam-10622	10	4	with	with	ADP
bam-10622	10	5	ra	ra	PROPN
bam-10622	10	6	and	and	CCONJ
bam-10622	10	7	the	the	DET
bam-10622	10	8	mean	mean	ADJ
bam-10622	10	9	age	age	NOUN
bam-10622	10	10	of	of	ADP
bam-10622	10	11	49.83±2.58	49.83±2.58	NUM
bam-10622	10	12	years	year	NOUN
bam-10622	10	13	were	be	AUX
bam-10622	10	14	enrolled	enrol	VERB
bam-10622	10	15	.	.	PUNCT
bam-10622	11	1	twenty	twenty	NUM
bam-10622	11	2	eight	eight	NUM
bam-10622	11	3	cases	case	NOUN
bam-10622	11	4	(	(	PUNCT
bam-10622	11	5	80	80	NUM
bam-10622	11	6	%	%	NOUN
bam-10622	11	7	)	)	PUNCT
bam-10622	11	8	were	be	AUX
bam-10622	11	9	female	female	ADJ
bam-10622	11	10	and	and	CCONJ
bam-10622	11	11	7	7	NUM
bam-10622	11	12	cases	case	NOUN
bam-10622	11	13	(	(	PUNCT
bam-10622	11	14	20	20	NUM
bam-10622	11	15	%	%	NOUN
bam-10622	11	16	)	)	PUNCT
bam-10622	11	17	were	be	AUX
bam-10622	11	18	male	male	ADJ
bam-10622	11	19	.	.	PUNCT
bam-10622	12	1	the	the	DET
bam-10622	12	2	mean	mean	ADJ
bam-10622	12	3	homa	homa	NOUN
bam-10622	12	4	-	-	PUNCT
bam-10622	12	5	ir	ir	NOUN
bam-10622	12	6	before	before	ADV
bam-10622	12	7	and	and	CCONJ
bam-10622	12	8	after	after	ADP
bam-10622	12	9	consumption	consumption	NOUN
bam-10622	12	10	of	of	ADP
bam-10622	12	11	oral	oral	ADJ
bam-10622	12	12	magnesium	magnesium	NOUN
bam-10622	12	13	were	be	AUX
bam-10622	12	14	3.04±0.29	3.04±0.29	NOUN
bam-10622	12	15	and	and	CCONJ
bam-10622	12	16	2.43±0.19	2.43±0.19	NUM
bam-10622	12	17	,	,	PUNCT
bam-10622	12	18	respectively	respectively	ADV
bam-10622	12	19	.	.	PUNCT
bam-10622	13	1	statistically	statistically	ADV
bam-10622	13	2	significant	significant	ADJ
bam-10622	13	3	differences	difference	NOUN
bam-10622	13	4	were	be	AUX
bam-10622	13	5	found	find	VERB
bam-10622	13	6	between	between	ADP
bam-10622	13	7	fbs	fbs	PROPN
bam-10622	13	8	,	,	PUNCT
bam-10622	13	9	insulin	insulin	NOUN
bam-10622	13	10	and	and	CCONJ
bam-10622	13	11	homa	homa	NOUN
bam-10622	13	12	-	-	PUNCT
bam-10622	13	13	ir	ir	NOUN
bam-10622	13	14	before	before	ADV
bam-10622	13	15	and	and	CCONJ
bam-10622	13	16	after	after	ADP
bam-10622	13	17	consumption	consumption	NOUN
bam-10622	13	18	of	of	ADP
bam-10622	13	19	oral	oral	ADJ
bam-10622	13	20	magnesium	magnesium	NOUN
bam-10622	13	21	(	(	PUNCT
bam-10622	13	22	p<0.05	p<0.05	NOUN
bam-10622	13	23	)	)	PUNCT
bam-10622	13	24	.	.	PUNCT
bam-10622	14	1	our	our	PRON
bam-10622	14	2	data	datum	NOUN
bam-10622	14	3	suggested	suggest	VERB
bam-10622	14	4	that	that	SCONJ
bam-10622	14	5	magnesium	magnesium	NOUN
bam-10622	14	6	supplementation	supplementation	NOUN
bam-10622	14	7	reduces	reduce	VERB
bam-10622	14	8	fbs	fb	VERB
bam-10622	14	9	,	,	PUNCT
bam-10622	14	10	insulin	insulin	NOUN
bam-10622	14	11	and	and	CCONJ
bam-10622	14	12	homa	homa	NOUN
bam-10622	14	13	-	-	PUNCT
bam-10622	14	14	ir	ir	PROPN
bam-10622	14	15	in	in	ADP
bam-10622	14	16	patients	patient	NOUN
bam-10622	14	17	with	with	ADP
bam-10622	14	18	rheumatoid	rheumatoid	NOUN
bam-10622	14	19	arthritis	arthritis	NOUN
bam-10622	14	20	.	.	PUNCT
bam-10622	15	1	thus	thus	ADV
bam-10622	15	2	,	,	PUNCT
bam-10622	15	3	magnesium	magnesium	NOUN
bam-10622	15	4	supplements	supplement	NOUN
bam-10622	15	5	may	may	AUX
bam-10622	15	6	be	be	AUX
bam-10622	15	7	an	an	DET
bam-10622	15	8	alternative	alternative	ADJ
bam-10622	15	9	method	method	NOUN
bam-10622	15	10	for	for	ADP
bam-10622	15	11	prevention	prevention	NOUN
bam-10622	15	12	of	of	ADP
bam-10622	15	13	type	type	NOUN
bam-10622	15	14	2	2	NUM
bam-10622	15	15	diabetes	diabetes	NOUN
bam-10622	15	16	in	in	ADP
bam-10622	15	17	ra	ra	PROPN
bam-10622	15	18	patients	patient	NOUN
bam-10622	15	19	.	.	PUNCT
bam-10622	16	1	key	key	ADJ
bam-10622	16	2	words	word	NOUN
bam-10622	16	3	:	:	PUNCT
bam-10622	16	4	magnesium	magnesium	NOUN
bam-10622	16	5	;	;	PUNCT
bam-10622	16	6	insulin	insulin	NOUN
bam-10622	16	7	resistance	resistance	NOUN
bam-10622	16	8	;	;	PUNCT
bam-10622	16	9	rheumatoid	rheumatoid	NOUN
bam-10622	16	10	arthritis	arthritis	NOUN
bam-10622	16	11	.	.	PUNCT
bam-10622	17	1	eur	eur	PROPN
bam-10622	17	2	j	j	PROPN
bam-10622	17	3	transl	transl	PROPN
bam-10622	17	4	myol	myol	ADV
bam-10622	17	5	32	32	NUM
bam-10622	17	6	(	(	PUNCT
bam-10622	17	7	3	3	NUM
bam-10622	17	8	):	):	PUNCT
bam-10622	17	9	10622	10622	NUM
bam-10622	17	10	,	,	PUNCT
bam-10622	17	11	2022	2022	NUM
bam-10622	17	12	doi	doi	NOUN
bam-10622	17	13	:	:	PUNCT
bam-10622	17	14	10.4081	10.4081	NUM
bam-10622	17	15	/	/	SYM
bam-10622	17	16	ejtm.2022.10622	ejtm.2022.10622	NOUN
bam-10622	17	17	rheumatoid	rheumatoid	NOUN
bam-10622	17	18	arthritis	arthritis	NOUN
bam-10622	17	19	(	(	PUNCT
bam-10622	17	20	ra	ra	NOUN
bam-10622	17	21	)	)	PUNCT
bam-10622	17	22	is	be	AUX
bam-10622	17	23	a	a	DET
bam-10622	17	24	multifactorial	multifactorial	ADJ
bam-10622	17	25	chronic	chronic	ADJ
bam-10622	17	26	inflammatory	inflammatory	ADJ
bam-10622	17	27	autoimmune	autoimmune	ADJ
bam-10622	17	28	disease	disease	NOUN
bam-10622	17	29	with	with	ADP
bam-10622	17	30	unknown	unknown	ADJ
bam-10622	17	31	etiology	etiology	NOUN
bam-10622	17	32	,	,	PUNCT
bam-10622	17	33	progressing	progress	VERB
bam-10622	17	34	to	to	ADP
bam-10622	17	35	synovial	synovial	ADJ
bam-10622	17	36	inflammation	inflammation	NOUN
bam-10622	17	37	,	,	PUNCT
bam-10622	17	38	pain	pain	NOUN
bam-10622	17	39	and	and	CCONJ
bam-10622	17	40	stiffness	stiffness	NOUN
bam-10622	17	41	of	of	ADP
bam-10622	17	42	numerous	numerous	ADJ
bam-10622	17	43	joints.1	joints.1	NOUN
bam-10622	17	44	no	no	DET
bam-10622	17	45	pathognomonic	pathognomonic	ADJ
bam-10622	17	46	test	test	NOUN
bam-10622	17	47	exists	exist	VERB
bam-10622	17	48	for	for	ADP
bam-10622	17	49	ra	ra	NOUN
bam-10622	17	50	diagnosis	diagnosis	NOUN
bam-10622	17	51	,	,	PUNCT
bam-10622	17	52	but	but	CCONJ
bam-10622	17	53	a	a	DET
bam-10622	17	54	combination	combination	NOUN
bam-10622	17	55	of	of	ADP
bam-10622	17	56	clinical	clinical	ADJ
bam-10622	17	57	,	,	PUNCT
bam-10622	17	58	laboratory	laboratory	NOUN
bam-10622	17	59	and	and	CCONJ
bam-10622	17	60	imaging	imaging	NOUN
bam-10622	17	61	features	feature	NOUN
bam-10622	17	62	is	be	AUX
bam-10622	17	63	helpful	helpful	ADJ
bam-10622	17	64	.	.	PUNCT
bam-10622	18	1	the	the	DET
bam-10622	18	2	annual	annual	ADJ
bam-10622	18	3	incidence	incidence	NOUN
bam-10622	18	4	rate	rate	NOUN
bam-10622	18	5	of	of	ADP
bam-10622	18	6	ra	ra	PROPN
bam-10622	18	7	is	be	AUX
bam-10622	18	8	0.5	0.5	NUM
bam-10622	18	9	-	-	SYM
bam-10622	18	10	1	1	NUM
bam-10622	18	11	%	%	NOUN
bam-10622	18	12	as	as	SCONJ
bam-10622	18	13	it	it	PRON
bam-10622	18	14	is	be	AUX
bam-10622	18	15	the	the	DET
bam-10622	18	16	most	most	ADV
bam-10622	18	17	common	common	ADJ
bam-10622	18	18	chronic	chronic	ADJ
bam-10622	18	19	inflammatory	inflammatory	ADJ
bam-10622	18	20	disease	disease	NOUN
bam-10622	18	21	in	in	ADP
bam-10622	18	22	india	india	PROPN
bam-10622	18	23	with	with	ADP
bam-10622	18	24	prevalence	prevalence	NOUN
bam-10622	18	25	of	of	ADP
bam-10622	18	26	0.75%.2,3	0.75%.2,3	NUM
bam-10622	18	27	its	its	PRON
bam-10622	18	28	prevalence	prevalence	NOUN
bam-10622	18	29	in	in	ADP
bam-10622	18	30	females	female	NOUN
bam-10622	18	31	is	be	AUX
bam-10622	18	32	almost	almost	ADV
bam-10622	18	33	three	three	NUM
bam-10622	18	34	times	time	NOUN
bam-10622	18	35	higher	high	ADJ
bam-10622	18	36	than	than	ADP
bam-10622	18	37	males.4	males.4	PROPN
bam-10622	18	38	several	several	ADJ
bam-10622	18	39	studies	study	NOUN
bam-10622	18	40	have	have	AUX
bam-10622	18	41	shown	show	VERB
bam-10622	18	42	the	the	DET
bam-10622	18	43	association	association	NOUN
bam-10622	18	44	between	between	ADP
bam-10622	18	45	ra	ra	PROPN
bam-10622	18	46	and	and	CCONJ
bam-10622	18	47	cardiovascular	cardiovascular	ADJ
bam-10622	18	48	diseases	disease	NOUN
bam-10622	18	49	and	and	CCONJ
bam-10622	18	50	it	it	PRON
bam-10622	18	51	increases	increase	VERB
bam-10622	18	52	the	the	DET
bam-10622	18	53	risk	risk	NOUN
bam-10622	18	54	of	of	ADP
bam-10622	18	55	cardiovascular	cardiovascular	ADJ
bam-10622	18	56	death	death	NOUN
bam-10622	18	57	up	up	ADP
bam-10622	18	58	to	to	ADP
bam-10622	18	59	50%.5	50%.5	NUM
bam-10622	18	60	recent	recent	ADJ
bam-10622	18	61	studies	study	NOUN
bam-10622	18	62	have	have	AUX
bam-10622	18	63	shown	show	VERB
bam-10622	18	64	that	that	SCONJ
bam-10622	18	65	insulin	insulin	NOUN
bam-10622	18	66	resistance	resistance	NOUN
bam-10622	18	67	(	(	PUNCT
bam-10622	18	68	ir	ir	NOUN
bam-10622	18	69	)	)	PUNCT
bam-10622	18	70	and	and	CCONJ
bam-10622	18	71	type	type	NOUN
bam-10622	18	72	2	2	NUM
bam-10622	18	73	diabetes	diabetes	NOUN
bam-10622	18	74	are	be	AUX
bam-10622	18	75	more	more	ADV
bam-10622	18	76	prevalent	prevalent	ADJ
bam-10622	18	77	in	in	ADP
bam-10622	18	78	ra	ra	PROPN
bam-10622	18	79	patients	patient	NOUN
bam-10622	18	80	than	than	ADP
bam-10622	18	81	normal	normal	ADJ
bam-10622	18	82	population.6	population.6	NOUN
bam-10622	19	1	del	del	PROPN
bam-10622	19	2	rincón	rincón	PROPN
bam-10622	19	3	et	et	PROPN
bam-10622	19	4	al	al	PROPN
bam-10622	19	5	.	.	PROPN
bam-10622	19	6	reported	report	VERB
bam-10622	19	7	a	a	DET
bam-10622	19	8	significant	significant	ADJ
bam-10622	19	9	correlation	correlation	NOUN
bam-10622	19	10	between	between	ADP
bam-10622	19	11	type	type	NOUN
bam-10622	19	12	2	2	NUM
bam-10622	19	13	diabetes	diabetes	NOUN
bam-10622	19	14	and	and	CCONJ
bam-10622	19	15	carotid	carotid	VERB
bam-10622	19	16	atherosclerotic	atherosclerotic	ADJ
bam-10622	19	17	plaque	plaque	NOUN
bam-10622	19	18	in	in	ADP
bam-10622	19	19	ra	ra	PROPN
bam-10622	19	20	magnesium	magnesium	NOUN
bam-10622	19	21	supplementation	supplementation	NOUN
bam-10622	19	22	in	in	ADP
bam-10622	19	23	rheumatoid	rheumatoid	NOUN
bam-10622	19	24	arthritis	arthritis	NOUN
bam-10622	19	25	eur	eur	PROPN
bam-10622	19	26	j	j	PROPN
bam-10622	19	27	transl	transl	PROPN
bam-10622	19	28	myol	myol	ADV
bam-10622	19	29	32	32	NUM
bam-10622	19	30	(	(	PUNCT
bam-10622	19	31	3	3	NUM
bam-10622	19	32	):	):	PUNCT
bam-10622	19	33	10622	10622	NUM
bam-10622	19	34	,	,	PUNCT
bam-10622	19	35	2022	2022	NUM
bam-10622	19	36	doi	doi	NOUN
bam-10622	19	37	:	:	PUNCT
bam-10622	19	38	10.4081	10.4081	NUM
bam-10622	19	39	/	/	SYM
bam-10622	19	40	ejtm.2022.10622	ejtm.2022.10622	NUM
bam-10622	19	41	2	2	NUM
bam-10622	19	42	patients.7	patients.7	VERB
bam-10622	19	43	one	one	NUM
bam-10622	19	44	reason	reason	NOUN
bam-10622	19	45	for	for	ADP
bam-10622	19	46	this	this	DET
bam-10622	19	47	correlation	correlation	NOUN
bam-10622	19	48	is	be	AUX
bam-10622	19	49	high	high	ADJ
bam-10622	19	50	inflammatory	inflammatory	ADJ
bam-10622	19	51	factor	factor	NOUN
bam-10622	19	52	level	level	NOUN
bam-10622	19	53	like	like	ADP
bam-10622	19	54	tumor	tumor	NOUN
bam-10622	19	55	necrosis	necrosis	NOUN
bam-10622	19	56	factor	factor	NOUN
bam-10622	19	57	(	(	PUNCT
bam-10622	19	58	tnf	tnf	PROPN
bam-10622	19	59	)	)	PUNCT
bam-10622	19	60	,	,	PUNCT
bam-10622	19	61	interleukin	interleukin	NOUN
bam-10622	19	62	(	(	PUNCT
bam-10622	19	63	il)-6	il)-6	NUM
bam-10622	19	64	,	,	PUNCT
bam-10622	19	65	il-1	il-1	PUNCT
bam-10622	19	66	and	and	CCONJ
bam-10622	19	67	il-8	il-8	NOUN
bam-10622	19	68	but	but	CCONJ
bam-10622	19	69	the	the	DET
bam-10622	19	70	exact	exact	ADJ
bam-10622	19	71	cause	cause	NOUN
bam-10622	19	72	of	of	ADP
bam-10622	19	73	this	this	DET
bam-10622	19	74	correlation	correlation	NOUN
bam-10622	19	75	is	be	AUX
bam-10622	19	76	unclear.8	unclear.8	ADV
bam-10622	19	77	as	as	SCONJ
bam-10622	19	78	type	type	NOUN
bam-10622	19	79	2	2	NUM
bam-10622	19	80	diabetes	diabetes	NOUN
bam-10622	19	81	is	be	AUX
bam-10622	19	82	a	a	DET
bam-10622	19	83	traditional	traditional	ADJ
bam-10622	19	84	risk	risk	NOUN
bam-10622	19	85	factor	factor	NOUN
bam-10622	19	86	for	for	ADP
bam-10622	19	87	cardiovascular	cardiovascular	ADJ
bam-10622	19	88	diseases	disease	NOUN
bam-10622	19	89	,	,	PUNCT
bam-10622	19	90	prevention	prevention	NOUN
bam-10622	19	91	and	and	CCONJ
bam-10622	19	92	control	control	NOUN
bam-10622	19	93	of	of	ADP
bam-10622	19	94	ir	ir	PROPN
bam-10622	19	95	and	and	CCONJ
bam-10622	19	96	type	type	VERB
bam-10622	19	97	2	2	NUM
bam-10622	19	98	diabetes	diabetes	NOUN
bam-10622	19	99	in	in	ADP
bam-10622	19	100	patient	patient	NOUN
bam-10622	19	101	with	with	ADP
bam-10622	19	102	ra	ra	PROPN
bam-10622	19	103	is	be	AUX
bam-10622	19	104	so	so	ADV
bam-10622	19	105	important.9	important.9	NOUN
bam-10622	19	106	the	the	DET
bam-10622	19	107	overall	overall	ADJ
bam-10622	19	108	mechanism	mechanism	NOUN
bam-10622	19	109	of	of	ADP
bam-10622	19	110	the	the	DET
bam-10622	19	111	insulin	insulin	NOUN
bam-10622	19	112	resistance	resistance	NOUN
bam-10622	19	113	pathogenesis	pathogenesis	NOUN
bam-10622	19	114	is	be	AUX
bam-10622	19	115	still	still	ADV
bam-10622	19	116	unknown	unknown	ADJ
bam-10622	19	117	.	.	PUNCT
bam-10622	20	1	magnesium	magnesium	NOUN
bam-10622	20	2	(	(	PUNCT
bam-10622	20	3	mg	mg	PROPN
bam-10622	20	4	)	)	PUNCT
bam-10622	20	5	,	,	PUNCT
bam-10622	20	6	a	a	DET
bam-10622	20	7	predominant	predominant	ADJ
bam-10622	20	8	intracellular	intracellular	ADJ
bam-10622	20	9	ion	ion	NOUN
bam-10622	20	10	,	,	PUNCT
bam-10622	20	11	is	be	AUX
bam-10622	20	12	a	a	DET
bam-10622	20	13	crucial	crucial	ADJ
bam-10622	20	14	metallic	metallic	ADJ
bam-10622	20	15	co	co	NOUN
bam-10622	20	16	-	-	NOUN
bam-10622	20	17	factor	factor	NOUN
bam-10622	20	18	of	of	ADP
bam-10622	20	19	many	many	ADJ
bam-10622	20	20	enzymatic	enzymatic	ADJ
bam-10622	20	21	reactions	reaction	NOUN
bam-10622	20	22	involved	involve	VERB
bam-10622	20	23	in	in	ADP
bam-10622	20	24	post	post	ADJ
bam-10622	20	25	-	-	ADJ
bam-10622	20	26	receptor	receptor	NOUN
bam-10622	20	27	signaling	signaling	NOUN
bam-10622	20	28	and	and	CCONJ
bam-10622	20	29	is	be	AUX
bam-10622	20	30	critically	critically	ADV
bam-10622	20	31	involved	involve	VERB
bam-10622	20	32	in	in	ADP
bam-10622	20	33	energy	energy	NOUN
bam-10622	20	34	metabolism	metabolism	NOUN
bam-10622	20	35	,	,	PUNCT
bam-10622	20	36	fatty	fatty	NOUN
bam-10622	20	37	acid	acid	NOUN
bam-10622	20	38	synthesis	synthesis	NOUN
bam-10622	20	39	and	and	CCONJ
bam-10622	20	40	glucose	glucose	NOUN
bam-10622	20	41	utilization.9	utilization.9	NOUN
bam-10622	20	42	it	it	PRON
bam-10622	20	43	is	be	AUX
bam-10622	20	44	believed	believe	VERB
bam-10622	20	45	that	that	SCONJ
bam-10622	20	46	its	its	PRON
bam-10622	20	47	deficiency	deficiency	NOUN
bam-10622	20	48	can	can	AUX
bam-10622	20	49	contribute	contribute	VERB
bam-10622	20	50	to	to	ADP
bam-10622	20	51	insulin	insulin	NOUN
bam-10622	20	52	resistance	resistance	NOUN
bam-10622	20	53	and	and	CCONJ
bam-10622	20	54	epidemiological	epidemiological	ADJ
bam-10622	20	55	studies	study	NOUN
bam-10622	20	56	have	have	AUX
bam-10622	20	57	described	describe	VERB
bam-10622	20	58	an	an	DET
bam-10622	20	59	inverse	inverse	NOUN
bam-10622	20	60	association	association	NOUN
bam-10622	20	61	between	between	ADP
bam-10622	20	62	the	the	DET
bam-10622	20	63	intake	intake	ADJ
bam-10622	20	64	levels	level	NOUN
bam-10622	20	65	of	of	ADP
bam-10622	20	66	mg	mg	PROPN
bam-10622	20	67	rich	rich	ADJ
bam-10622	20	68	foods	food	NOUN
bam-10622	20	69	and	and	CCONJ
bam-10622	20	70	ms.10,11	ms.10,11	NOUN
bam-10622	20	71	recent	recent	ADJ
bam-10622	20	72	evidences	evidence	NOUN
bam-10622	20	73	suggest	suggest	VERB
bam-10622	20	74	that	that	SCONJ
bam-10622	20	75	magnesium	magnesium	NOUN
bam-10622	20	76	deficiency	deficiency	NOUN
bam-10622	20	77	plays	play	VERB
bam-10622	20	78	an	an	DET
bam-10622	20	79	important	important	ADJ
bam-10622	20	80	role	role	NOUN
bam-10622	20	81	in	in	ADP
bam-10622	20	82	decreasing	decrease	VERB
bam-10622	20	83	insulin	insulin	NOUN
bam-10622	20	84	resistance	resistance	NOUN
bam-10622	20	85	and	and	CCONJ
bam-10622	20	86	some	some	DET
bam-10622	20	87	others	other	NOUN
bam-10622	20	88	believe	believe	VERB
bam-10622	20	89	that	that	SCONJ
bam-10622	20	90	its	its	PRON
bam-10622	20	91	deficiency	deficiency	NOUN
bam-10622	20	92	is	be	AUX
bam-10622	20	93	associated	associate	VERB
bam-10622	20	94	with	with	ADP
bam-10622	20	95	insulin	insulin	NOUN
bam-10622	20	96	resistance.12	resistance.12	NOUN
bam-10622	20	97	-	-	SYM
bam-10622	20	98	14	14	NUM
bam-10622	20	99	lopez	lopez	NOUN
bam-10622	20	100	-	-	PUNCT
bam-10622	20	101	ridaura	ridaura	NOUN
bam-10622	20	102	et	et	PROPN
bam-10622	20	103	al	al	PROPN
bam-10622	20	104	.	.	PROPN
bam-10622	20	105	showed	show	VERB
bam-10622	20	106	that	that	SCONJ
bam-10622	20	107	magnesium	magnesium	NOUN
bam-10622	20	108	deficiency	deficiency	NOUN
bam-10622	20	109	is	be	AUX
bam-10622	20	110	common	common	ADJ
bam-10622	20	111	in	in	ADP
bam-10622	20	112	patients	patient	NOUN
bam-10622	20	113	with	with	ADP
bam-10622	20	114	diabetes	diabetes	NOUN
bam-10622	20	115	as	as	ADV
bam-10622	20	116	well	well	ADV
bam-10622	20	117	as	as	ADP
bam-10622	20	118	in	in	ADP
bam-10622	20	119	a	a	DET
bam-10622	20	120	cohort	cohort	NOUN
bam-10622	20	121	study	study	NOUN
bam-10622	20	122	has	have	AUX
bam-10622	20	123	shown	show	VERB
bam-10622	20	124	that	that	SCONJ
bam-10622	20	125	the	the	DET
bam-10622	20	126	risk	risk	NOUN
bam-10622	20	127	of	of	ADP
bam-10622	20	128	diabetes	diabetes	NOUN
bam-10622	20	129	in	in	ADP
bam-10622	20	130	people	people	NOUN
bam-10622	20	131	with	with	ADP
bam-10622	20	132	high	high	ADJ
bam-10622	20	133	magnesium	magnesium	NOUN
bam-10622	20	134	levels	level	NOUN
bam-10622	20	135	were	be	AUX
bam-10622	20	136	significantly	significantly	ADV
bam-10622	20	137	lower.15	lower.15	PROPN
bam-10622	20	138	guerreroromero	guerreroromero	PROPN
bam-10622	20	139	et	et	PROPN
bam-10622	20	140	al	al	PROPN
bam-10622	20	141	.	.	PROPN
bam-10622	20	142	reported	report	VERB
bam-10622	20	143	that	that	DET
bam-10622	20	144	oral	oral	ADJ
bam-10622	20	145	magnesium	magnesium	NOUN
bam-10622	20	146	in	in	ADP
bam-10622	20	147	nondiabetic	nondiabetic	ADJ
bam-10622	20	148	patients	patient	NOUN
bam-10622	20	149	with	with	ADP
bam-10622	20	150	low	low	ADJ
bam-10622	20	151	magnesium	magnesium	NOUN
bam-10622	20	152	improves	improve	VERB
bam-10622	20	153	insulin	insulin	NOUN
bam-10622	20	154	sensitivity.16	sensitivity.16	NOUN
bam-10622	20	155	in	in	ADP
bam-10622	20	156	chronic	chronic	ADJ
bam-10622	20	157	inflammatory	inflammatory	ADJ
bam-10622	20	158	diseases	disease	NOUN
bam-10622	20	159	like	like	ADP
bam-10622	20	160	ra	ra	PROPN
bam-10622	20	161	magnesium	magnesium	NOUN
bam-10622	20	162	decreases	decrease	NOUN
bam-10622	20	163	and	and	CCONJ
bam-10622	20	164	its	its	PRON
bam-10622	20	165	reduction	reduction	NOUN
bam-10622	20	166	is	be	AUX
bam-10622	20	167	one	one	NUM
bam-10622	20	168	of	of	ADP
bam-10622	20	169	the	the	DET
bam-10622	20	170	diagnostic	diagnostic	ADJ
bam-10622	20	171	criteria	criterion	NOUN
bam-10622	20	172	for	for	ADP
bam-10622	20	173	of	of	ADP
bam-10622	20	174	ra.17	ra.17	NOUN
bam-10622	20	175	although	although	SCONJ
bam-10622	20	176	there	there	PRON
bam-10622	20	177	is	be	VERB
bam-10622	20	178	evidence	evidence	NOUN
bam-10622	20	179	to	to	PART
bam-10622	20	180	suggest	suggest	VERB
bam-10622	20	181	that	that	SCONJ
bam-10622	20	182	magnesium	magnesium	NOUN
bam-10622	20	183	supplementation	supplementation	NOUN
bam-10622	20	184	may	may	AUX
bam-10622	20	185	help	help	VERB
bam-10622	20	186	improve	improve	VERB
bam-10622	20	187	insulin	insulin	NOUN
bam-10622	20	188	sensitivity	sensitivity	NOUN
bam-10622	20	189	in	in	ADP
bam-10622	20	190	type	type	NOUN
bam-10622	20	191	2	2	NUM
bam-10622	20	192	diabetes	diabetes	NOUN
bam-10622	20	193	patients	patient	NOUN
bam-10622	20	194	and	and	CCONJ
bam-10622	20	195	that	that	SCONJ
bam-10622	20	196	it	it	PRON
bam-10622	20	197	may	may	AUX
bam-10622	20	198	be	be	AUX
bam-10622	20	199	useful	useful	ADJ
bam-10622	20	200	as	as	ADP
bam-10622	20	201	an	an	DET
bam-10622	20	202	adjuvant	adjuvant	ADJ
bam-10622	20	203	therapy	therapy	NOUN
bam-10622	20	204	,	,	PUNCT
bam-10622	20	205	the	the	DET
bam-10622	20	206	benefits	benefit	NOUN
bam-10622	20	207	of	of	ADP
bam-10622	20	208	magnesium	magnesium	NOUN
bam-10622	20	209	supplementation	supplementation	NOUN
bam-10622	20	210	in	in	ADP
bam-10622	20	211	ra	ra	PROPN
bam-10622	20	212	patients	patient	NOUN
bam-10622	20	213	has	have	AUX
bam-10622	20	214	not	not	PART
bam-10622	20	215	yet	yet	ADV
bam-10622	20	216	been	be	AUX
bam-10622	20	217	established	establish	VERB
bam-10622	20	218	.	.	PUNCT
bam-10622	21	1	the	the	DET
bam-10622	21	2	aim	aim	NOUN
bam-10622	21	3	of	of	ADP
bam-10622	21	4	this	this	DET
bam-10622	21	5	study	study	NOUN
bam-10622	21	6	was	be	AUX
bam-10622	21	7	to	to	PART
bam-10622	21	8	evaluate	evaluate	VERB
bam-10622	21	9	the	the	DET
bam-10622	21	10	effect	effect	NOUN
bam-10622	21	11	of	of	ADP
bam-10622	21	12	300	300	NUM
bam-10622	21	13	mg	mg	NUM
bam-10622	21	14	/	/	SYM
bam-10622	21	15	day	day	NOUN
bam-10622	21	16	magnesium	magnesium	NOUN
bam-10622	21	17	supplementation	supplementation	NOUN
bam-10622	21	18	on	on	ADP
bam-10622	21	19	insulin	insulin	NOUN
bam-10622	21	20	resistance	resistance	NOUN
bam-10622	21	21	and	and	CCONJ
bam-10622	21	22	fasting	fast	VERB
bam-10622	21	23	blood	blood	NOUN
bam-10622	21	24	sugar	sugar	NOUN
bam-10622	21	25	(	(	PUNCT
bam-10622	21	26	fbs	fbs	PROPN
bam-10622	21	27	)	)	PUNCT
bam-10622	21	28	of	of	ADP
bam-10622	21	29	patients	patient	NOUN
bam-10622	21	30	with	with	ADP
bam-10622	21	31	rheumatoid	rheumatoid	NOUN
bam-10622	21	32	arthritis	arthritis	NOUN
bam-10622	21	33	.	.	PUNCT
bam-10622	22	1	materials	material	NOUN
bam-10622	22	2	and	and	CCONJ
bam-10622	22	3	methods	method	NOUN
bam-10622	22	4	study	study	NOUN
bam-10622	22	5	participant	participant	NOUN
bam-10622	22	6	in	in	ADP
bam-10622	22	7	this	this	DET
bam-10622	22	8	prospective	prospective	ADJ
bam-10622	22	9	uncontrolled	uncontrolled	ADJ
bam-10622	22	10	before	before	ADP
bam-10622	22	11	-	-	PUNCT
bam-10622	22	12	after	after	ADP
bam-10622	22	13	study	study	NOUN
bam-10622	22	14	,	,	PUNCT
bam-10622	22	15	patients	patient	NOUN
bam-10622	22	16	referring	refer	VERB
bam-10622	22	17	to	to	ADP
bam-10622	22	18	rheumatology	rheumatology	NOUN
bam-10622	22	19	clinics	clinic	NOUN
bam-10622	22	20	of	of	ADP
bam-10622	22	21	qom	qom	PROPN
bam-10622	22	22	city	city	PROPN
bam-10622	22	23	from	from	ADP
bam-10622	22	24	january	january	PROPN
bam-10622	22	25	2020	2020	NUM
bam-10622	22	26	to	to	ADP
bam-10622	22	27	january	january	PROPN
bam-10622	22	28	2021	2021	NUM
bam-10622	22	29	were	be	AUX
bam-10622	22	30	evaluated	evaluate	VERB
bam-10622	22	31	.	.	PUNCT
bam-10622	23	1	the	the	DET
bam-10622	23	2	ra	ra	PROPN
bam-10622	23	3	was	be	AUX
bam-10622	23	4	diagnosed	diagnose	VERB
bam-10622	23	5	according	accord	VERB
bam-10622	23	6	to	to	ADP
bam-10622	23	7	american	american	PROPN
bam-10622	23	8	college	college	PROPN
bam-10622	23	9	of	of	ADP
bam-10622	23	10	rheumatology	rheumatology	NOUN
bam-10622	23	11	’s	’s	PART
bam-10622	23	12	criteria	criterion	NOUN
bam-10622	23	13	which	which	PRON
bam-10622	23	14	was	be	AUX
bam-10622	23	15	revised	revise	VERB
bam-10622	23	16	in	in	ADP
bam-10622	23	17	1978.18	1978.18	NUM
bam-10622	23	18	patients	patient	NOUN
bam-10622	23	19	with	with	ADP
bam-10622	23	20	type	type	NOUN
bam-10622	23	21	2	2	NUM
bam-10622	23	22	diabetes	diabetes	NOUN
bam-10622	23	23	mellitus	mellitus	NOUN
bam-10622	23	24	,	,	PUNCT
bam-10622	23	25	treated	treat	VERB
bam-10622	23	26	with	with	ADP
bam-10622	23	27	prednisolone	prednisolone	PROPN
bam-10622	23	28	at	at	ADP
bam-10622	23	29	a	a	DET
bam-10622	23	30	dose	dose	NOUN
bam-10622	23	31	higher	high	ADJ
bam-10622	23	32	than	than	ADP
bam-10622	23	33	7.5	7.5	NUM
bam-10622	23	34	mg	mg	NUM
bam-10622	23	35	/	/	SYM
bam-10622	23	36	day	day	NOUN
bam-10622	23	37	,	,	PUNCT
bam-10622	23	38	candidate	candidate	NOUN
bam-10622	23	39	for	for	ADP
bam-10622	23	40	drug	drug	NOUN
bam-10622	23	41	therapy	therapy	NOUN
bam-10622	23	42	and	and	CCONJ
bam-10622	23	43	patients	patient	NOUN
bam-10622	23	44	with	with	ADP
bam-10622	23	45	liver	liver	NOUN
bam-10622	23	46	and	and	CCONJ
bam-10622	23	47	kidney	kidney	NOUN
bam-10622	23	48	diseases	disease	NOUN
bam-10622	23	49	,	,	PUNCT
bam-10622	23	50	ischemic	ischemic	ADJ
bam-10622	23	51	heart	heart	NOUN
bam-10622	23	52	failure	failure	NOUN
bam-10622	23	53	,	,	PUNCT
bam-10622	23	54	lupus	lupus	NOUN
bam-10622	23	55	,	,	PUNCT
bam-10622	23	56	and	and	CCONJ
bam-10622	23	57	pregnant	pregnant	ADJ
bam-10622	23	58	women	woman	NOUN
bam-10622	23	59	were	be	AUX
bam-10622	23	60	excluded	exclude	VERB
bam-10622	23	61	from	from	ADP
bam-10622	23	62	the	the	DET
bam-10622	23	63	study	study	NOUN
bam-10622	23	64	.	.	PUNCT
bam-10622	24	1	all	all	DET
bam-10622	24	2	patients	patient	NOUN
bam-10622	24	3	completed	complete	VERB
bam-10622	24	4	a	a	DET
bam-10622	24	5	questionnaire	questionnaire	NOUN
bam-10622	24	6	and	and	CCONJ
bam-10622	24	7	demographic	demographic	ADJ
bam-10622	24	8	characteristics	characteristic	NOUN
bam-10622	24	9	were	be	AUX
bam-10622	24	10	recorded	record	VERB
bam-10622	24	11	.	.	PUNCT
bam-10622	25	1	the	the	DET
bam-10622	25	2	study	study	NOUN
bam-10622	25	3	protocol	protocol	NOUN
bam-10622	25	4	was	be	AUX
bam-10622	25	5	approved	approve	VERB
bam-10622	25	6	by	by	ADP
bam-10622	25	7	medical	medical	ADJ
bam-10622	25	8	ethics	ethic	NOUN
bam-10622	25	9	committee	committee	PROPN
bam-10622	25	10	of	of	ADP
bam-10622	25	11	islamic	islamic	PROPN
bam-10622	25	12	azad	azad	PROPN
bam-10622	25	13	university	university	PROPN
bam-10622	25	14	of	of	ADP
bam-10622	25	15	qom	qom	PROPN
bam-10622	25	16	medical	medical	PROPN
bam-10622	25	17	branch	branch	PROPN
bam-10622	25	18	(	(	PUNCT
bam-10622	25	19	medical	medical	ADJ
bam-10622	25	20	ethics	ethic	NOUN
bam-10622	25	21	committee	committee	PROPN
bam-10622	25	22	approve	approve	VERB
bam-10622	25	23	number	number	NOUN
bam-10622	25	24	:	:	PUNCT
bam-10622	25	25	q78	q78	NUM
bam-10622	25	26	-	-	PUNCT
bam-10622	25	27	18537	18537	NUM
bam-10622	25	28	)	)	PUNCT
bam-10622	25	29	and	and	CCONJ
bam-10622	25	30	it	it	PRON
bam-10622	25	31	was	be	AUX
bam-10622	25	32	performed	perform	VERB
bam-10622	25	33	in	in	ADP
bam-10622	25	34	accordance	accordance	NOUN
bam-10622	25	35	with	with	ADP
bam-10622	25	36	the	the	DET
bam-10622	25	37	principles	principle	NOUN
bam-10622	25	38	of	of	ADP
bam-10622	25	39	the	the	DET
bam-10622	25	40	declaration	declaration	NOUN
bam-10622	25	41	of	of	ADP
bam-10622	25	42	helsinki	helsinki	PROPN
bam-10622	25	43	in	in	ADP
bam-10622	25	44	medical	medical	ADJ
bam-10622	25	45	ethics	ethic	NOUN
bam-10622	25	46	.	.	PUNCT
bam-10622	26	1	also	also	ADV
bam-10622	26	2	,	,	PUNCT
bam-10622	26	3	written	write	VERB
bam-10622	26	4	informed	informed	ADJ
bam-10622	26	5	consent	consent	NOUN
bam-10622	26	6	was	be	AUX
bam-10622	26	7	obtained	obtain	VERB
bam-10622	26	8	from	from	ADP
bam-10622	26	9	all	all	DET
bam-10622	26	10	participants	participant	NOUN
bam-10622	26	11	prior	prior	ADV
bam-10622	26	12	to	to	ADP
bam-10622	26	13	enrollment	enrollment	NOUN
bam-10622	26	14	in	in	ADP
bam-10622	26	15	the	the	DET
bam-10622	26	16	study	study	NOUN
bam-10622	26	17	.	.	PUNCT
bam-10622	27	1	study	study	NOUN
bam-10622	27	2	protocol	protocol	PROPN
bam-10622	27	3	and	and	CCONJ
bam-10622	27	4	measurement	measurement	NOUN
bam-10622	27	5	first	first	ADV
bam-10622	27	6	,	,	PUNCT
bam-10622	27	7	the	the	DET
bam-10622	27	8	patients	patient	NOUN
bam-10622	27	9	received	receive	VERB
bam-10622	27	10	the	the	DET
bam-10622	27	11	routine	routine	ADJ
bam-10622	27	12	rheumatoid	rheumatoid	NOUN
bam-10622	27	13	arthritis	arthritis	NOUN
bam-10622	27	14	treatment	treatment	NOUN
bam-10622	27	15	including	include	VERB
bam-10622	27	16	5	5	NUM
bam-10622	27	17	mg	mg	NOUN
bam-10622	27	18	prednisolone	prednisolone	PROPN
bam-10622	27	19	and	and	CCONJ
bam-10622	27	20	200	200	NUM
bam-10622	27	21	mg	mg	PROPN
bam-10622	27	22	hydroxychloroquine	hydroxychloroquine	PROPN
bam-10622	27	23	daily	daily	ADV
bam-10622	27	24	for	for	ADP
bam-10622	27	25	6	6	NUM
bam-10622	27	26	months	month	NOUN
bam-10622	27	27	and	and	CCONJ
bam-10622	27	28	fbs	fbs	PROPN
bam-10622	27	29	and	and	CCONJ
bam-10622	27	30	insulin	insulin	NOUN
bam-10622	27	31	levels	level	NOUN
bam-10622	27	32	were	be	AUX
bam-10622	27	33	measured	measure	VERB
bam-10622	27	34	after	after	ADP
bam-10622	27	35	12	12	NUM
bam-10622	27	36	hours	hour	NOUN
bam-10622	27	37	overnight	overnight	ADJ
bam-10622	27	38	fasting	fasting	NOUN
bam-10622	27	39	.	.	PUNCT
bam-10622	28	1	then	then	ADV
bam-10622	28	2	,	,	PUNCT
bam-10622	28	3	they	they	PRON
bam-10622	28	4	received	receive	VERB
bam-10622	28	5	the	the	DET
bam-10622	28	6	routine	routine	ADJ
bam-10622	28	7	arthritis	arthritis	NOUN
bam-10622	28	8	rheumatoid	rheumatoid	NOUN
bam-10622	28	9	treatment	treatment	NOUN
bam-10622	28	10	in	in	ADP
bam-10622	28	11	addition	addition	NOUN
bam-10622	28	12	to	to	ADP
bam-10622	28	13	300	300	NUM
bam-10622	28	14	mg	mg	NUM
bam-10622	28	15	/	/	SYM
bam-10622	28	16	day	day	NOUN
bam-10622	28	17	oral	oral	ADJ
bam-10622	28	18	magnesium	magnesium	NOUN
bam-10622	28	19	sulfate	sulfate	NOUN
bam-10622	28	20	capsule	capsule	NOUN
bam-10622	28	21	manufactured	manufacture	VERB
bam-10622	28	22	by	by	ADP
bam-10622	28	23	nature	nature	NOUN
bam-10622	28	24	co	co	PROPN
bam-10622	28	25	,	,	PUNCT
bam-10622	28	26	canada	canada	PROPN
bam-10622	28	27	for	for	ADP
bam-10622	28	28	6	6	NUM
bam-10622	28	29	months	month	NOUN
bam-10622	28	30	and	and	CCONJ
bam-10622	28	31	fbs	fbs	PROPN
bam-10622	28	32	and	and	CCONJ
bam-10622	28	33	insulin	insulin	NOUN
bam-10622	28	34	levels	level	NOUN
bam-10622	28	35	were	be	AUX
bam-10622	28	36	measured	measure	VERB
bam-10622	28	37	after	after	ADP
bam-10622	28	38	12	12	NUM
bam-10622	28	39	hours	hour	NOUN
bam-10622	28	40	overnight	overnight	ADV
bam-10622	28	41	fasting	fasting	NOUN
bam-10622	28	42	and	and	CCONJ
bam-10622	28	43	were	be	AUX
bam-10622	28	44	compared	compare	VERB
bam-10622	28	45	with	with	ADP
bam-10622	28	46	baseline	baseline	ADJ
bam-10622	28	47	indexes	index	NOUN
bam-10622	28	48	.	.	PUNCT
bam-10622	29	1	blood	blood	NOUN
bam-10622	29	2	insulin	insulin	NOUN
bam-10622	29	3	was	be	AUX
bam-10622	29	4	measured	measure	VERB
bam-10622	29	5	by	by	ADP
bam-10622	29	6	elisa	elisa	NOUN
bam-10622	29	7	method	method	NOUN
bam-10622	29	8	.	.	PUNCT
bam-10622	30	1	the	the	DET
bam-10622	30	2	homeostasis	homeostasis	NOUN
bam-10622	30	3	model	model	NOUN
bam-10622	30	4	assessment	assessment	NOUN
bam-10622	30	5	of	of	ADP
bam-10622	30	6	insulin	insulin	NOUN
bam-10622	30	7	resistance	resistance	NOUN
bam-10622	30	8	(	(	PUNCT
bam-10622	30	9	homa	homa	PROPN
bam-10622	30	10	ir	ir	PROPN
bam-10622	30	11	)	)	PUNCT
bam-10622	30	12	was	be	AUX
bam-10622	30	13	used	use	VERB
bam-10622	30	14	for	for	ADP
bam-10622	30	15	determining	determine	VERB
bam-10622	30	16	insulin	insulin	NOUN
bam-10622	30	17	resistance	resistance	NOUN
bam-10622	30	18	.	.	PUNCT
bam-10622	31	1	homa	homa	PROPN
bam-10622	31	2	ir	ir	PROPN
bam-10622	31	3	is	be	AUX
bam-10622	31	4	widely	widely	ADV
bam-10622	31	5	used	use	VERB
bam-10622	31	6	as	as	ADP
bam-10622	31	7	a	a	DET
bam-10622	31	8	noninvasive	noninvasive	ADJ
bam-10622	31	9	surrogate	surrogate	ADJ
bam-10622	31	10	marker	marker	NOUN
bam-10622	31	11	of	of	ADP
bam-10622	31	12	insulin	insulin	NOUN
bam-10622	31	13	resistance	resistance	NOUN
bam-10622	31	14	,	,	PUNCT
bam-10622	31	15	which	which	PRON
bam-10622	31	16	is	be	AUX
bam-10622	31	17	calculated	calculate	VERB
bam-10622	31	18	by	by	ADP
bam-10622	31	19	multiplying	multiply	VERB
bam-10622	31	20	fasting	fast	VERB
bam-10622	31	21	insulin	insulin	NOUN
bam-10622	32	1	[	[	X
bam-10622	32	2	µiu	µiu	ADJ
bam-10622	32	3	/	/	SYM
bam-10622	32	4	ml	ml	NOUN
bam-10622	32	5	]	]	PUNCT
bam-10622	32	6	×	×	NOUN
bam-10622	32	7	fasting	fast	VERB
bam-10622	32	8	glucose	glucose	NOUN
bam-10622	32	9	[	[	X
bam-10622	32	10	mg	mg	NUM
bam-10622	32	11	/	/	SYM
bam-10622	32	12	dl])/405.19	dl])/405.19	NOUN
bam-10622	32	13	,	,	PUNCT
bam-10622	32	14	20	20	NUM
bam-10622	32	15	insulin	insulin	NOUN
bam-10622	32	16	resistance	resistance	NOUN
bam-10622	32	17	was	be	AUX
bam-10622	32	18	considered	consider	VERB
bam-10622	32	19	when	when	SCONJ
bam-10622	32	20	homa	homa	NOUN
bam-10622	32	21	-	-	PUNCT
bam-10622	32	22	ir	ir	PROPN
bam-10622	32	23	was	be	AUX
bam-10622	32	24	higher	high	ADJ
bam-10622	32	25	than	than	ADP
bam-10622	32	26	2.7.21	2.7.21	NUM
bam-10622	32	27	statistical	statistical	ADJ
bam-10622	32	28	analysis	analysis	NOUN
bam-10622	32	29	continuous	continuous	ADJ
bam-10622	32	30	quantitative	quantitative	ADJ
bam-10622	32	31	data	datum	NOUN
bam-10622	32	32	are	be	AUX
bam-10622	32	33	expressed	express	VERB
bam-10622	32	34	as	as	ADP
bam-10622	32	35	mean±standard	mean±standard	NOUN
bam-10622	32	36	deviation	deviation	NOUN
bam-10622	32	37	(	(	PUNCT
bam-10622	32	38	sd	sd	NOUN
bam-10622	32	39	)	)	PUNCT
bam-10622	32	40	.	.	PUNCT
bam-10622	33	1	two	two	NUM
bam-10622	33	2	-	-	PUNCT
bam-10622	33	3	tailed	tail	VERB
bam-10622	33	4	parametric	parametric	ADJ
bam-10622	33	5	tests	test	NOUN
bam-10622	33	6	were	be	AUX
bam-10622	33	7	used	use	VERB
bam-10622	33	8	for	for	ADP
bam-10622	33	9	comparison	comparison	NOUN
bam-10622	33	10	of	of	ADP
bam-10622	33	11	normally	normally	ADV
bam-10622	33	12	distributed	distribute	VERB
bam-10622	33	13	variables	variable	NOUN
bam-10622	33	14	,	,	PUNCT
bam-10622	33	15	and	and	CCONJ
bam-10622	33	16	nonparametric	nonparametric	NOUN
bam-10622	33	17	tests	test	NOUN
bam-10622	33	18	to	to	PART
bam-10622	33	19	compare	compare	VERB
bam-10622	33	20	variables	variable	NOUN
bam-10622	33	21	when	when	SCONJ
bam-10622	33	22	the	the	DET
bam-10622	33	23	assumption	assumption	NOUN
bam-10622	33	24	of	of	ADP
bam-10622	33	25	normal	normal	ADJ
bam-10622	33	26	distribution	distribution	NOUN
bam-10622	33	27	was	be	AUX
bam-10622	33	28	not	not	PART
bam-10622	33	29	met	meet	VERB
bam-10622	33	30	.	.	PUNCT
bam-10622	34	1	student	student	NOUN
bam-10622	34	2	’s	’s	PART
bam-10622	34	3	paired	pair	VERB
bam-10622	34	4	t	t	NOUN
bam-10622	34	5	-	-	PUNCT
bam-10622	34	6	tests	test	NOUN
bam-10622	34	7	or	or	CCONJ
bam-10622	34	8	wilcoxon	wilcoxon	ADJ
bam-10622	34	9	tests	test	NOUN
bam-10622	34	10	were	be	AUX
bam-10622	34	11	performed	perform	VERB
bam-10622	34	12	before	before	ADV
bam-10622	34	13	and	and	CCONJ
bam-10622	34	14	after	after	ADP
bam-10622	34	15	treatment	treatment	NOUN
bam-10622	34	16	for	for	ADP
bam-10622	34	17	comparison	comparison	NOUN
bam-10622	34	18	,	,	PUNCT
bam-10622	34	19	and	and	CCONJ
bam-10622	34	20	independent	independent	ADJ
bam-10622	34	21	t	t	NOUN
bam-10622	34	22	-	-	PUNCT
bam-10622	34	23	tests	test	NOUN
bam-10622	34	24	or	or	CCONJ
bam-10622	34	25	mann	mann	PROPN
bam-10622	34	26	-	-	PUNCT
bam-10622	34	27	whitney	whitney	PROPN
bam-10622	34	28	tests	test	NOUN
bam-10622	34	29	were	be	AUX
bam-10622	34	30	table	table	NOUN
bam-10622	34	31	1	1	NUM
bam-10622	34	32	.	.	PUNCT
bam-10622	34	33	analyzed	analyze	VERB
bam-10622	34	34	parameters	parameter	NOUN
bam-10622	34	35	before	before	ADP
bam-10622	34	36	and	and	CCONJ
bam-10622	34	37	after	after	ADP
bam-10622	34	38	consumption	consumption	NOUN
bam-10622	34	39	of	of	ADP
bam-10622	34	40	oral	oral	ADJ
bam-10622	34	41	magnesium	magnesium	NOUN
bam-10622	34	42	after	after	ADP
bam-10622	34	43	mg	mg	PROPN
bam-10622	34	44	intake	intake	PROPN
bam-10622	34	45	(	(	PUNCT
bam-10622	34	46	n=35	n=35	PROPN
bam-10622	34	47	)	)	PUNCT
bam-10622	34	48	before	before	ADP
bam-10622	34	49	mg	mg	PROPN
bam-10622	34	50	intake	intake	PROPN
bam-10622	34	51	(	(	PUNCT
bam-10622	34	52	n=35	n=35	PROPN
bam-10622	34	53	)	)	PUNCT
bam-10622	34	54	characteristics	characteristic	NOUN
bam-10622	34	55	95.60±1.46	95.60±1.46	NUM
bam-10622	34	56	102.31±2.04	102.31±2.04	NUM
bam-10622	34	57	fbs	fbs	X
bam-10622	34	58	(	(	PUNCT
bam-10622	34	59	mg	mg	PROPN
bam-10622	34	60	/	/	SYM
bam-10622	34	61	dl	dl	PROPN
bam-10622	34	62	)	)	PUNCT
bam-10622	34	63	10.34±0.81	10.34±0.81	PROPN
bam-10622	34	64	11.93±1.10	11.93±1.10	PROPN
bam-10622	34	65	insulin	insulin	NOUN
bam-10622	34	66	(	(	PUNCT
bam-10622	34	67	µiu	µiu	ADJ
bam-10622	34	68	/	/	SYM
bam-10622	34	69	ml	ml	NOUN
bam-10622	34	70	)	)	PUNCT
bam-10622	34	71	2.43±0.19	2.43±0.19	PROPN
bam-10622	34	72	3.04±0.29	3.04±0.29	NOUN
bam-10622	34	73	homa	homa	NOUN
bam-10622	34	74	-	-	PUNCT
bam-10622	34	75	ir	ir	PROPN
bam-10622	34	76	magnesium	magnesium	NOUN
bam-10622	34	77	supplementation	supplementation	NOUN
bam-10622	34	78	in	in	ADP
bam-10622	34	79	rheumatoid	rheumatoid	NOUN
bam-10622	34	80	arthritis	arthritis	NOUN
bam-10622	34	81	eur	eur	PROPN
bam-10622	34	82	j	j	PROPN
bam-10622	34	83	transl	transl	PROPN
bam-10622	34	84	myol	myol	ADV
bam-10622	34	85	32	32	NUM
bam-10622	34	86	(	(	PUNCT
bam-10622	34	87	3	3	NUM
bam-10622	34	88	):	):	PUNCT
bam-10622	34	89	10622	10622	NUM
bam-10622	34	90	,	,	PUNCT
bam-10622	34	91	2022	2022	NUM
bam-10622	34	92	doi	doi	NOUN
bam-10622	34	93	:	:	PUNCT
bam-10622	34	94	10.4081	10.4081	NUM
bam-10622	34	95	/	/	SYM
bam-10622	34	96	ejtm.2022.10622	ejtm.2022.10622	NUM
bam-10622	34	97	3	3	NUM
bam-10622	34	98	used	use	VERB
bam-10622	34	99	for	for	ADP
bam-10622	34	100	non	non	ADJ
bam-10622	34	101	-	-	ADJ
bam-10622	34	102	paired	paired	ADJ
bam-10622	34	103	comparison	comparison	NOUN
bam-10622	34	104	.	.	PUNCT
bam-10622	35	1	in	in	ADP
bam-10622	35	2	addition	addition	NOUN
bam-10622	35	3	,	,	PUNCT
bam-10622	35	4	categorical	categorical	ADJ
bam-10622	35	5	variables	variable	NOUN
bam-10622	35	6	were	be	AUX
bam-10622	35	7	compared	compare	VERB
bam-10622	35	8	by	by	ADP
bam-10622	35	9	chi	chi	ADJ
bam-10622	35	10	-	-	PUNCT
bam-10622	35	11	squared	square	VERB
bam-10622	35	12	or	or	CCONJ
bam-10622	35	13	fisher	fisher	NOUN
bam-10622	35	14	exact	exact	ADJ
bam-10622	35	15	tests	test	NOUN
bam-10622	35	16	.	.	PUNCT
bam-10622	36	1	a	a	DET
bam-10622	36	2	p	p	NOUN
bam-10622	36	3	value	value	NOUN
bam-10622	36	4	less	less	ADJ
bam-10622	36	5	than	than	ADP
bam-10622	36	6	0.05	0.05	NUM
bam-10622	36	7	was	be	AUX
bam-10622	36	8	considered	consider	VERB
bam-10622	36	9	being	be	AUX
bam-10622	36	10	statistically	statistically	ADV
bam-10622	36	11	significant	significant	ADJ
bam-10622	36	12	.	.	PUNCT
bam-10622	37	1	data	datum	NOUN
bam-10622	37	2	analysis	analysis	NOUN
bam-10622	37	3	was	be	AUX
bam-10622	37	4	performed	perform	VERB
bam-10622	37	5	using	use	VERB
bam-10622	37	6	the	the	DET
bam-10622	37	7	“	"	PUNCT
bam-10622	37	8	statistical	statistical	ADJ
bam-10622	37	9	package	package	NOUN
bam-10622	37	10	for	for	ADP
bam-10622	37	11	the	the	DET
bam-10622	37	12	social	social	ADJ
bam-10622	37	13	science	science	NOUN
bam-10622	37	14	”	"	PUNCT
bam-10622	37	15	(	(	PUNCT
bam-10622	37	16	spss	spss	PROPN
bam-10622	37	17	,	,	PUNCT
bam-10622	37	18	inc	inc	PROPN
bam-10622	37	19	.	.	PROPN
bam-10622	37	20	,	,	PUNCT
bam-10622	37	21	chicago	chicago	PROPN
bam-10622	37	22	,	,	PUNCT
bam-10622	37	23	il	il	PROPN
bam-10622	37	24	,	,	PUNCT
bam-10622	37	25	usa	usa	PROPN
bam-10622	37	26	)	)	PUNCT
bam-10622	37	27	version	version	NOUN
bam-10622	37	28	16.0	16.0	NUM
bam-10622	37	29	.	.	PUNCT
bam-10622	38	1	results	result	VERB
bam-10622	38	2	thirty	thirty	NUM
bam-10622	38	3	five	five	NUM
bam-10622	38	4	patients	patient	NOUN
bam-10622	38	5	with	with	ADP
bam-10622	38	6	rheumatoid	rheumatoid	NOUN
bam-10622	38	7	arthritis	arthritis	NOUN
bam-10622	38	8	and	and	CCONJ
bam-10622	38	9	the	the	DET
bam-10622	38	10	mean	mean	ADJ
bam-10622	38	11	age	age	NOUN
bam-10622	38	12	of	of	ADP
bam-10622	38	13	49.83±2.58	49.83±2.58	NUM
bam-10622	38	14	years	year	NOUN
bam-10622	38	15	were	be	AUX
bam-10622	38	16	enrolled	enrol	VERB
bam-10622	38	17	.	.	PUNCT
bam-10622	39	1	twenty	twenty	NUM
bam-10622	39	2	eight	eight	NUM
bam-10622	39	3	cases	case	NOUN
bam-10622	39	4	(	(	PUNCT
bam-10622	39	5	80	80	NUM
bam-10622	39	6	%	%	NOUN
bam-10622	39	7	)	)	PUNCT
bam-10622	39	8	were	be	AUX
bam-10622	39	9	female	female	ADJ
bam-10622	39	10	and	and	CCONJ
bam-10622	39	11	7	7	NUM
bam-10622	39	12	cases	case	NOUN
bam-10622	39	13	(	(	PUNCT
bam-10622	39	14	20	20	NUM
bam-10622	39	15	%	%	NOUN
bam-10622	39	16	)	)	PUNCT
bam-10622	39	17	were	be	AUX
bam-10622	39	18	male	male	ADJ
bam-10622	39	19	.	.	PUNCT
bam-10622	40	1	the	the	DET
bam-10622	40	2	mean	mean	ADJ
bam-10622	40	3	glucose	glucose	NOUN
bam-10622	40	4	,	,	PUNCT
bam-10622	40	5	insulin	insulin	NOUN
bam-10622	40	6	and	and	CCONJ
bam-10622	40	7	insulin	insulin	NOUN
bam-10622	40	8	resistance	resistance	NOUN
bam-10622	40	9	before	before	ADV
bam-10622	40	10	and	and	CCONJ
bam-10622	40	11	after	after	ADP
bam-10622	40	12	oral	oral	ADJ
bam-10622	40	13	magnesium	magnesium	NOUN
bam-10622	40	14	consumption	consumption	NOUN
bam-10622	40	15	are	be	AUX
bam-10622	40	16	shown	show	VERB
bam-10622	40	17	in	in	ADP
bam-10622	40	18	table	table	NOUN
bam-10622	40	19	1	1	NUM
bam-10622	40	20	.	.	PUNCT
bam-10622	41	1	the	the	DET
bam-10622	41	2	mean	mean	ADJ
bam-10622	41	3	homa	homa	NOUN
bam-10622	41	4	-	-	PUNCT
bam-10622	41	5	ir	ir	NOUN
bam-10622	41	6	before	before	ADV
bam-10622	41	7	and	and	CCONJ
bam-10622	41	8	after	after	ADP
bam-10622	41	9	consumption	consumption	NOUN
bam-10622	41	10	of	of	ADP
bam-10622	41	11	oral	oral	ADJ
bam-10622	41	12	magnesium	magnesium	NOUN
bam-10622	41	13	were	be	AUX
bam-10622	41	14	3.04±0.29	3.04±0.29	NOUN
bam-10622	41	15	and	and	CCONJ
bam-10622	41	16	2.43±0.19	2.43±0.19	NUM
bam-10622	41	17	,	,	PUNCT
bam-10622	41	18	respectively	respectively	ADV
bam-10622	41	19	.	.	PUNCT
bam-10622	42	1	before	before	ADP
bam-10622	42	2	consumption	consumption	NOUN
bam-10622	42	3	of	of	ADP
bam-10622	42	4	oral	oral	ADJ
bam-10622	42	5	magnesium	magnesium	NOUN
bam-10622	42	6	,	,	PUNCT
bam-10622	42	7	5.71	5.71	NUM
bam-10622	42	8	%	%	NOUN
bam-10622	42	9	(	(	PUNCT
bam-10622	42	10	2/35	2/35	NUM
bam-10622	42	11	)	)	PUNCT
bam-10622	42	12	of	of	ADP
bam-10622	42	13	the	the	DET
bam-10622	42	14	patients	patient	NOUN
bam-10622	42	15	had	have	VERB
bam-10622	42	16	fbs	fbs	PROPN
bam-10622	42	17	≥126	≥126	NOUN
bam-10622	42	18	mg	mg	PROPN
bam-10622	42	19	/	/	SYM
bam-10622	42	20	dl	dl	PROPN
bam-10622	42	21	and	and	CCONJ
bam-10622	42	22	45.71	45.71	NUM
bam-10622	42	23	%	%	NOUN
bam-10622	42	24	(	(	PUNCT
bam-10622	42	25	16/35	16/35	NUM
bam-10622	42	26	)	)	PUNCT
bam-10622	42	27	had	have	VERB
bam-10622	42	28	fbs	fb	VERB
bam-10622	42	29	≥99	≥99	NUM
bam-10622	42	30	mg	mg	PROPN
bam-10622	42	31	/	/	SYM
bam-10622	42	32	dl	dl	PROPN
bam-10622	42	33	.	.	PUNCT
bam-10622	43	1	but	but	CCONJ
bam-10622	43	2	after	after	ADP
bam-10622	43	3	consumption	consumption	NOUN
bam-10622	43	4	of	of	ADP
bam-10622	43	5	oral	oral	ADJ
bam-10622	43	6	magnesium	magnesium	NOUN
bam-10622	43	7	,	,	PUNCT
bam-10622	43	8	fbs≥	fbs≥	NOUN
bam-10622	43	9	126	126	NUM
bam-10622	43	10	mg	mg	PROPN
bam-10622	43	11	/	/	SYM
bam-10622	43	12	dl	dl	PROPN
bam-10622	43	13	was	be	AUX
bam-10622	43	14	not	not	PART
bam-10622	43	15	detected	detect	VERB
bam-10622	43	16	and	and	CCONJ
bam-10622	43	17	fbs	fb	VERB
bam-10622	43	18	≥99	≥99	NUM
bam-10622	43	19	mg	mg	PROPN
bam-10622	43	20	/	/	SYM
bam-10622	43	21	dl	dl	PROPN
bam-10622	43	22	was	be	AUX
bam-10622	43	23	only	only	ADV
bam-10622	43	24	observed	observe	VERB
bam-10622	43	25	in	in	ADP
bam-10622	43	26	40	40	NUM
bam-10622	43	27	%	%	NOUN
bam-10622	43	28	(	(	PUNCT
bam-10622	43	29	14/35	14/35	NUM
bam-10622	43	30	)	)	PUNCT
bam-10622	43	31	of	of	ADP
bam-10622	43	32	the	the	DET
bam-10622	43	33	patients	patient	NOUN
bam-10622	43	34	.	.	PUNCT
bam-10622	44	1	also	also	ADV
bam-10622	44	2	,	,	PUNCT
bam-10622	44	3	insulin	insulin	NOUN
bam-10622	44	4	resistance	resistance	NOUN
bam-10622	44	5	was	be	AUX
bam-10622	44	6	found	find	VERB
bam-10622	44	7	in	in	ADP
bam-10622	44	8	71.42	71.42	NUM
bam-10622	44	9	%	%	NOUN
bam-10622	44	10	(	(	PUNCT
bam-10622	44	11	25/35	25/35	NUM
bam-10622	44	12	)	)	PUNCT
bam-10622	44	13	of	of	ADP
bam-10622	44	14	the	the	DET
bam-10622	44	15	patients	patient	NOUN
bam-10622	44	16	(	(	PUNCT
bam-10622	44	17	table	table	NOUN
bam-10622	44	18	2	2	NUM
bam-10622	44	19	)	)	PUNCT
bam-10622	44	20	.	.	PUNCT
bam-10622	45	1	statistically	statistically	ADV
bam-10622	45	2	significant	significant	ADJ
bam-10622	45	3	differences	difference	NOUN
bam-10622	45	4	were	be	AUX
bam-10622	45	5	found	find	VERB
bam-10622	45	6	between	between	ADP
bam-10622	45	7	fbs	fbs	PROPN
bam-10622	45	8	,	,	PUNCT
bam-10622	45	9	insulin	insulin	NOUN
bam-10622	45	10	and	and	CCONJ
bam-10622	45	11	homa	homa	NOUN
bam-10622	45	12	-	-	PUNCT
bam-10622	45	13	ir	ir	NOUN
bam-10622	45	14	before	before	ADV
bam-10622	45	15	and	and	CCONJ
bam-10622	45	16	after	after	ADP
bam-10622	45	17	consumption	consumption	NOUN
bam-10622	45	18	of	of	ADP
bam-10622	45	19	oral	oral	ADJ
bam-10622	45	20	magnesium	magnesium	NOUN
bam-10622	45	21	(	(	PUNCT
bam-10622	45	22	p<0.05	p<0.05	NOUN
bam-10622	45	23	)	)	PUNCT
bam-10622	45	24	(	(	PUNCT
bam-10622	45	25	figure	figure	NOUN
bam-10622	45	26	1	1	NUM
bam-10622	45	27	and	and	CCONJ
bam-10622	45	28	figure	figure	VERB
bam-10622	45	29	2	2	NUM
bam-10622	45	30	)	)	PUNCT
bam-10622	45	31	.	.	PUNCT
bam-10622	46	1	comparison	comparison	NOUN
bam-10622	46	2	of	of	ADP
bam-10622	46	3	the	the	DET
bam-10622	46	4	mean	mean	ADJ
bam-10622	46	5	fbs	fbs	ADJ
bam-10622	46	6	,	,	PUNCT
bam-10622	46	7	insulin	insulin	NOUN
bam-10622	46	8	,	,	PUNCT
bam-10622	46	9	and	and	CCONJ
bam-10622	46	10	homa	homa	NOUN
bam-10622	46	11	-	-	PUNCT
bam-10622	46	12	ir	ir	NOUN
bam-10622	46	13	before	before	ADV
bam-10622	46	14	and	and	CCONJ
bam-10622	46	15	after	after	ADP
bam-10622	46	16	consumption	consumption	NOUN
bam-10622	46	17	of	of	ADP
bam-10622	46	18	oral	oral	ADJ
bam-10622	46	19	magnesium	magnesium	NOUN
bam-10622	46	20	with	with	ADP
bam-10622	46	21	%	%	PROPN
bam-10622	46	22	95	95	NUM
bam-10622	46	23	ci	ci	NOUN
bam-10622	46	24	had	have	VERB
bam-10622	46	25	statistically	statistically	ADV
bam-10622	46	26	significant	significant	ADJ
bam-10622	46	27	differences	difference	NOUN
bam-10622	46	28	(	(	PUNCT
bam-10622	46	29	p<0.05	p<0.05	NOUN
bam-10622	46	30	)	)	PUNCT
bam-10622	46	31	.	.	PUNCT
bam-10622	47	1	discussion	discussion	NOUN
bam-10622	47	2	the	the	DET
bam-10622	47	3	present	present	ADJ
bam-10622	47	4	study	study	NOUN
bam-10622	47	5	aimed	aim	VERB
bam-10622	47	6	to	to	PART
bam-10622	47	7	determine	determine	VERB
bam-10622	47	8	the	the	DET
bam-10622	47	9	effect	effect	NOUN
bam-10622	47	10	of	of	ADP
bam-10622	47	11	magnesium	magnesium	NOUN
bam-10622	47	12	supplementation	supplementation	NOUN
bam-10622	47	13	on	on	ADP
bam-10622	47	14	fbs	fbs	PROPN
bam-10622	47	15	,	,	PUNCT
bam-10622	47	16	insulin	insulin	NOUN
bam-10622	47	17	level	level	NOUN
bam-10622	47	18	and	and	CCONJ
bam-10622	47	19	homa	homa	NOUN
bam-10622	47	20	-	-	PUNCT
bam-10622	47	21	ir	ir	PROPN
bam-10622	47	22	in	in	ADP
bam-10622	47	23	ra	ra	PROPN
bam-10622	47	24	patients	patient	NOUN
bam-10622	47	25	.	.	PUNCT
bam-10622	48	1	rheumatoid	rheumatoid	VERB
bam-10622	48	2	arthritis	arthritis	NOUN
bam-10622	48	3	is	be	AUX
bam-10622	48	4	a	a	DET
bam-10622	48	5	systemic	systemic	ADJ
bam-10622	48	6	autoimmune	autoimmune	ADJ
bam-10622	48	7	disease	disease	NOUN
bam-10622	48	8	which	which	PRON
bam-10622	48	9	initially	initially	ADV
bam-10622	48	10	presents	present	VERB
bam-10622	48	11	as	as	ADP
bam-10622	48	12	chronic	chronic	ADJ
bam-10622	48	13	synovial	synovial	ADJ
bam-10622	48	14	inflammation	inflammation	NOUN
bam-10622	48	15	of	of	ADP
bam-10622	48	16	multiple	multiple	ADJ
bam-10622	48	17	joints.1	joints.1	NOUN
bam-10622	48	18	patients	patient	NOUN
bam-10622	48	19	with	with	ADP
bam-10622	48	20	chronic	chronic	ADJ
bam-10622	48	21	inflammatory	inflammatory	ADJ
bam-10622	48	22	diseases	disease	NOUN
bam-10622	48	23	such	such	ADJ
bam-10622	48	24	as	as	ADP
bam-10622	48	25	ra	ra	PROPN
bam-10622	48	26	are	be	AUX
bam-10622	48	27	at	at	ADP
bam-10622	48	28	increased	increase	VERB
bam-10622	48	29	risk	risk	NOUN
bam-10622	48	30	of	of	ADP
bam-10622	48	31	developing	develop	VERB
bam-10622	48	32	type	type	NOUN
bam-10622	48	33	2	2	NUM
bam-10622	48	34	diabetes	diabetes	NOUN
bam-10622	48	35	as	as	ADP
bam-10622	48	36	a	a	DET
bam-10622	48	37	result	result	NOUN
bam-10622	48	38	of	of	ADP
bam-10622	48	39	impaired	impaired	ADJ
bam-10622	48	40	glucose	glucose	NOUN
bam-10622	48	41	metabolism.22	metabolism.22	NOUN
bam-10622	48	42	magnesium	magnesium	NOUN
bam-10622	48	43	is	be	AUX
bam-10622	48	44	an	an	DET
bam-10622	48	45	essential	essential	ADJ
bam-10622	48	46	nutrient	nutrient	NOUN
bam-10622	48	47	and	and	CCONJ
bam-10622	48	48	fourth	fourth	ADJ
bam-10622	48	49	most	most	ADV
bam-10622	48	50	abundant	abundant	ADJ
bam-10622	48	51	mineral	mineral	NOUN
bam-10622	48	52	table	table	NOUN
bam-10622	48	53	2	2	NUM
bam-10622	48	54	.	.	PUNCT
bam-10622	48	55	comparison	comparison	NOUN
bam-10622	48	56	of	of	ADP
bam-10622	48	57	the	the	DET
bam-10622	48	58	means	mean	NOUN
bam-10622	48	59	before	before	ADV
bam-10622	48	60	and	and	CCONJ
bam-10622	48	61	after	after	ADP
bam-10622	48	62	consumption	consumption	NOUN
bam-10622	48	63	of	of	ADP
bam-10622	48	64	oral	oral	ADJ
bam-10622	48	65	magnesium	magnesium	NOUN
bam-10622	48	66	p	p	NOUN
bam-10622	48	67	-	-	PUNCT
bam-10622	48	68	value	value	NOUN
bam-10622	48	69	mean	mean	NOUN
bam-10622	48	70	paired	pair	VERB
bam-10622	48	71	differences	difference	NOUN
bam-10622	48	72	<	<	NOUN
bam-10622	48	73	0.05	0.05	NUM
bam-10622	48	74	6.71±12.18	6.71±12.18	NUM
bam-10622	48	75	(	(	PUNCT
bam-10622	48	76	mg	mg	PROPN
bam-10622	48	77	/	/	SYM
bam-10622	48	78	dl	dl	NOUN
bam-10622	48	79	)	)	PUNCT
bam-10622	48	80	pair	pair	NOUN
bam-10622	48	81	1	1	NUM
bam-10622	48	82	fbs	fb	VERB
bam-10622	48	83	1	1	NUM
bam-10622	48	84	fbs	fb	VERB
bam-10622	48	85	2	2	NUM
bam-10622	48	86	<	<	NOUN
bam-10622	48	87	0.05	0.05	NUM
bam-10622	48	88	1.58±4.52	1.58±4.52	NOUN
bam-10622	48	89	(	(	PUNCT
bam-10622	48	90	mg	mg	PROPN
bam-10622	48	91	/	/	SYM
bam-10622	48	92	dl	dl	NOUN
bam-10622	48	93	)	)	PUNCT
bam-10622	48	94	pair	pair	NOUN
bam-10622	48	95	2	2	NUM
bam-10622	48	96	insulin	insulin	NOUN
bam-10622	48	97	1	1	NUM
bam-10622	48	98	insulin	insulin	NOUN
bam-10622	48	99	2	2	NUM
bam-10622	48	100	<	<	NOUN
bam-10622	48	101	0.05	0.05	NUM
bam-10622	49	1	0.61±1.20	0.61±1.20	NUM
bam-10622	49	2	pair	pair	NOUN
bam-10622	49	3	3	3	NUM
bam-10622	49	4	homa	homa	NOUN
bam-10622	49	5	-	-	PUNCT
bam-10622	49	6	ir	ir	PROPN
bam-10622	49	7	1	1	NUM
bam-10622	49	8	homa	homa	NOUN
bam-10622	49	9	-	-	PUNCT
bam-10622	49	10	ir	ir	PROPN
bam-10622	49	11	2	2	NUM
bam-10622	49	12	fig	fig	NOUN
bam-10622	49	13	1	1	NUM
bam-10622	49	14	.	.	PUNCT
bam-10622	50	1	comparative	comparative	ADJ
bam-10622	50	2	values	value	NOUN
bam-10622	50	3	for	for	ADP
bam-10622	50	4	fbs	fbs	PROPN
bam-10622	50	5	.	.	PUNCT
bam-10622	50	6	magnesium	magnesium	NOUN
bam-10622	50	7	supplementation	supplementation	NOUN
bam-10622	50	8	in	in	ADP
bam-10622	50	9	rheumatoid	rheumatoid	NOUN
bam-10622	50	10	arthritis	arthritis	NOUN
bam-10622	50	11	eur	eur	PROPN
bam-10622	50	12	j	j	PROPN
bam-10622	50	13	transl	transl	PROPN
bam-10622	50	14	myol	myol	ADV
bam-10622	50	15	32	32	NUM
bam-10622	50	16	(	(	PUNCT
bam-10622	50	17	3	3	NUM
bam-10622	50	18	):	):	PUNCT
bam-10622	50	19	10622	10622	NUM
bam-10622	50	20	,	,	PUNCT
bam-10622	50	21	2022	2022	NUM
bam-10622	50	22	doi	doi	NOUN
bam-10622	50	23	:	:	PUNCT
bam-10622	50	24	10.4081	10.4081	NUM
bam-10622	50	25	/	/	SYM
bam-10622	50	26	ejtm.2022.10622	ejtm.2022.10622	NUM
bam-10622	50	27	4	4	NUM
bam-10622	50	28	found	find	VERB
bam-10622	50	29	in	in	ADP
bam-10622	50	30	the	the	DET
bam-10622	50	31	body.17	body.17	NOUN
bam-10622	50	32	it	it	PRON
bam-10622	50	33	plays	play	VERB
bam-10622	50	34	an	an	DET
bam-10622	50	35	important	important	ADJ
bam-10622	50	36	role	role	NOUN
bam-10622	50	37	in	in	ADP
bam-10622	50	38	the	the	DET
bam-10622	50	39	regulation	regulation	NOUN
bam-10622	50	40	of	of	ADP
bam-10622	50	41	glucose	glucose	NOUN
bam-10622	50	42	metabolism	metabolism	NOUN
bam-10622	50	43	as	as	ADP
bam-10622	50	44	a	a	DET
bam-10622	50	45	cofactor	cofactor	NOUN
bam-10622	50	46	in	in	ADP
bam-10622	50	47	enzymatic	enzymatic	ADJ
bam-10622	50	48	reactions	reaction	NOUN
bam-10622	50	49	and	and	CCONJ
bam-10622	50	50	insulin	insulin	NOUN
bam-10622	50	51	activity.9	activity.9	NOUN
bam-10622	50	52	-	-	PUNCT
bam-10622	50	53	11	11	NUM
bam-10622	50	54	its	its	PRON
bam-10622	50	55	levels	level	NOUN
bam-10622	50	56	changes	change	VERB
bam-10622	50	57	in	in	ADP
bam-10622	50	58	chronic	chronic	ADJ
bam-10622	50	59	inflammations	inflammation	NOUN
bam-10622	50	60	and	and	CCONJ
bam-10622	50	61	low	low	ADJ
bam-10622	50	62	mg	mg	NOUN
bam-10622	50	63	level	level	NOUN
bam-10622	50	64	have	have	AUX
bam-10622	50	65	been	be	AUX
bam-10622	50	66	suggested	suggest	VERB
bam-10622	50	67	to	to	PART
bam-10622	50	68	be	be	AUX
bam-10622	50	69	reasonable	reasonable	ADJ
bam-10622	50	70	marker	marker	NOUN
bam-10622	50	71	of	of	ADP
bam-10622	50	72	ra.17	ra.17	NOUN
bam-10622	50	73	in	in	ADP
bam-10622	50	74	this	this	DET
bam-10622	50	75	study	study	NOUN
bam-10622	50	76	,	,	PUNCT
bam-10622	50	77	the	the	DET
bam-10622	50	78	mean	mean	ADJ
bam-10622	50	79	homa	homa	PROPN
bam-10622	50	80	-	-	PUNCT
bam-10622	50	81	ir	ir	PROPN
bam-10622	50	82	reduced	reduce	VERB
bam-10622	50	83	after	after	ADP
bam-10622	50	84	6	6	NUM
bam-10622	50	85	months	month	NOUN
bam-10622	50	86	mg	mg	PROPN
bam-10622	50	87	consumption	consumption	NOUN
bam-10622	50	88	.	.	PUNCT
bam-10622	51	1	hadjistavri	hadjistavri	PROPN
bam-10622	51	2	et	et	PROPN
bam-10622	51	3	al	al	PROPN
bam-10622	51	4	.	.	PROPN
bam-10622	51	5	,	,	PUNCT
bam-10622	51	6	2009	2009	NUM
bam-10622	51	7	suggested	suggest	VERB
bam-10622	51	8	that	that	SCONJ
bam-10622	51	9	using	use	VERB
bam-10622	51	10	a	a	DET
bam-10622	51	11	high	high	ADJ
bam-10622	51	12	dosage	dosage	NOUN
bam-10622	51	13	of	of	ADP
bam-10622	51	14	mg	mg	PROPN
bam-10622	51	15	pidolate	pidolate	NOUN
bam-10622	51	16	(	(	PUNCT
bam-10622	51	17	600	600	NUM
bam-10622	51	18	mg	mg	NUM
bam-10622	51	19	)	)	PUNCT
bam-10622	51	20	,	,	PUNCT
bam-10622	51	21	in	in	ADP
bam-10622	51	22	hypertensive	hypertensive	ADJ
bam-10622	51	23	patient	patient	NOUN
bam-10622	51	24	,	,	PUNCT
bam-10622	51	25	showed	show	VERB
bam-10622	51	26	a	a	DET
bam-10622	51	27	benefic	benefic	ADJ
bam-10622	51	28	effect	effect	NOUN
bam-10622	51	29	in	in	ADP
bam-10622	51	30	insulin	insulin	NOUN
bam-10622	51	31	resistance	resistance	NOUN
bam-10622	51	32	after	after	ADP
bam-10622	51	33	3	3	NUM
bam-10622	51	34	months	month	NOUN
bam-10622	51	35	’	'	PUNCT
bam-10622	51	36	supplementation.23	supplementation.23	NOUN
bam-10622	51	37	the	the	DET
bam-10622	51	38	results	result	NOUN
bam-10622	51	39	of	of	ADP
bam-10622	51	40	cahill	cahill	PROPN
bam-10622	51	41	et	et	PROPN
bam-10622	51	42	al	al	PROPN
bam-10622	51	43	.	.	PROPN
bam-10622	51	44	’s	’s	PART
bam-10622	51	45	study	study	PROPN
bam-10622	51	46	indicated	indicate	VERB
bam-10622	51	47	that	that	SCONJ
bam-10622	51	48	higher	high	ADJ
bam-10622	51	49	dietary	dietary	ADJ
bam-10622	51	50	magnesium	magnesium	NOUN
bam-10622	51	51	intake	intake	NOUN
bam-10622	51	52	is	be	AUX
bam-10622	51	53	strongly	strongly	ADV
bam-10622	51	54	associated	associate	VERB
bam-10622	51	55	with	with	ADP
bam-10622	51	56	the	the	DET
bam-10622	51	57	attenuation	attenuation	NOUN
bam-10622	51	58	of	of	ADP
bam-10622	51	59	insulin	insulin	NOUN
bam-10622	51	60	resistance	resistance	NOUN
bam-10622	51	61	.	.	PUNCT
bam-10622	52	1	they	they	PRON
bam-10622	52	2	also	also	ADV
bam-10622	52	3	found	find	VERB
bam-10622	52	4	a	a	DET
bam-10622	52	5	strong	strong	ADJ
bam-10622	52	6	inverse	inverse	NOUN
bam-10622	52	7	association	association	NOUN
bam-10622	52	8	between	between	ADP
bam-10622	52	9	dietary	dietary	ADJ
bam-10622	52	10	magnesium	magnesium	NOUN
bam-10622	52	11	with	with	ADP
bam-10622	52	12	ir.24	ir.24	NOUN
bam-10622	52	13	several	several	ADJ
bam-10622	52	14	studies	study	NOUN
bam-10622	52	15	have	have	AUX
bam-10622	52	16	correlated	correlate	VERB
bam-10622	52	17	low	low	ADJ
bam-10622	52	18	serum	serum	NOUN
bam-10622	52	19	magnesium	magnesium	NOUN
bam-10622	52	20	with	with	ADP
bam-10622	52	21	increased	increase	VERB
bam-10622	52	22	insulin	insulin	NOUN
bam-10622	52	23	resistance.13,14,25	resistance.13,14,25	NOUN
bam-10622	52	24	contrary	contrary	ADJ
bam-10622	52	25	to	to	ADP
bam-10622	52	26	us	we	PRON
bam-10622	52	27	,	,	PUNCT
bam-10622	52	28	in	in	ADP
bam-10622	52	29	a	a	DET
bam-10622	52	30	study	study	NOUN
bam-10622	52	31	by	by	ADP
bam-10622	52	32	lima	lima	PROPN
bam-10622	52	33	de	de	PROPN
bam-10622	52	34	souza	souza	PROPN
bam-10622	52	35	-	-	PUNCT
bam-10622	52	36	silva	silva	PROPN
bam-10622	52	37	mde	mde	PROPN
bam-10622	52	38	et	et	PROPN
bam-10622	52	39	al	al	PROPN
bam-10622	52	40	.	.	PROPN
bam-10622	52	41	,	,	PUNCT
bam-10622	52	42	2014	2014	NUM
bam-10622	52	43	showed	show	VERB
bam-10622	52	44	that	that	SCONJ
bam-10622	52	45	12	12	NUM
bam-10622	52	46	weeks	week	NOUN
bam-10622	52	47	of	of	ADP
bam-10622	52	48	taking	take	VERB
bam-10622	52	49	chelated	chelated	ADJ
bam-10622	52	50	mg	mg	NOUN
bam-10622	52	51	(	(	PUNCT
bam-10622	52	52	400	400	NUM
bam-10622	52	53	mg	mg	NOUN
bam-10622	52	54	/	/	SYM
bam-10622	52	55	day	day	NOUN
bam-10622	52	56	)	)	PUNCT
bam-10622	52	57	or	or	CCONJ
bam-10622	52	58	placebo	placebo	NOUN
bam-10622	52	59	,	,	PUNCT
bam-10622	52	60	did	do	AUX
bam-10622	52	61	not	not	PART
bam-10622	52	62	show	show	VERB
bam-10622	52	63	significant	significant	ADJ
bam-10622	52	64	variation	variation	NOUN
bam-10622	52	65	in	in	ADP
bam-10622	52	66	fasting	fast	VERB
bam-10622	52	67	glucose	glucose	NOUN
bam-10622	52	68	,	,	PUNCT
bam-10622	52	69	insulin	insulin	NOUN
bam-10622	52	70	,	,	PUNCT
bam-10622	52	71	and	and	CCONJ
bam-10622	52	72	homa	homa	NOUN
bam-10622	52	73	-	-	PUNCT
bam-10622	52	74	ir.26	ir.26	NOUN
bam-10622	52	75	furthermore	furthermore	ADV
bam-10622	52	76	,	,	PUNCT
bam-10622	52	77	lee	lee	PROPN
bam-10622	52	78	et	et	PROPN
bam-10622	52	79	al	al	PROPN
bam-10622	52	80	.	.	PROPN
bam-10622	52	81	,	,	PUNCT
bam-10622	52	82	2009	2009	NUM
bam-10622	52	83	revealed	reveal	VERB
bam-10622	52	84	that	that	SCONJ
bam-10622	52	85	with	with	ADP
bam-10622	52	86	300	300	NUM
bam-10622	52	87	mg	mg	PROPN
bam-10622	52	88	daily	daily	ADJ
bam-10622	52	89	elemental	elemental	ADJ
bam-10622	52	90	magnesium	magnesium	NOUN
bam-10622	52	91	or	or	CCONJ
bam-10622	52	92	placebo	placebo	NOUN
bam-10622	52	93	for	for	ADP
bam-10622	52	94	12	12	NUM
bam-10622	52	95	weeks	week	NOUN
bam-10622	52	96	,	,	PUNCT
bam-10622	52	97	no	no	DET
bam-10622	52	98	significant	significant	ADJ
bam-10622	52	99	differences	difference	NOUN
bam-10622	52	100	were	be	AUX
bam-10622	52	101	found	find	VERB
bam-10622	52	102	between	between	ADP
bam-10622	52	103	homa	homa	NOUN
bam-10622	52	104	-	-	PUNCT
bam-10622	52	105	ir	ir	PROPN
bam-10622	52	106	in	in	ADP
bam-10622	52	107	intervention	intervention	NOUN
bam-10622	52	108	and	and	CCONJ
bam-10622	52	109	control	control	PROPN
bam-10622	52	110	groups.27	groups.27	PROPN
bam-10622	52	111	magnesium	magnesium	PROPN
bam-10622	52	112	has	have	AUX
bam-10622	52	113	received	receive	VERB
bam-10622	52	114	considerable	considerable	ADJ
bam-10622	52	115	interest	interest	NOUN
bam-10622	52	116	for	for	ADP
bam-10622	52	117	its	its	PRON
bam-10622	52	118	potential	potential	NOUN
bam-10622	52	119	in	in	ADP
bam-10622	52	120	improving	improve	VERB
bam-10622	52	121	insulin	insulin	NOUN
bam-10622	52	122	sensitivity	sensitivity	NOUN
bam-10622	52	123	and	and	CCONJ
bam-10622	52	124	preventing	prevent	VERB
bam-10622	52	125	diabetes.28	diabetes.28	NOUN
bam-10622	52	126	the	the	DET
bam-10622	52	127	association	association	NOUN
bam-10622	52	128	between	between	ADP
bam-10622	52	129	ra	ra	PROPN
bam-10622	52	130	and	and	CCONJ
bam-10622	52	131	diabetes	diabetes	NOUN
bam-10622	52	132	is	be	AUX
bam-10622	52	133	not	not	PART
bam-10622	52	134	straightforward	straightforward	ADJ
bam-10622	52	135	.	.	PUNCT
bam-10622	53	1	patients	patient	NOUN
bam-10622	53	2	with	with	ADP
bam-10622	53	3	rheumatoid	rheumatoid	NOUN
bam-10622	53	4	arthritis	arthritis	NOUN
bam-10622	53	5	tend	tend	VERB
bam-10622	53	6	to	to	PART
bam-10622	53	7	be	be	AUX
bam-10622	53	8	more	more	ADV
bam-10622	53	9	inactive	inactive	ADJ
bam-10622	53	10	because	because	SCONJ
bam-10622	53	11	of	of	ADP
bam-10622	53	12	joint	joint	ADJ
bam-10622	53	13	pain	pain	NOUN
bam-10622	53	14	and	and	CCONJ
bam-10622	53	15	fatigue.29	fatigue.29	NOUN
bam-10622	53	16	in	in	ADP
bam-10622	53	17	addition	addition	NOUN
bam-10622	53	18	,	,	PUNCT
bam-10622	53	19	compared	compare	VERB
bam-10622	53	20	with	with	ADP
bam-10622	53	21	non	non	ADJ
bam-10622	53	22	ra	ra	PROPN
bam-10622	53	23	controls	control	NOUN
bam-10622	53	24	,	,	PUNCT
bam-10622	53	25	rheumatoid	rheumatoid	NOUN
bam-10622	53	26	arthritis	arthritis	NOUN
bam-10622	53	27	patients	patient	NOUN
bam-10622	53	28	tend	tend	VERB
bam-10622	53	29	to	to	PART
bam-10622	53	30	have	have	AUX
bam-10622	53	31	decreased	decrease	VERB
bam-10622	53	32	lean	lean	ADJ
bam-10622	53	33	muscle	muscle	NOUN
bam-10622	53	34	mass	mass	NOUN
bam-10622	53	35	and	and	CCONJ
bam-10622	53	36	central	central	ADJ
bam-10622	53	37	adiposity	adiposity	NOUN
bam-10622	53	38	which	which	PRON
bam-10622	53	39	are	be	AUX
bam-10622	53	40	considered	consider	VERB
bam-10622	53	41	as	as	SCONJ
bam-10622	53	42	diabetes	diabetes	NOUN
bam-10622	53	43	risk	risk	NOUN
bam-10622	53	44	factors.30	factors.30	VERB
bam-10622	53	45	some	some	PRON
bam-10622	53	46	of	of	ADP
bam-10622	53	47	these	these	DET
bam-10622	53	48	differences	difference	NOUN
bam-10622	53	49	may	may	AUX
bam-10622	53	50	result	result	VERB
bam-10622	53	51	from	from	ADP
bam-10622	53	52	differences	difference	NOUN
bam-10622	53	53	in	in	ADP
bam-10622	53	54	the	the	DET
bam-10622	53	55	duration	duration	NOUN
bam-10622	53	56	or	or	CCONJ
bam-10622	53	57	design	design	NOUN
bam-10622	53	58	of	of	ADP
bam-10622	53	59	the	the	DET
bam-10622	53	60	study	study	NOUN
bam-10622	53	61	,	,	PUNCT
bam-10622	53	62	type	type	NOUN
bam-10622	53	63	and	and	CCONJ
bam-10622	53	64	dose	dose	NOUN
bam-10622	53	65	of	of	ADP
bam-10622	53	66	magnesium	magnesium	NOUN
bam-10622	53	67	,	,	PUNCT
bam-10622	53	68	or	or	CCONJ
bam-10622	53	69	ethnic	ethnic	ADJ
bam-10622	53	70	background	background	NOUN
bam-10622	53	71	of	of	ADP
bam-10622	53	72	the	the	DET
bam-10622	53	73	subjects.15,31,32	subjects.15,31,32	PROPN
bam-10622	53	74	mg	mg	PROPN
bam-10622	53	75	is	be	AUX
bam-10622	53	76	essential	essential	ADJ
bam-10622	53	77	for	for	ADP
bam-10622	53	78	the	the	DET
bam-10622	53	79	phosphorilation	phosphorilation	NOUN
bam-10622	53	80	of	of	ADP
bam-10622	53	81	tyrosine	tyrosine	PROPN
bam-10622	53	82	kinase	kinase	PROPN
bam-10622	53	83	on	on	ADP
bam-10622	53	84	the	the	DET
bam-10622	53	85	insulin	insulin	NOUN
bam-10622	53	86	receptor	receptor	NOUN
bam-10622	53	87	,	,	PUNCT
bam-10622	53	88	as	as	ADV
bam-10622	53	89	well	well	ADV
bam-10622	53	90	as	as	ADP
bam-10622	53	91	for	for	ADP
bam-10622	53	92	other	other	ADJ
bam-10622	53	93	protein	protein	NOUN
bam-10622	53	94	kinases	kinase	NOUN
bam-10622	53	95	involved	involve	VERB
bam-10622	53	96	in	in	ADP
bam-10622	53	97	post	post	ADJ
bam-10622	53	98	-	-	ADJ
bam-10622	53	99	receptor	receptor	ADJ
bam-10622	53	100	insulin	insulin	NOUN
bam-10622	53	101	signaling.33	signaling.33	NOUN
bam-10622	53	102	for	for	ADP
bam-10622	53	103	these	these	DET
bam-10622	53	104	reasons	reason	NOUN
bam-10622	53	105	,	,	PUNCT
bam-10622	53	106	mg	mg	PROPN
bam-10622	53	107	replacement	replacement	NOUN
bam-10622	53	108	may	may	AUX
bam-10622	53	109	contribute	contribute	VERB
bam-10622	53	110	to	to	ADP
bam-10622	53	111	reducing	reduce	VERB
bam-10622	53	112	insulin	insulin	NOUN
bam-10622	53	113	levels	level	NOUN
bam-10622	53	114	and	and	CCONJ
bam-10622	53	115	fasting	fast	VERB
bam-10622	53	116	glucose	glucose	NOUN
bam-10622	53	117	levels.26	levels.26	ADJ
bam-10622	53	118	magnesium	magnesium	NOUN
bam-10622	53	119	supplementation	supplementation	NOUN
bam-10622	53	120	is	be	AUX
bam-10622	53	121	considered	consider	VERB
bam-10622	53	122	a	a	DET
bam-10622	53	123	food	food	NOUN
bam-10622	53	124	supplement	supplement	NOUN
bam-10622	53	125	,	,	PUNCT
bam-10622	53	126	not	not	PART
bam-10622	53	127	a	a	DET
bam-10622	53	128	drug	drug	NOUN
bam-10622	53	129	,	,	PUNCT
bam-10622	53	130	and	and	CCONJ
bam-10622	53	131	it	it	PRON
bam-10622	53	132	is	be	AUX
bam-10622	53	133	available	available	ADJ
bam-10622	53	134	in	in	ADP
bam-10622	53	135	many	many	ADJ
bam-10622	53	136	countries	country	NOUN
bam-10622	53	137	.	.	PUNCT
bam-10622	54	1	in	in	ADP
bam-10622	54	2	this	this	DET
bam-10622	54	3	study	study	NOUN
bam-10622	54	4	,	,	PUNCT
bam-10622	54	5	statistically	statistically	ADV
bam-10622	54	6	significant	significant	ADJ
bam-10622	54	7	differences	difference	NOUN
bam-10622	54	8	were	be	AUX
bam-10622	54	9	found	find	VERB
bam-10622	54	10	between	between	ADP
bam-10622	54	11	fbs	fbs	PROPN
bam-10622	54	12	,	,	PUNCT
bam-10622	54	13	insulin	insulin	NOUN
bam-10622	54	14	and	and	CCONJ
bam-10622	54	15	homa	homa	NOUN
bam-10622	54	16	-	-	PUNCT
bam-10622	54	17	ir	ir	NOUN
bam-10622	54	18	before	before	ADV
bam-10622	54	19	and	and	CCONJ
bam-10622	54	20	after	after	ADP
bam-10622	54	21	magnesium	magnesium	NOUN
bam-10622	54	22	supplementation	supplementation	NOUN
bam-10622	54	23	.	.	PUNCT
bam-10622	55	1	a	a	DET
bam-10622	55	2	study	study	NOUN
bam-10622	55	3	by	by	ADP
bam-10622	55	4	guerreroromero	guerreroromero	NOUN
bam-10622	55	5	and	and	CCONJ
bam-10622	55	6	rodriguez	rodriguez	PROPN
bam-10622	55	7	-	-	PUNCT
bam-10622	55	8	moran	moran	PROPN
bam-10622	55	9	(	(	PUNCT
bam-10622	55	10	2005	2005	NUM
bam-10622	55	11	)	)	PUNCT
bam-10622	55	12	reported	report	VERB
bam-10622	55	13	a	a	DET
bam-10622	55	14	beneficial	beneficial	ADJ
bam-10622	55	15	effect	effect	NOUN
bam-10622	55	16	of	of	ADP
bam-10622	55	17	magnesium	magnesium	NOUN
bam-10622	55	18	supplementation	supplementation	NOUN
bam-10622	55	19	on	on	ADP
bam-10622	55	20	fasting	fast	VERB
bam-10622	55	21	and	and	CCONJ
bam-10622	55	22	postprandial	postprandial	ADJ
bam-10622	55	23	glucose	glucose	NOUN
bam-10622	55	24	levels	level	NOUN
bam-10622	55	25	and	and	CCONJ
bam-10622	55	26	insulin	insulin	NOUN
bam-10622	55	27	sensitivity	sensitivity	NOUN
bam-10622	55	28	in	in	ADP
bam-10622	55	29	type	type	NOUN
bam-10622	55	30	2	2	NUM
bam-10622	55	31	diabetics	diabetic	NOUN
bam-10622	55	32	with	with	ADP
bam-10622	55	33	a	a	DET
bam-10622	55	34	low	low	ADJ
bam-10622	55	35	total	total	ADJ
bam-10622	55	36	serum	serum	NOUN
bam-10622	55	37	magnesium	magnesium	NOUN
bam-10622	55	38	level.32	level.32	VERB
bam-10622	55	39	most	most	ADJ
bam-10622	55	40	of	of	ADP
bam-10622	55	41	epidemiologic	epidemiologic	ADJ
bam-10622	55	42	studies	study	NOUN
bam-10622	55	43	have	have	AUX
bam-10622	55	44	shown	show	VERB
bam-10622	55	45	an	an	DET
bam-10622	55	46	inverse	inverse	NOUN
bam-10622	55	47	association	association	NOUN
bam-10622	55	48	between	between	ADP
bam-10622	55	49	magnesium	magnesium	NOUN
bam-10622	55	50	intake	intake	NOUN
bam-10622	55	51	and	and	CCONJ
bam-10622	55	52	fasting	fast	VERB
bam-10622	55	53	insulin	insulin	NOUN
bam-10622	55	54	concentration	concentration	NOUN
bam-10622	55	55	or	or	CCONJ
bam-10622	55	56	the	the	DET
bam-10622	55	57	incidence	incidence	NOUN
bam-10622	55	58	of	of	ADP
bam-10622	55	59	type	type	NOUN
bam-10622	55	60	2	2	NUM
bam-10622	55	61	diabetes.9,15,31	diabetes.9,15,31	NOUN
bam-10622	55	62	in	in	ADP
bam-10622	55	63	this	this	DET
bam-10622	55	64	study	study	NOUN
bam-10622	55	65	we	we	PRON
bam-10622	55	66	were	be	AUX
bam-10622	55	67	not	not	PART
bam-10622	55	68	able	able	ADJ
bam-10622	55	69	to	to	PART
bam-10622	55	70	adjust	adjust	VERB
bam-10622	55	71	for	for	ADP
bam-10622	55	72	significant	significant	ADJ
bam-10622	55	73	risk	risk	NOUN
bam-10622	55	74	factors	factor	NOUN
bam-10622	55	75	associated	associate	VERB
bam-10622	55	76	with	with	ADP
bam-10622	55	77	risk	risk	NOUN
bam-10622	55	78	for	for	ADP
bam-10622	55	79	diabetes	diabetes	NOUN
bam-10622	55	80	.	.	PUNCT
bam-10622	56	1	for	for	ADP
bam-10622	56	2	example	example	NOUN
bam-10622	56	3	,	,	PUNCT
bam-10622	56	4	bmi	bmi	NOUN
bam-10622	56	5	,	,	PUNCT
bam-10622	56	6	age	age	NOUN
bam-10622	56	7	,	,	PUNCT
bam-10622	56	8	family	family	NOUN
bam-10622	56	9	history	history	NOUN
bam-10622	56	10	,	,	PUNCT
bam-10622	56	11	gestational	gestational	ADJ
bam-10622	56	12	diabetes	diabete	NOUN
bam-10622	56	13	and	and	CCONJ
bam-10622	56	14	sedentary	sedentary	ADJ
bam-10622	56	15	lifestyle	lifestyle	NOUN
bam-10622	56	16	were	be	AUX
bam-10622	56	17	not	not	PART
bam-10622	56	18	available	available	ADJ
bam-10622	56	19	in	in	ADP
bam-10622	56	20	this	this	DET
bam-10622	56	21	study	study	NOUN
bam-10622	56	22	.	.	PUNCT
bam-10622	57	1	also	also	ADV
bam-10622	57	2	,	,	PUNCT
bam-10622	57	3	exposure	exposure	NOUN
bam-10622	57	4	to	to	ADP
bam-10622	57	5	corticosteroids	corticosteroid	NOUN
bam-10622	57	6	did	do	AUX
bam-10622	57	7	not	not	PART
bam-10622	57	8	allow	allow	VERB
bam-10622	57	9	for	for	ADP
bam-10622	57	10	adequate	adequate	ADJ
bam-10622	57	11	control	control	NOUN
bam-10622	57	12	of	of	ADP
bam-10622	57	13	the	the	DET
bam-10622	57	14	contribution	contribution	NOUN
bam-10622	57	15	of	of	ADP
bam-10622	57	16	corticosteroids	corticosteroid	NOUN
bam-10622	57	17	to	to	ADP
bam-10622	57	18	development	development	NOUN
bam-10622	57	19	of	of	ADP
bam-10622	57	20	diabetes	diabetes	NOUN
bam-10622	57	21	.	.	PUNCT
bam-10622	58	1	since	since	SCONJ
bam-10622	58	2	magnesium	magnesium	NOUN
bam-10622	58	3	intake	intake	NOUN
bam-10622	58	4	is	be	AUX
bam-10622	58	5	highly	highly	ADV
bam-10622	58	6	associated	associate	VERB
bam-10622	58	7	with	with	ADP
bam-10622	58	8	other	other	ADJ
bam-10622	58	9	healthy	healthy	ADJ
bam-10622	58	10	lifestyle	lifestyle	NOUN
bam-10622	58	11	and	and	CCONJ
bam-10622	58	12	dietary	dietary	ADJ
bam-10622	58	13	factors	factor	NOUN
bam-10622	58	14	,	,	PUNCT
bam-10622	58	15	such	such	ADJ
bam-10622	58	16	as	as	ADP
bam-10622	58	17	cereal	cereal	NOUN
bam-10622	58	18	fiber	fiber	NOUN
bam-10622	58	19	and	and	CCONJ
bam-10622	58	20	calcium	calcium	NOUN
bam-10622	58	21	intakes	intake	NOUN
bam-10622	58	22	,	,	PUNCT
bam-10622	58	23	excluding	exclude	VERB
bam-10622	58	24	the	the	DET
bam-10622	58	25	effect	effect	NOUN
bam-10622	58	26	of	of	ADP
bam-10622	58	27	magnesium	magnesium	NOUN
bam-10622	58	28	intake	intake	NOUN
bam-10622	58	29	on	on	ADP
bam-10622	58	30	diabetes	diabetes	NOUN
bam-10622	58	31	fig	fig	NOUN
bam-10622	58	32	2	2	NUM
bam-10622	58	33	.	.	PUNCT
bam-10622	58	34	comparative	comparative	ADJ
bam-10622	58	35	values	value	NOUN
bam-10622	58	36	for	for	ADP
bam-10622	58	37	homa	homa	NOUN
bam-10622	58	38	-	-	PUNCT
bam-10622	58	39	ir	ir	PROPN
bam-10622	58	40	.	.	PROPN
bam-10622	58	41	magnesium	magnesium	NOUN
bam-10622	58	42	supplementation	supplementation	NOUN
bam-10622	58	43	in	in	ADP
bam-10622	58	44	rheumatoid	rheumatoid	NOUN
bam-10622	58	45	arthritis	arthritis	NOUN
bam-10622	58	46	eur	eur	PROPN
bam-10622	58	47	j	j	PROPN
bam-10622	58	48	transl	transl	PROPN
bam-10622	58	49	myol	myol	ADV
bam-10622	58	50	32	32	NUM
bam-10622	58	51	(	(	PUNCT
bam-10622	58	52	3	3	NUM
bam-10622	58	53	):	):	PUNCT
bam-10622	58	54	10622	10622	NUM
bam-10622	58	55	,	,	PUNCT
bam-10622	58	56	2022	2022	NUM
bam-10622	58	57	doi	doi	NOUN
bam-10622	58	58	:	:	PUNCT
bam-10622	58	59	10.4081	10.4081	NUM
bam-10622	58	60	/	/	SYM
bam-10622	58	61	ejtm.2022.10622	ejtm.2022.10622	NUM
bam-10622	58	62	5	5	NUM
bam-10622	58	63	risk	risk	NOUN
bam-10622	58	64	from	from	ADP
bam-10622	58	65	other	other	ADJ
bam-10622	58	66	factors	factor	NOUN
bam-10622	58	67	are	be	AUX
bam-10622	58	68	difficult	difficult	ADJ
bam-10622	58	69	.	.	PUNCT
bam-10622	59	1	so	so	ADV
bam-10622	59	2	,	,	PUNCT
bam-10622	59	3	the	the	DET
bam-10622	59	4	potential	potential	ADJ
bam-10622	59	5	influences	influence	NOUN
bam-10622	59	6	of	of	ADP
bam-10622	59	7	these	these	DET
bam-10622	59	8	factors	factor	NOUN
bam-10622	59	9	deserve	deserve	VERB
bam-10622	59	10	consideration.34	consideration.34	NOUN
bam-10622	59	11	in	in	ADP
bam-10622	59	12	conclusion	conclusion	NOUN
bam-10622	59	13	,	,	PUNCT
bam-10622	59	14	this	this	DET
bam-10622	59	15	study	study	NOUN
bam-10622	59	16	showed	show	VERB
bam-10622	59	17	that	that	SCONJ
bam-10622	59	18	magnesium	magnesium	NOUN
bam-10622	59	19	supplementation	supplementation	NOUN
bam-10622	59	20	reduces	reduce	VERB
bam-10622	59	21	fbs	fb	VERB
bam-10622	59	22	,	,	PUNCT
bam-10622	59	23	insulin	insulin	NOUN
bam-10622	59	24	and	and	CCONJ
bam-10622	59	25	homa	homa	NOUN
bam-10622	59	26	-	-	PUNCT
bam-10622	59	27	ir	ir	PROPN
bam-10622	59	28	in	in	ADP
bam-10622	59	29	patients	patient	NOUN
bam-10622	59	30	with	with	ADP
bam-10622	59	31	rheumatoid	rheumatoid	NOUN
bam-10622	59	32	arthritis	arthritis	NOUN
bam-10622	59	33	.	.	PUNCT
bam-10622	60	1	thus	thus	ADV
bam-10622	60	2	magnesium	magnesium	NOUN
bam-10622	60	3	supplements	supplement	NOUN
bam-10622	60	4	could	could	AUX
bam-10622	60	5	be	be	AUX
bam-10622	60	6	an	an	DET
bam-10622	60	7	alternative	alternative	ADJ
bam-10622	60	8	method	method	NOUN
bam-10622	60	9	for	for	ADP
bam-10622	60	10	the	the	DET
bam-10622	60	11	prevention	prevention	NOUN
bam-10622	60	12	of	of	ADP
bam-10622	60	13	type	type	NOUN
bam-10622	60	14	2	2	NUM
bam-10622	60	15	diabetes	diabetes	NOUN
bam-10622	60	16	in	in	ADP
bam-10622	60	17	ra	ra	PROPN
bam-10622	60	18	patients	patient	NOUN
bam-10622	60	19	.	.	PUNCT
bam-10622	61	1	list	list	NOUN
bam-10622	61	2	of	of	ADP
bam-10622	61	3	acronyms	acronym	NOUN
bam-10622	61	4	fbs	fb	VERB
bam-10622	61	5	fasting	fast	VERB
bam-10622	61	6	blood	blood	NOUN
bam-10622	61	7	sugar	sugar	NOUN
bam-10622	61	8	homa	homa	PROPN
bam-10622	61	9	-	-	PUNCT
bam-10622	61	10	ir	ir	NOUN
bam-10622	61	11	homeostasis	homeostasis	NOUN
bam-10622	61	12	model	model	NOUN
bam-10622	61	13	assessment	assessment	NOUN
bam-10622	61	14	of	of	ADP
bam-10622	61	15	insulin	insulin	NOUN
bam-10622	61	16	resistance	resistance	NOUN
bam-10622	61	17	il-1	il-1	ADP
bam-10622	61	18	–	–	PUNCT
bam-10622	61	19	interleukin	interleukin	NOUN
bam-10622	61	20	1	1	NUM
bam-10622	61	21	il-6	il-6	NOUN
bam-10622	61	22	–	–	PUNCT
bam-10622	61	23	interleukin	interleukin	NOUN
bam-10622	61	24	6	6	NUM
bam-10622	61	25	il-8	il-8	NOUN
bam-10622	61	26	–	–	PUNCT
bam-10622	61	27	interleukin	interleukin	NOUN
bam-10622	61	28	8	8	NUM
bam-10622	61	29	ir	ir	NOUN
bam-10622	61	30	insulin	insulin	NOUN
bam-10622	61	31	resistance	resistance	NOUN
bam-10622	61	32	ra	ra	PROPN
bam-10622	61	33	rheumatoid	rheumatoid	PROPN
bam-10622	61	34	arthritis	arthritis	PROPN
bam-10622	61	35	tnf	tnf	PROPN
bam-10622	61	36	tumor	tumor	NOUN
bam-10622	61	37	necrosis	necrosis	NOUN
bam-10622	61	38	factor	factor	NOUN
bam-10622	61	39	contributions	contribution	NOUN
bam-10622	61	40	of	of	ADP
bam-10622	61	41	authors	author	NOUN
bam-10622	61	42	all	all	DET
bam-10622	61	43	authors	author	NOUN
bam-10622	61	44	have	have	AUX
bam-10622	61	45	substantially	substantially	ADV
bam-10622	61	46	contributed	contribute	VERB
bam-10622	61	47	to	to	ADP
bam-10622	61	48	the	the	DET
bam-10622	61	49	study	study	NOUN
bam-10622	61	50	and	and	CCONJ
bam-10622	61	51	have	have	AUX
bam-10622	61	52	read	read	VERB
bam-10622	61	53	and	and	CCONJ
bam-10622	61	54	approved	approve	VERB
bam-10622	61	55	the	the	DET
bam-10622	61	56	final	final	ADJ
bam-10622	61	57	edited	edited	ADJ
bam-10622	61	58	paper	paper	NOUN
bam-10622	61	59	.	.	PUNCT
bam-10622	62	1	acknowledgments	acknowledgment	NOUN
bam-10622	62	2	none	none	NOUN
bam-10622	62	3	funding	fund	VERB
bam-10622	62	4	none	none	NOUN
bam-10622	62	5	.	.	PUNCT
bam-10622	63	1	conflict	conflict	NOUN
bam-10622	63	2	of	of	ADP
bam-10622	63	3	interest	interest	NOUN
bam-10622	63	4	the	the	DET
bam-10622	63	5	authors	author	NOUN
bam-10622	63	6	declare	declare	VERB
bam-10622	63	7	no	no	DET
bam-10622	63	8	conflict	conflict	NOUN
bam-10622	63	9	of	of	ADP
bam-10622	63	10	interest	interest	NOUN
bam-10622	63	11	.	.	PUNCT
bam-10622	64	1	ethical	ethical	ADJ
bam-10622	64	2	publication	publication	NOUN
bam-10622	64	3	statements	statement	NOUN
bam-10622	64	4	we	we	PRON
bam-10622	64	5	confirm	confirm	VERB
bam-10622	64	6	that	that	SCONJ
bam-10622	64	7	we	we	PRON
bam-10622	64	8	have	have	AUX
bam-10622	64	9	read	read	VERB
bam-10622	64	10	the	the	DET
bam-10622	64	11	journal	journal	NOUN
bam-10622	64	12	’s	’s	PART
bam-10622	64	13	position	position	NOUN
bam-10622	64	14	on	on	ADP
bam-10622	64	15	issues	issue	NOUN
bam-10622	64	16	involved	involve	VERB
bam-10622	64	17	in	in	ADP
bam-10622	64	18	ethical	ethical	ADJ
bam-10622	64	19	publication	publication	NOUN
bam-10622	64	20	and	and	CCONJ
bam-10622	64	21	affirm	affirm	NOUN
bam-10622	64	22	that	that	SCONJ
bam-10622	64	23	this	this	DET
bam-10622	64	24	report	report	NOUN
bam-10622	64	25	is	be	AUX
bam-10622	64	26	consistent	consistent	ADJ
bam-10622	64	27	with	with	ADP
bam-10622	64	28	those	those	DET
bam-10622	64	29	guidelines	guideline	NOUN
bam-10622	64	30	.	.	PUNCT
bam-10622	65	1	corresponding	correspond	VERB
bam-10622	65	2	author	author	PROPN
bam-10622	65	3	mohammad	mohammad	PROPN
bam-10622	65	4	gharehbeglou	gharehbeglou	PROPN
bam-10622	65	5	,	,	PUNCT
bam-10622	65	6	department	department	NOUN
bam-10622	65	7	of	of	ADP
bam-10622	65	8	anesthesiology	anesthesiology	NOUN
bam-10622	65	9	and	and	CCONJ
bam-10622	65	10	critical	critical	ADJ
bam-10622	65	11	care	care	NOUN
bam-10622	65	12	medicine	medicine	NOUN
bam-10622	65	13	,	,	PUNCT
bam-10622	65	14	school	school	NOUN
bam-10622	65	15	of	of	ADP
bam-10622	65	16	medicine	medicine	NOUN
bam-10622	65	17	,	,	PUNCT
bam-10622	65	18	zahedan	zahedan	PROPN
bam-10622	65	19	university	university	PROPN
bam-10622	65	20	of	of	ADP
bam-10622	65	21	medical	medical	ADJ
bam-10622	65	22	science	science	NOUN
bam-10622	65	23	,	,	PUNCT
bam-10622	65	24	zahedan	zahedan	PROPN
bam-10622	65	25	,	,	PUNCT
bam-10622	65	26	iran	iran	PROPN
bam-10622	65	27	and	and	CCONJ
bam-10622	65	28	department	department	NOUN
bam-10622	65	29	of	of	ADP
bam-10622	65	30	anesthesiology	anesthesiology	NOUN
bam-10622	65	31	and	and	CCONJ
bam-10622	65	32	critical	critical	ADJ
bam-10622	65	33	care	care	NOUN
bam-10622	65	34	medicine	medicine	NOUN
bam-10622	65	35	,	,	PUNCT
bam-10622	65	36	school	school	NOUN
bam-10622	65	37	of	of	ADP
bam-10622	65	38	medicine	medicine	NOUN
bam-10622	65	39	,	,	PUNCT
bam-10622	65	40	shahid	shahid	PROPN
bam-10622	65	41	beheshti	beheshti	VERB
bam-10622	65	42	university	university	NOUN
bam-10622	65	43	of	of	ADP
bam-10622	65	44	medical	medical	ADJ
bam-10622	65	45	science	science	NOUN
bam-10622	65	46	,	,	PUNCT
bam-10622	65	47	tehran	tehran	PROPN
bam-10622	65	48	,	,	PUNCT
bam-10622	65	49	iran	iran	PROPN
bam-10622	65	50	.	.	PUNCT
bam-10622	66	1	orcid	orcid	NOUN
bam-10622	67	1	i	i	PRON
bam-10622	67	2	d	d	NOUN
bam-10622	67	3	:	:	PUNCT
bam-10622	67	4	0000	0000	NUM
bam-10622	67	5	-	-	PUNCT
bam-10622	67	6	0002	0002	NUM
bam-10622	67	7	-	-	PUNCT
bam-10622	67	8	6925	6925	NUM
bam-10622	67	9	-	-	SYM
bam-10622	67	10	7934	7934	NUM
bam-10622	67	11	e	e	NOUN
bam-10622	67	12	-	-	NOUN
bam-10622	67	13	mail	mail	NOUN
bam-10622	67	14	:	:	PUNCT
bam-10622	67	15	m.gharehbeglou@zaums.ac.ir	m.gharehbeglou@zaums.ac.ir	ADJ
bam-10622	67	16	e	e	NOUN
bam-10622	67	17	-	-	NOUN
bam-10622	67	18	mails	mail	NOUN
bam-10622	67	19	and	and	CCONJ
bam-10622	67	20	orcid	orcid	NOUN
bam-10622	68	1	i	i	INTJ
bam-10622	68	2	d	d	PROPN
bam-10622	68	3	of	of	ADP
bam-10622	68	4	co	co	NOUN
bam-10622	68	5	-	-	NOUN
bam-10622	68	6	authors	author	NOUN
bam-10622	68	7	mohsen	mohsen	PROPN
bam-10622	68	8	norouzi	norouzi	PROPN
bam-10622	68	9	:	:	PUNCT
bam-10622	69	1	mohsennovrouzi@gmail.com	mohsennovrouzi@gmail.com	X
bam-10622	69	2	orcid	orcid	NOUN
bam-10622	70	1	i	i	PRON
bam-10622	70	2	d	d	NOUN
bam-10622	70	3	:	:	PUNCT
bam-10622	70	4	0000	0000	NUM
bam-10622	70	5	-	-	PUNCT
bam-10622	70	6	0003	0003	NUM
bam-10622	70	7	-	-	PUNCT
bam-10622	70	8	3066	3066	NUM
bam-10622	70	9	-	-	PUNCT
bam-10622	70	10	218x	218x	NUM
bam-10622	70	11	boshra	boshra	ADJ
bam-10622	70	12	rezvankhah	rezvankhah	NOUN
bam-10622	70	13	:	:	PUNCT
bam-10622	71	1	b.rezvankhah@gmail.com	b.rezvankhah@gmail.com	PROPN
bam-10622	71	2	orcid	orcid	PROPN
bam-10622	72	1	i	i	PRON
bam-10622	72	2	d	d	NOUN
bam-10622	72	3	:	:	PUNCT
bam-10622	72	4	0000	0000	NUM
bam-10622	72	5	-	-	PUNCT
bam-10622	72	6	0002	0002	NUM
bam-10622	72	7	-	-	PUNCT
bam-10622	72	8	9922	9922	NUM
bam-10622	72	9	-	-	SYM
bam-10622	72	10	8966	8966	NUM
bam-10622	72	11	mohammad	mohammad	PROPN
bam-10622	72	12	reza	reza	PROPN
bam-10622	72	13	haeri	haeri	PROPN
bam-10622	72	14	:	:	PUNCT
bam-10622	72	15	haeri.mr@googlemail.com	haeri.mr@googlemail.com	X
bam-10622	72	16	orcid	orcid	PROPN
bam-10622	73	1	i	i	PRON
bam-10622	73	2	d	d	NOUN
bam-10622	73	3	:	:	PUNCT
bam-10622	73	4	0000	0000	NUM
bam-10622	73	5	-	-	PUNCT
bam-10622	73	6	0002	0002	NUM
bam-10622	73	7	-	-	PUNCT
bam-10622	73	8	1584	1584	NUM
bam-10622	73	9	-	-	SYM
bam-10622	73	10	5298	5298	NUM
bam-10622	73	11	hosein	hosein	PROPN
bam-10622	73	12	heydari	heydari	NOUN
bam-10622	73	13	:	:	PUNCT
bam-10622	73	14	hoseinheydari3375@yahoo.com	hoseinheydari3375@yahoo.com	X
bam-10622	74	1	orcid	orcid	NOUN
bam-10622	75	1	i	i	PRON
bam-10622	75	2	d	d	NOUN
bam-10622	75	3	:	:	PUNCT
bam-10622	75	4	0000	0000	NUM
bam-10622	75	5	-	-	PUNCT
bam-10622	75	6	0002	0002	NUM
bam-10622	75	7	-	-	PUNCT
bam-10622	75	8	8627	8627	NUM
bam-10622	75	9	-	-	PUNCT
bam-10622	75	10	9625	9625	NUM
bam-10622	75	11	javad	javad	PROPN
bam-10622	75	12	tafaroji	tafaroji	PROPN
bam-10622	75	13	:	:	PUNCT
bam-10622	75	14	javad883@yahoo.com	javad883@yahoo.com	X
bam-10622	76	1	orcid	orcid	PROPN
bam-10622	77	1	i	i	PRON
bam-10622	77	2	d	d	NOUN
bam-10622	77	3	:	:	PUNCT
bam-10622	77	4	0000	0000	NUM
bam-10622	77	5	-	-	PUNCT
bam-10622	77	6	0003	0003	NUM
bam-10622	77	7	-	-	PUNCT
bam-10622	77	8	0598	0598	NUM
bam-10622	77	9	-	-	SYM
bam-10622	77	10	9949	9949	NUM
bam-10622	77	11	navid	navid	PROPN
bam-10622	77	12	shafigh	shafigh	PROPN
bam-10622	77	13	:	:	PUNCT
bam-10622	78	1	navid_shafigh2005@yahoo.com	navid_shafigh2005@yahoo.com	X
bam-10622	78	2	orcid	orcid	NOUN
bam-10622	79	1	i	i	PRON
bam-10622	79	2	d	d	NOUN
bam-10622	79	3	:	:	PUNCT
bam-10622	79	4	0000	0000	NUM
bam-10622	79	5	-	-	PUNCT
bam-10622	79	6	0002	0002	NUM
bam-10622	79	7	-	-	PUNCT
bam-10622	79	8	1314	1314	NUM
bam-10622	79	9	-	-	PUNCT
bam-10622	79	10	296x	296x	NUM
bam-10622	79	11	jamshid	jamshid	NOUN
bam-10622	79	12	ordoni	ordoni	NOUN
bam-10622	79	13	avval	avval	PROPN
bam-10622	79	14	:	:	PUNCT
bam-10622	79	15	mzaj_ordoni@yahoo.com	mzaj_ordoni@yahoo.com	X
bam-10622	79	16	orcid	orcid	PROPN
bam-10622	80	1	i	i	PRON
bam-10622	80	2	d	d	NOUN
bam-10622	80	3	:	:	PUNCT
bam-10622	80	4	0000	0000	NUM
bam-10622	80	5	-	-	PUNCT
bam-10622	80	6	0003	0003	NUM
bam-10622	80	7	-	-	PUNCT
bam-10622	80	8	4675	4675	NUM
bam-10622	80	9	-	-	PUNCT
bam-10622	80	10	2761	2761	NUM
bam-10622	80	11	alireza	alireza	PROPN
bam-10622	80	12	rahat	rahat	PROPN
bam-10622	80	13	dahmardeh	dahmardeh	PROPN
bam-10622	80	14	:	:	PUNCT
bam-10622	81	1	dr.dahmardeh@gmail.com	dr.dahmardeh@gmail.com	PROPN
bam-10622	81	2	orcid	orcid	PROPN
bam-10622	82	1	i	i	PRON
bam-10622	82	2	d	d	NOUN
bam-10622	82	3	:	:	PUNCT
bam-10622	82	4	0000	0000	NUM
bam-10622	82	5	-	-	PUNCT
bam-10622	82	6	0002	0002	NUM
bam-10622	82	7	-	-	PUNCT
bam-10622	82	8	5705	5705	NUM
bam-10622	82	9	-	-	PUNCT
bam-10622	82	10	6481	6481	NUM
bam-10622	82	11	niyoosha	niyoosha	PROPN
bam-10622	82	12	masoumzadeh	masoumzadeh	NOUN
bam-10622	82	13	:	:	PUNCT
bam-10622	83	1	passerby_62@yahoo.com	passerby_62@yahoo.com	X
bam-10622	83	2	orcid	orcid	NOUN
bam-10622	84	1	i	i	PRON
bam-10622	84	2	d	d	NOUN
bam-10622	84	3	:	:	PUNCT
bam-10622	84	4	0000	0000	NUM
bam-10622	84	5	-	-	PUNCT
bam-10622	84	6	0002	0002	NUM
bam-10622	84	7	-	-	PUNCT
bam-10622	84	8	2222	2222	NUM
bam-10622	84	9	-	-	SYM
bam-10622	84	10	4713	4713	NUM
bam-10622	84	11	references	reference	NOUN
bam-10622	84	12	1	1	NUM
bam-10622	84	13	.	.	PUNCT
bam-10622	85	1	del	del	PROPN
bam-10622	85	2	rincón	rincón	PROPN
bam-10622	85	3	i	i	PROPN
bam-10622	85	4	d	d	PROPN
bam-10622	85	5	,	,	PUNCT
bam-10622	85	6	williams	williams	PROPN
bam-10622	85	7	k	k	PROPN
bam-10622	85	8	,	,	PUNCT
bam-10622	85	9	stern	stern	PROPN
bam-10622	85	10	mp	mp	PROPN
bam-10622	85	11	,	,	PUNCT
bam-10622	85	12	freeman	freeman	PROPN
bam-10622	85	13	gl	gl	PROPN
bam-10622	85	14	,	,	PUNCT
bam-10622	85	15	escalante	escalante	PROPN
bam-10622	85	16	a.	a.	PROPN
bam-10622	85	17	high	high	ADJ
bam-10622	85	18	incidence	incidence	NOUN
bam-10622	85	19	of	of	ADP
bam-10622	85	20	cardiovascular	cardiovascular	ADJ
bam-10622	85	21	events	event	NOUN
bam-10622	85	22	in	in	ADP
bam-10622	85	23	a	a	DET
bam-10622	85	24	rheumatoid	rheumatoid	NOUN
bam-10622	85	25	arthritis	arthritis	NOUN
bam-10622	85	26	cohort	cohort	NOUN
bam-10622	85	27	not	not	PART
bam-10622	85	28	explained	explain	VERB
bam-10622	85	29	by	by	ADP
bam-10622	85	30	traditional	traditional	ADJ
bam-10622	85	31	cardiac	cardiac	ADJ
bam-10622	85	32	risk	risk	NOUN
bam-10622	85	33	factors	factor	NOUN
bam-10622	85	34	.	.	PUNCT
bam-10622	86	1	arthritis	arthritis	NOUN
bam-10622	86	2	rheum	rheum	NOUN
bam-10622	86	3	.	.	PUNCT
bam-10622	87	1	2001	2001	NUM
bam-10622	87	2	dec;44(12):273745	dec;44(12):273745	NOUN
bam-10622	87	3	.	.	PUNCT
bam-10622	88	1	doi	doi	NOUN
bam-10622	88	2	:	:	PUNCT
bam-10622	88	3	10.1002/1529	10.1002/1529	NUM
bam-10622	88	4	-	-	SYM
bam-10622	88	5	0131(200112)44:12	0131(200112)44:12	NUM
bam-10622	88	6	<	<	X
bam-10622	88	7	2737::aid	2737::aid	NUM
bam-10622	88	8	-	-	PUNCT
bam-10622	88	9	art460>3.0.co;2-%23	art460>3.0.co;2-%23	PROPN
bam-10622	88	10	.	.	PUNCT
bam-10622	89	1	2	2	NUM
bam-10622	89	2	.	.	X
bam-10622	89	3	scott	scott	PROPN
bam-10622	89	4	dl	dl	PROPN
bam-10622	89	5	,	,	PUNCT
bam-10622	89	6	wolfe	wolfe	PROPN
bam-10622	89	7	f	f	PROPN
bam-10622	89	8	,	,	PUNCT
bam-10622	89	9	huizinga	huizinga	PROPN
bam-10622	89	10	tw	tw	INTJ
bam-10622	89	11	.	.	PUNCT
bam-10622	90	1	rheumatoid	rheumatoid	VERB
bam-10622	90	2	arthritis	arthritis	NOUN
bam-10622	90	3	.	.	PUNCT
bam-10622	91	1	lancet	lancet	PROPN
bam-10622	91	2	.	.	PUNCT
bam-10622	92	1	2010	2010	NUM
bam-10622	92	2	;	;	PUNCT
bam-10622	92	3	376(9746	376(9746	NUM
bam-10622	92	4	):	):	PUNCT
bam-10622	92	5	1094	1094	NUM
bam-10622	92	6	-	-	SYM
bam-10622	92	7	108doi	108doi	NUM
bam-10622	92	8	:	:	PUNCT
bam-10622	92	9	10.1016	10.1016	NUM
bam-10622	92	10	/	/	SYM
bam-10622	92	11	s0140	s0140	PROPN
bam-10622	92	12	-	-	PUNCT
bam-10622	92	13	6736(10)60826	6736(10)60826	NOUN
bam-10622	92	14	-	-	PUNCT
bam-10622	92	15	4	4	NUM
bam-10622	92	16	.	.	NOUN
bam-10622	93	1	3	3	NUM
bam-10622	93	2	.	.	X
bam-10622	93	3	malaviya	malaviya	PROPN
bam-10622	94	1	an	an	PROPN
bam-10622	94	2	,	,	PUNCT
bam-10622	94	3	kapoor	kapoor	PROPN
bam-10622	94	4	sk	sk	PROPN
bam-10622	94	5	,	,	PUNCT
bam-10622	94	6	singh	singh	PROPN
bam-10622	94	7	rr	rr	PROPN
bam-10622	94	8	,	,	PUNCT
bam-10622	94	9	kumar	kumar	PROPN
bam-10622	94	10	a	a	PROPN
bam-10622	94	11	,	,	PUNCT
bam-10622	94	12	pande	pande	NOUN
bam-10622	94	13	i.	i.	NOUN
bam-10622	94	14	prevalence	prevalence	NOUN
bam-10622	94	15	of	of	ADP
bam-10622	94	16	rheumatoid	rheumatoid	NOUN
bam-10622	94	17	arthritis	arthritis	NOUN
bam-10622	94	18	in	in	ADP
bam-10622	94	19	the	the	DET
bam-10622	94	20	adult	adult	NOUN
bam-10622	94	21	indian	indian	ADJ
bam-10622	94	22	population	population	NOUN
bam-10622	94	23	.	.	PUNCT
bam-10622	95	1	rheumatol	rheumatol	PROPN
bam-10622	95	2	int	int	PROPN
bam-10622	95	3	.	.	PUNCT
bam-10622	96	1	1993	1993	NUM
bam-10622	96	2	;	;	PUNCT
bam-10622	96	3	13(4	13(4	NUM
bam-10622	96	4	):	):	PUNCT
bam-10622	96	5	131	131	NUM
bam-10622	96	6	-	-	SYM
bam-10622	96	7	34	34	NUM
bam-10622	96	8	.	.	PUNCT
bam-10622	97	1	doi	doi	NOUN
bam-10622	97	2	:	:	PUNCT
bam-10622	97	3	10.1007	10.1007	NUM
bam-10622	97	4	/	/	SYM
bam-10622	97	5	bf00301258	bf00301258	NOUN
bam-10622	97	6	.	.	PUNCT
bam-10622	98	1	4	4	X
bam-10622	98	2	.	.	X
bam-10622	98	3	ahlmen	ahlmen	PROPN
bam-10622	98	4	m	m	PROPN
bam-10622	98	5	,	,	PUNCT
bam-10622	98	6	svensson	svensson	PROPN
bam-10622	98	7	b	b	PROPN
bam-10622	98	8	,	,	PUNCT
bam-10622	98	9	albertsson	albertsson	NOUN
bam-10622	98	10	k	k	PROPN
bam-10622	98	11	,	,	PUNCT
bam-10622	98	12	forslind	forslind	PROPN
bam-10622	98	13	k	k	PROPN
bam-10622	98	14	,	,	PUNCT
bam-10622	98	15	hafstrom	hafstrom	PROPN
bam-10622	98	16	i.	i.	PROPN
bam-10622	98	17	influence	influence	NOUN
bam-10622	98	18	of	of	ADP
bam-10622	98	19	gender	gender	NOUN
bam-10622	98	20	on	on	ADP
bam-10622	98	21	assessments	assessment	NOUN
bam-10622	98	22	of	of	ADP
bam-10622	98	23	disease	disease	NOUN
bam-10622	98	24	activity	activity	NOUN
bam-10622	98	25	and	and	CCONJ
bam-10622	98	26	function	function	NOUN
bam-10622	98	27	in	in	ADP
bam-10622	98	28	early	early	ADJ
bam-10622	98	29	rheumatoid	rheumatoid	NOUN
bam-10622	98	30	arthritis	arthritis	NOUN
bam-10622	98	31	in	in	ADP
bam-10622	98	32	relation	relation	NOUN
bam-10622	98	33	to	to	ADP
bam-10622	98	34	radiographic	radiographic	ADJ
bam-10622	98	35	joint	joint	ADJ
bam-10622	98	36	damage	damage	NOUN
bam-10622	98	37	.	.	PUNCT
bam-10622	99	1	ann	ann	PROPN
bam-10622	99	2	rheum	rheum	PROPN
bam-10622	99	3	dis	dis	PROPN
bam-10622	99	4	.	.	PUNCT
bam-10622	100	1	2010	2010	NUM
bam-10622	100	2	;	;	PUNCT
bam-10622	101	1	69(1	69(1	NUM
bam-10622	101	2	):	):	PUNCT
bam-10622	101	3	230	230	NUM
bam-10622	101	4	-	-	SYM
bam-10622	101	5	3	3	NUM
bam-10622	101	6	.	.	PUNCT
bam-10622	101	7	doi	doi	NOUN
bam-10622	101	8	:	:	PUNCT
bam-10622	101	9	10.1136	10.1136	NUM
bam-10622	101	10	/	/	SYM
bam-10622	101	11	ard.2008	ard.2008	NOUN
bam-10622	101	12	.	.	NOUN
bam-10622	101	13	102244	102244	NUM
bam-10622	101	14	.	.	PUNCT
bam-10622	102	1	5	5	NUM
bam-10622	102	2	.	.	X
bam-10622	102	3	aviña	aviña	PROPN
bam-10622	102	4	-	-	PUNCT
bam-10622	102	5	zubieta	zubieta	PROPN
bam-10622	102	6	ja	ja	PROPN
bam-10622	102	7	,	,	PUNCT
bam-10622	102	8	choi	choi	PROPN
bam-10622	102	9	hk	hk	PROPN
bam-10622	102	10	,	,	PUNCT
bam-10622	102	11	sadatsafavi	sadatsafavi	NOUN
bam-10622	102	12	m	m	PROPN
bam-10622	102	13	,	,	PUNCT
bam-10622	102	14	etminan	etminan	PROPN
bam-10622	102	15	m	m	PROPN
bam-10622	102	16	,	,	PUNCT
bam-10622	102	17	esdaile	esdaile	PROPN
bam-10622	102	18	jm	jm	PROPN
bam-10622	102	19	,	,	PUNCT
bam-10622	102	20	lacaille	lacaille	PROPN
bam-10622	102	21	d.	d.	PROPN
bam-10622	102	22	risk	risk	NOUN
bam-10622	102	23	of	of	ADP
bam-10622	102	24	cardiovascular	cardiovascular	ADJ
bam-10622	102	25	mortality	mortality	NOUN
bam-10622	102	26	in	in	ADP
bam-10622	102	27	patients	patient	NOUN
bam-10622	102	28	with	with	ADP
bam-10622	102	29	rheumatoid	rheumatoid	NOUN
bam-10622	102	30	arthritis	arthritis	NOUN
bam-10622	102	31	:	:	PUNCT
bam-10622	102	32	a	a	DET
bam-10622	102	33	meta	meta	ADJ
bam-10622	102	34	-	-	PUNCT
bam-10622	102	35	analysis	analysis	NOUN
bam-10622	102	36	of	of	ADP
bam-10622	102	37	observational	observational	ADJ
bam-10622	102	38	studies	study	NOUN
bam-10622	102	39	.	.	PUNCT
bam-10622	103	1	arthritis	arthritis	NOUN
bam-10622	103	2	rheum	rheum	NOUN
bam-10622	103	3	.	.	PUNCT
bam-10622	104	1	2008	2008	NUM
bam-10622	104	2	dec	dec	PROPN
bam-10622	104	3	15;59(12):1690	15;59(12):1690	NUM
bam-10622	104	4	-	-	SYM
bam-10622	104	5	7	7	NUM
bam-10622	104	6	.	.	PUNCT
bam-10622	104	7	doi	doi	NOUN
bam-10622	104	8	:	:	PUNCT
bam-10622	104	9	10.1002	10.1002	NUM
bam-10622	104	10	/	/	SYM
bam-10622	104	11	art.24092	art.24092	NOUN
bam-10622	104	12	.	.	PUNCT
bam-10622	105	1	6	6	X
bam-10622	105	2	.	.	X
bam-10622	105	3	solomon	solomon	PROPN
bam-10622	105	4	dh	dh	PROPN
bam-10622	105	5	,	,	PUNCT
bam-10622	105	6	love	love	NOUN
bam-10622	105	7	tj	tj	NOUN
bam-10622	105	8	,	,	PUNCT
bam-10622	105	9	canning	can	VERB
bam-10622	105	10	c	c	NOUN
bam-10622	105	11	,	,	PUNCT
bam-10622	105	12	schneeweiss	schneeweiss	PROPN
bam-10622	105	13	s	s	PART
bam-10622	105	14	:	:	PUNCT
bam-10622	105	15	risk	risk	NOUN
bam-10622	105	16	of	of	ADP
bam-10622	105	17	diabetes	diabetes	NOUN
bam-10622	105	18	among	among	ADP
bam-10622	105	19	patients	patient	NOUN
bam-10622	105	20	with	with	ADP
bam-10622	105	21	rheumatoid	rheumatoid	NOUN
bam-10622	105	22	arthritis	arthritis	NOUN
bam-10622	105	23	,	,	PUNCT
bam-10622	105	24	psoriatic	psoriatic	ADJ
bam-10622	105	25	arthritis	arthritis	NOUN
bam-10622	105	26	and	and	CCONJ
bam-10622	105	27	psoriasis	psoriasis	NOUN
bam-10622	105	28	.	.	PUNCT
bam-10622	106	1	ann	ann	PROPN
bam-10622	106	2	rheum	rheum	PROPN
bam-10622	106	3	dis	dis	PROPN
bam-10622	106	4	2010	2010	NUM
bam-10622	106	5	,	,	PUNCT
bam-10622	106	6	69:2114	69:2114	NOUN
bam-10622	106	7	-	-	SYM
bam-10622	106	8	2117	2117	NUM
bam-10622	106	9	.	.	PUNCT
bam-10622	107	1	doi	doi	NOUN
bam-10622	107	2	:	:	PUNCT
bam-10622	107	3	10.1136	10.1136	NUM
bam-10622	107	4	/	/	SYM
bam-10622	107	5	ard.2009.125476	ard.2009.125476	PROPN
bam-10622	107	6	.	.	PUNCT
bam-10622	107	7	epub	epub	PROPN
bam-10622	107	8	2010	2010	NUM
bam-10622	107	9	jun	jun	PROPN
bam-10622	107	10	28	28	NUM
bam-10622	107	11	.	.	PUNCT
bam-10622	108	1	7	7	X
bam-10622	108	2	.	.	X
bam-10622	108	3	del	del	PROPN
bam-10622	108	4	rincón	rincón	PROPN
bam-10622	108	5	i	i	PROPN
bam-10622	108	6	,	,	PUNCT
bam-10622	108	7	freeman	freeman	PROPN
bam-10622	108	8	gl	gl	PROPN
bam-10622	108	9	,	,	PUNCT
bam-10622	108	10	haas	haas	PROPN
bam-10622	108	11	rw	rw	PROPN
bam-10622	108	12	,	,	PUNCT
bam-10622	108	13	o'leary	o'leary	PROPN
bam-10622	108	14	dh	dh	PROPN
bam-10622	108	15	,	,	PUNCT
bam-10622	108	16	escalante	escalante	PROPN
bam-10622	108	17	a.	a.	PROPN
bam-10622	108	18	relative	relative	PROPN
bam-10622	108	19	contribution	contribution	NOUN
bam-10622	108	20	of	of	ADP
bam-10622	108	21	cardiovascular	cardiovascular	ADJ
bam-10622	108	22	risk	risk	NOUN
bam-10622	108	23	factors	factor	NOUN
bam-10622	108	24	and	and	CCONJ
bam-10622	108	25	rheumatoid	rheumatoid	VERB
bam-10622	108	26	arthritis	arthritis	NOUN
bam-10622	108	27	clinical	clinical	ADJ
bam-10622	108	28	manifestations	manifestation	NOUN
bam-10622	108	29	to	to	ADP
bam-10622	108	30	atherosclerosis	atherosclerosis	NOUN
bam-10622	108	31	.	.	PUNCT
bam-10622	109	1	arthritis	arthritis	NOUN
bam-10622	109	2	rheum	rheum	NOUN
bam-10622	109	3	.	.	PUNCT
bam-10622	110	1	2005	2005	NUM
bam-10622	110	2	nov;52(11):3413	nov;52(11):3413	NOUN
bam-10622	110	3	-	-	PUNCT
bam-10622	110	4	23	23	NUM
bam-10622	110	5	.	.	PUNCT
bam-10622	111	1	doi	doi	NOUN
bam-10622	111	2	:	:	PUNCT
bam-10622	111	3	10.1002	10.1002	NUM
bam-10622	111	4	/	/	SYM
bam-10622	111	5	art.21397	art.21397	NOUN
bam-10622	111	6	.	.	NOUN
bam-10622	111	7	8	8	NUM
bam-10622	111	8	.	.	PUNCT
bam-10622	112	1	popa	popa	NOUN
bam-10622	112	2	c	c	NOUN
bam-10622	112	3	,	,	PUNCT
bam-10622	112	4	netea	netea	NOUN
bam-10622	112	5	mg	mg	PROPN
bam-10622	112	6	,	,	PUNCT
bam-10622	112	7	van	van	PROPN
bam-10622	112	8	riel	riel	PROPN
bam-10622	112	9	pl	pl	PROPN
bam-10622	112	10	,	,	PUNCT
bam-10622	112	11	van	van	PROPN
bam-10622	112	12	der	der	PROPN
bam-10622	112	13	meer	meer	PROPN
bam-10622	112	14	jw	jw	PROPN
bam-10622	112	15	,	,	PUNCT
bam-10622	112	16	stalenhoef	stalenhoef	PROPN
bam-10622	112	17	af	af	PROPN
bam-10622	112	18	.	.	PUNCT
bam-10622	113	1	the	the	DET
bam-10622	113	2	role	role	NOUN
bam-10622	113	3	of	of	ADP
bam-10622	113	4	tnfin	tnfin	NOUN
bam-10622	113	5	chronic	chronic	ADJ
bam-10622	113	6	inflammatory	inflammatory	ADJ
bam-10622	113	7	conditions	condition	NOUN
bam-10622	113	8	,	,	PUNCT
bam-10622	113	9	intermediary	intermediary	ADJ
bam-10622	113	10	metabolism	metabolism	NOUN
bam-10622	113	11	,	,	PUNCT
bam-10622	113	12	and	and	CCONJ
bam-10622	113	13	cardiovascular	cardiovascular	ADJ
bam-10622	113	14	risk	risk	NOUN
bam-10622	113	15	.	.	PUNCT
bam-10622	114	1	j	j	PROPN
bam-10622	114	2	lipid	lipid	PROPN
bam-10622	114	3	res	re	NOUN
bam-10622	114	4	.	.	PUNCT
bam-10622	114	5	2007	2007	NUM
bam-10622	114	6	;	;	PUNCT
bam-10622	114	7	48	48	NUM
bam-10622	114	8	:	:	PUNCT
bam-10622	114	9	751	751	NUM
bam-10622	114	10	-	-	SYM
bam-10622	114	11	62	62	NUM
bam-10622	114	12	.	.	PUNCT
bam-10622	115	1	doi	doi	NOUN
bam-10622	115	2	:	:	PUNCT
bam-10622	115	3	10.1194	10.1194	NUM
bam-10622	115	4	/	/	SYM
bam-10622	115	5	jlr.r600021jlr200	jlr.r600021jlr200	PROPN
bam-10622	115	6	.	.	PUNCT
bam-10622	116	1	epub	epub	PROPN
bam-10622	116	2	2007	2007	NUM
bam-10622	116	3	jan	jan	PROPN
bam-10622	116	4	2	2	NUM
bam-10622	116	5	.	.	NOUN
bam-10622	116	6	9	9	NUM
bam-10622	116	7	.	.	X
bam-10622	117	1	barbagallo	barbagallo	PROPN
bam-10622	117	2	m	m	PROPN
bam-10622	117	3	,	,	PUNCT
bam-10622	117	4	dominguez	dominguez	PROPN
bam-10622	117	5	lj	lj	PROPN
bam-10622	117	6	,	,	PUNCT
bam-10622	117	7	galioto	galioto	PROPN
bam-10622	117	8	a	a	PROPN
bam-10622	117	9	,	,	PUNCT
bam-10622	117	10	ferlisi	ferlisi	ADJ
bam-10622	117	11	a	a	PRON
bam-10622	117	12	,	,	PUNCT
bam-10622	117	13	cani	cani	PROPN
bam-10622	117	14	c	c	PROPN
bam-10622	117	15	,	,	PUNCT
bam-10622	117	16	malfa	malfa	PROPN
bam-10622	117	17	l	l	PROPN
bam-10622	117	18	,	,	PUNCT
bam-10622	117	19	pineo	pineo	VERB
bam-10622	117	20	a	a	DET
bam-10622	117	21	,	,	PUNCT
bam-10622	117	22	busardo	busardo	NOUN
bam-10622	117	23	'	'	PUNCT
bam-10622	117	24	a	a	PROPN
bam-10622	117	25	,	,	PUNCT
bam-10622	117	26	paolisso	paolisso	NOUN
bam-10622	117	27	g.	g.	NOUN
bam-10622	117	28	role	role	NOUN
bam-10622	117	29	of	of	ADP
bam-10622	117	30	magnesium	magnesium	NOUN
bam-10622	117	31	in	in	ADP
bam-10622	117	32	insulin	insulin	NOUN
bam-10622	117	33	action	action	NOUN
bam-10622	117	34	,	,	PUNCT
bam-10622	117	35	diabetes	diabetes	NOUN
bam-10622	117	36	and	and	CCONJ
bam-10622	117	37	cardio	cardio	NOUN
bam-10622	117	38	-	-	PUNCT
bam-10622	117	39	metabolic	metabolic	NOUN
bam-10622	117	40	syndrome	syndrome	NOUN
bam-10622	117	41	x.	x.	NOUN
bam-10622	117	42	mol	mol	ADP
bam-10622	117	43	aspects	aspect	NOUN
bam-10622	117	44	med	me	VERB
bam-10622	117	45	.	.	PUNCT
bam-10622	118	1	2003	2003	NUM
bam-10622	118	2	feb	feb	PROPN
bam-10622	118	3	-	-	PUNCT
bam-10622	118	4	jun;24(1	jun;24(1	NOUN
bam-10622	118	5	-	-	ADJ
bam-10622	118	6	3):39	3):39	NUM
bam-10622	118	7	-	-	PUNCT
bam-10622	118	8	52	52	NUM
bam-10622	118	9	.	.	PUNCT
bam-10622	119	1	doi	doi	NOUN
bam-10622	119	2	:	:	PUNCT
bam-10622	119	3	10.1016	10.1016	NUM
bam-10622	119	4	/	/	SYM
bam-10622	119	5	s0098	s0098	PROPN
bam-10622	119	6	-	-	PUNCT
bam-10622	119	7	2997(02)00090	2997(02)00090	NOUN
bam-10622	119	8	-	-	PUNCT
bam-10622	119	9	0	0	NUM
bam-10622	119	10	.	.	NOUN
bam-10622	119	11	mailto:m.gharehbeglou@zaums.ac.ir	mailto:m.gharehbeglou@zaums.ac.ir	X
bam-10622	119	12	mailto:mohsennovrouzi@gmail.com	mailto:mohsennovrouzi@gmail.com	NOUN
bam-10622	119	13	mailto:b.rezvankhah@gmail.com	mailto:b.rezvankhah@gmail.com	X
bam-10622	119	14	mailto:haeri.mr@googlemail.com	mailto:haeri.mr@googlemail.com	X
bam-10622	119	15	mailto:hoseinheydari3375@yahoo.com	mailto:hoseinheydari3375@yahoo.com	PROPN
bam-10622	119	16	mailto:javad883@yahoo.com	mailto:javad883@yahoo.com	PROPN
bam-10622	119	17	mailto:navid_shafigh2005@yahoo.com	mailto:navid_shafigh2005@yahoo.com	X
bam-10622	120	1	mailto:mzaj_ordoni@yahoo.com	mailto:mzaj_ordoni@yahoo.com	PROPN
bam-10622	120	2	mailto:dr.dahmardeh@gmail.com	mailto:dr.dahmardeh@gmail.com	PROPN
bam-10622	120	3	mailto:passerby_62@yahoo.com	mailto:passerby_62@yahoo.com	PROPN
bam-10622	120	4	magnesium	magnesium	NOUN
bam-10622	120	5	supplementation	supplementation	NOUN
bam-10622	120	6	in	in	ADP
bam-10622	120	7	rheumatoid	rheumatoid	NOUN
bam-10622	120	8	arthritis	arthritis	NOUN
bam-10622	120	9	eur	eur	PROPN
bam-10622	120	10	j	j	PROPN
bam-10622	120	11	transl	transl	PROPN
bam-10622	120	12	myol	myol	ADV
bam-10622	120	13	32	32	NUM
bam-10622	120	14	(	(	PUNCT
bam-10622	120	15	3	3	NUM
bam-10622	120	16	):	):	PUNCT
bam-10622	120	17	10622	10622	NUM
bam-10622	120	18	,	,	PUNCT
bam-10622	120	19	2022	2022	NUM
bam-10622	120	20	doi	doi	NOUN
bam-10622	120	21	:	:	PUNCT
bam-10622	120	22	10.4081	10.4081	NUM
bam-10622	120	23	/	/	SYM
bam-10622	120	24	ejtm.2022.10622	ejtm.2022.10622	NUM
bam-10622	120	25	6	6	NUM
bam-10622	120	26	10	10	NUM
bam-10622	120	27	.	.	PUNCT
bam-10622	121	1	ma	ma	PROPN
bam-10622	121	2	b	b	PROPN
bam-10622	121	3	,	,	PUNCT
bam-10622	121	4	lawson	lawson	PROPN
bam-10622	121	5	ab	ab	PROPN
bam-10622	121	6	,	,	PUNCT
bam-10622	121	7	liese	liese	PROPN
bam-10622	121	8	ad	ad	NOUN
bam-10622	121	9	,	,	PUNCT
bam-10622	121	10	bell	bell	PROPN
bam-10622	121	11	ra	ra	PROPN
bam-10622	121	12	,	,	PUNCT
bam-10622	121	13	mayerdavis	mayerdavis	PROPN
bam-10622	121	14	ej	ej	PROPN
bam-10622	121	15	.	.	PROPN
bam-10622	121	16	dairy	dairy	NOUN
bam-10622	121	17	,	,	PUNCT
bam-10622	121	18	magnesium	magnesium	NOUN
bam-10622	121	19	,	,	PUNCT
bam-10622	121	20	and	and	CCONJ
bam-10622	121	21	calcium	calcium	NOUN
bam-10622	121	22	intake	intake	NOUN
bam-10622	121	23	in	in	ADP
bam-10622	121	24	relation	relation	NOUN
bam-10622	121	25	to	to	ADP
bam-10622	121	26	insulin	insulin	NOUN
bam-10622	121	27	sensitivity	sensitivity	NOUN
bam-10622	121	28	:	:	PUNCT
bam-10622	121	29	approaches	approach	NOUN
bam-10622	121	30	to	to	ADP
bam-10622	121	31	modeling	model	VERB
bam-10622	121	32	a	a	DET
bam-10622	121	33	dose	dose	NOUN
bam-10622	121	34	-	-	PUNCT
bam-10622	121	35	dependent	dependent	ADJ
bam-10622	121	36	association	association	NOUN
bam-10622	121	37	.	.	PUNCT
bam-10622	122	1	am	be	AUX
bam-10622	122	2	j	j	PROPN
bam-10622	122	3	epidemiol	epidemiol	PROPN
bam-10622	122	4	.	.	PUNCT
bam-10622	123	1	2006;164(5	2006;164(5	NUM
bam-10622	123	2	):	):	PUNCT
bam-10622	124	1	449	449	NUM
bam-10622	124	2	-	-	SYM
bam-10622	124	3	58	58	NUM
bam-10622	124	4	.	.	PUNCT
bam-10622	125	1	doi	doi	NOUN
bam-10622	125	2	:	:	PUNCT
bam-10622	125	3	10.1093/	10.1093/	NUM
bam-10622	125	4	aje	aje	PROPN
bam-10622	125	5	/	/	SYM
bam-10622	125	6	kwj246	kwj246	PROPN
bam-10622	125	7	.	.	PUNCT
bam-10622	126	1	epub	epub	PROPN
bam-10622	126	2	2006	2006	NUM
bam-10622	126	3	jul	jul	PROPN
bam-10622	126	4	21	21	NUM
bam-10622	126	5	.	.	PUNCT
bam-10622	127	1	11	11	NUM
bam-10622	127	2	.	.	PUNCT
bam-10622	128	1	he	he	PRON
bam-10622	128	2	k	k	PROPN
bam-10622	128	3	,	,	PUNCT
bam-10622	128	4	liu	liu	PROPN
bam-10622	128	5	k	k	PROPN
bam-10622	128	6	,	,	PUNCT
bam-10622	128	7	daviglus	daviglus	X
bam-10622	128	8	ml	ml	PROPN
bam-10622	128	9	,	,	PUNCT
bam-10622	128	10	morris	morris	PROPN
bam-10622	128	11	sj	sj	PROPN
bam-10622	128	12	,	,	PUNCT
bam-10622	128	13	loria	loria	PROPN
bam-10622	128	14	cm	cm	PROPN
bam-10622	128	15	,	,	PUNCT
bam-10622	128	16	van	van	PROPN
bam-10622	128	17	horn	horn	PROPN
bam-10622	128	18	l	l	PROPN
bam-10622	128	19	,	,	PUNCT
bam-10622	128	20	jacobs	jacobs	PROPN
bam-10622	128	21	dr	dr	PROPN
bam-10622	128	22	,	,	PUNCT
bam-10622	128	23	jr	jr	PROPN
bam-10622	128	24	.	.	PROPN
bam-10622	128	25	,	,	PUNCT
bam-10622	128	26	et	et	PROPN
bam-10622	128	27	al	al	PROPN
bam-10622	128	28	.	.	PROPN
bam-10622	128	29	magnesium	magnesium	PROPN
bam-10622	128	30	intake	intake	NOUN
bam-10622	128	31	and	and	CCONJ
bam-10622	128	32	incidence	incidence	NOUN
bam-10622	128	33	of	of	ADP
bam-10622	128	34	metabolic	metabolic	NOUN
bam-10622	128	35	syndrome	syndrome	NOUN
bam-10622	128	36	among	among	ADP
bam-10622	128	37	young	young	ADJ
bam-10622	128	38	adults	adult	NOUN
bam-10622	128	39	.	.	PUNCT
bam-10622	129	1	circulation	circulation	NOUN
bam-10622	129	2	.	.	PUNCT
bam-10622	130	1	2006	2006	NUM
bam-10622	130	2	;	;	PUNCT
bam-10622	130	3	113(13	113(13	NUM
bam-10622	130	4	):	):	PUNCT
bam-10622	130	5	1675	1675	NUM
bam-10622	130	6	-	-	SYM
bam-10622	130	7	82	82	NUM
bam-10622	130	8	.	.	PUNCT
bam-10622	131	1	doi	doi	PROPN
bam-10622	131	2	:	:	PUNCT
bam-10622	131	3	10.1161/	10.1161/	NUM
bam-10622	131	4	circulationaha	circulationaha	NOUN
bam-10622	131	5	.	.	PUNCT
bam-10622	132	1	105.588327	105.588327	X
bam-10622	132	2	.	.	PUNCT
bam-10622	132	3	epub	epub	PROPN
bam-10622	132	4	2006	2006	NUM
bam-10622	132	5	mar	mar	PROPN
bam-10622	132	6	27	27	NUM
bam-10622	132	7	.	.	PUNCT
bam-10622	133	1	12	12	NUM
bam-10622	133	2	.	.	PUNCT
bam-10622	134	1	simmons	simmon	NOUN
bam-10622	134	2	d	d	PROPN
bam-10622	134	3	,	,	PUNCT
bam-10622	134	4	joshi	joshi	PROPN
bam-10622	134	5	s	s	PROPN
bam-10622	134	6	,	,	PUNCT
bam-10622	134	7	shaw	shaw	PROPN
bam-10622	134	8	j.	j.	PROPN
bam-10622	134	9	hypomagnesaemia	hypomagnesaemia	PROPN
bam-10622	134	10	is	be	AUX
bam-10622	134	11	associated	associate	VERB
bam-10622	134	12	with	with	ADP
bam-10622	134	13	diabetes	diabetes	NOUN
bam-10622	134	14	:	:	PUNCT
bam-10622	134	15	not	not	PART
bam-10622	134	16	pre	pre	NOUN
bam-10622	134	17	-	-	NOUN
bam-10622	134	18	diabetes	diabetes	ADJ
bam-10622	134	19	,	,	PUNCT
bam-10622	134	20	obesity	obesity	NOUN
bam-10622	134	21	or	or	CCONJ
bam-10622	134	22	the	the	DET
bam-10622	134	23	metabolic	metabolic	NOUN
bam-10622	134	24	syndrome	syndrome	NOUN
bam-10622	134	25	.	.	PUNCT
bam-10622	135	1	diabetes	diabetes	NOUN
bam-10622	135	2	res	re	VERB
bam-10622	135	3	clin	clin	PROPN
bam-10622	135	4	pract	pract	PROPN
bam-10622	135	5	.	.	PUNCT
bam-10622	136	1	2010	2010	NUM
bam-10622	136	2	feb;87(2):261	feb;87(2):261	NUM
bam-10622	136	3	-	-	SYM
bam-10622	136	4	6	6	NUM
bam-10622	137	1	.	.	PUNCT
bam-10622	137	2	doi	doi	NOUN
bam-10622	137	3	:	:	PUNCT
bam-10622	137	4	10.1016/	10.1016/	NUM
bam-10622	137	5	j.diabres.2009.11.003	j.diabres.2009.11.003	PROPN
bam-10622	137	6	.	.	PROPN
bam-10622	137	7	epub	epub	PROPN
bam-10622	137	8	2009	2009	NUM
bam-10622	137	9	dec	dec	PROPN
bam-10622	137	10	8	8	NUM
bam-10622	137	11	.	.	PROPN
bam-10622	137	12	13	13	NUM
bam-10622	137	13	.	.	PUNCT
bam-10622	138	1	kim	kim	PROPN
bam-10622	138	2	dj	dj	PROPN
bam-10622	138	3	,	,	PUNCT
bam-10622	138	4	xun	xun	PROPN
bam-10622	138	5	p	p	PROPN
bam-10622	138	6	,	,	PUNCT
bam-10622	138	7	liu	liu	PROPN
bam-10622	138	8	k	k	PROPN
bam-10622	138	9	,	,	PUNCT
bam-10622	138	10	loria	loria	PROPN
bam-10622	138	11	c	c	PROPN
bam-10622	138	12	,	,	PUNCT
bam-10622	138	13	yokota	yokota	PROPN
bam-10622	138	14	k	k	PROPN
bam-10622	138	15	,	,	PUNCT
bam-10622	138	16	jacobs	jacobs	PROPN
bam-10622	138	17	dr	dr	PROPN
bam-10622	138	18	jr	jr	PROPN
bam-10622	138	19	,	,	PUNCT
bam-10622	138	20	he	he	PRON
bam-10622	138	21	k.	k.	PROPN
bam-10622	138	22	magnesium	magnesium	PROPN
bam-10622	138	23	intake	intake	PROPN
bam-10622	138	24	in	in	ADP
bam-10622	138	25	relation	relation	NOUN
bam-10622	138	26	to	to	ADP
bam-10622	138	27	systemic	systemic	ADJ
bam-10622	138	28	inflammation	inflammation	NOUN
bam-10622	138	29	,	,	PUNCT
bam-10622	138	30	insulin	insulin	NOUN
bam-10622	138	31	resistance	resistance	NOUN
bam-10622	138	32	,	,	PUNCT
bam-10622	138	33	and	and	CCONJ
bam-10622	138	34	the	the	DET
bam-10622	138	35	incidence	incidence	NOUN
bam-10622	138	36	of	of	ADP
bam-10622	138	37	diabetes	diabetes	NOUN
bam-10622	138	38	.	.	PUNCT
bam-10622	139	1	diabetes	diabetes	NOUN
bam-10622	139	2	care	care	NOUN
bam-10622	139	3	.	.	PUNCT
bam-10622	140	1	2010	2010	NUM
bam-10622	140	2	dec;33(12):2604	dec;33(12):2604	NOUN
bam-10622	140	3	-	-	PUNCT
bam-10622	140	4	10	10	NUM
bam-10622	140	5	.	.	PUNCT
bam-10622	141	1	doi	doi	NOUN
bam-10622	141	2	:	:	PUNCT
bam-10622	141	3	10.2337	10.2337	NUM
bam-10622	141	4	/	/	SYM
bam-10622	141	5	dc10	dc10	PROPN
bam-10622	141	6	-	-	PUNCT
bam-10622	141	7	0994	0994	NUM
bam-10622	141	8	.	.	PUNCT
bam-10622	142	1	epub	epub	PROPN
bam-10622	142	2	2010	2010	NUM
bam-10622	142	3	aug	aug	PROPN
bam-10622	142	4	31	31	NUM
bam-10622	142	5	.	.	PUNCT
bam-10622	143	1	14	14	NUM
bam-10622	143	2	.	.	PUNCT
bam-10622	144	1	song	song	PROPN
bam-10622	144	2	y	y	PROPN
bam-10622	144	3	,	,	PUNCT
bam-10622	144	4	manson	manson	PROPN
bam-10622	144	5	je	je	PROPN
bam-10622	144	6	,	,	PUNCT
bam-10622	144	7	buring	bur	VERB
bam-10622	144	8	je	je	PROPN
bam-10622	144	9	,	,	PUNCT
bam-10622	144	10	liu	liu	PROPN
bam-10622	144	11	s.	s.	PROPN
bam-10622	144	12	dietary	dietary	ADJ
bam-10622	144	13	magnesium	magnesium	NOUN
bam-10622	144	14	intake	intake	NOUN
bam-10622	144	15	in	in	ADP
bam-10622	144	16	relation	relation	NOUN
bam-10622	144	17	to	to	ADP
bam-10622	144	18	plasma	plasma	VERB
bam-10622	144	19	insulin	insulin	NOUN
bam-10622	144	20	levels	level	NOUN
bam-10622	144	21	and	and	CCONJ
bam-10622	144	22	risk	risk	NOUN
bam-10622	144	23	of	of	ADP
bam-10622	144	24	type	type	NOUN
bam-10622	144	25	2	2	NUM
bam-10622	144	26	diabetes	diabetes	NOUN
bam-10622	144	27	in	in	ADP
bam-10622	144	28	women	woman	NOUN
bam-10622	144	29	.	.	PUNCT
bam-10622	145	1	diabetes	diabetes	NOUN
bam-10622	145	2	care	care	VERB
bam-10622	145	3	2004	2004	NUM
bam-10622	145	4	;	;	PUNCT
bam-10622	145	5	27	27	NUM
bam-10622	145	6	:	:	SYM
bam-10622	145	7	59	59	NUM
bam-10622	145	8	-	-	SYM
bam-10622	145	9	65	65	NUM
bam-10622	145	10	.	.	PUNCT
bam-10622	146	1	doi	doi	NOUN
bam-10622	146	2	:	:	PUNCT
bam-10622	146	3	10.2337/	10.2337/	NUM
bam-10622	146	4	diacare.27.1.59	diacare.27.1.59	PROPN
bam-10622	146	5	.	.	PROPN
bam-10622	146	6	15	15	NUM
bam-10622	146	7	.	.	PUNCT
bam-10622	147	1	lopez	lopez	NOUN
bam-10622	147	2	-	-	PUNCT
bam-10622	147	3	ridaura	ridaura	NOUN
bam-10622	147	4	r	r	NOUN
bam-10622	147	5	,	,	PUNCT
bam-10622	147	6	willett	willett	PROPN
bam-10622	147	7	wc	wc	PROPN
bam-10622	147	8	,	,	PUNCT
bam-10622	147	9	rimm	rimm	PROPN
bam-10622	147	10	eb	eb	PROPN
bam-10622	147	11	,	,	PUNCT
bam-10622	147	12	liu	liu	PROPN
bam-10622	147	13	s	s	PROPN
bam-10622	147	14	,	,	PUNCT
bam-10622	147	15	stampfer	stampfer	PROPN
bam-10622	147	16	mj	mj	PROPN
bam-10622	147	17	,	,	PUNCT
bam-10622	147	18	manson	manson	PROPN
bam-10622	147	19	je	je	PROPN
bam-10622	147	20	,	,	PUNCT
bam-10622	147	21	et	et	PROPN
bam-10622	147	22	al	al	PROPN
bam-10622	147	23	.	.	PROPN
bam-10622	147	24	magnesium	magnesium	PROPN
bam-10622	147	25	intake	intake	NOUN
bam-10622	147	26	and	and	CCONJ
bam-10622	147	27	risk	risk	NOUN
bam-10622	147	28	of	of	ADP
bam-10622	147	29	type	type	NOUN
bam-10622	147	30	2	2	NUM
bam-10622	147	31	diabetes	diabetes	NOUN
bam-10622	147	32	in	in	ADP
bam-10622	147	33	men	man	NOUN
bam-10622	147	34	and	and	CCONJ
bam-10622	147	35	women	woman	NOUN
bam-10622	147	36	.	.	PUNCT
bam-10622	148	1	diabetes	diabetes	NOUN
bam-10622	148	2	care	care	VERB
bam-10622	148	3	2004	2004	NUM
bam-10622	148	4	;	;	PUNCT
bam-10622	148	5	27	27	NUM
bam-10622	148	6	:	:	SYM
bam-10622	148	7	134e40	134e40	X
bam-10622	148	8	.	.	PUNCT
bam-10622	149	1	doi	doi	NOUN
bam-10622	149	2	:	:	PUNCT
bam-10622	149	3	10.2337	10.2337	NUM
bam-10622	149	4	/	/	SYM
bam-10622	149	5	diacare.27.1.134	diacare.27.1.134	NUM
bam-10622	149	6	.	.	PUNCT
bam-10622	150	1	16	16	NUM
bam-10622	150	2	.	.	PUNCT
bam-10622	151	1	guerrero	guerrero	PROPN
bam-10622	151	2	-	-	PUNCT
bam-10622	151	3	romero	romero	PROPN
bam-10622	151	4	f	f	PROPN
bam-10622	151	5	,	,	PUNCT
bam-10622	151	6	tamez	tamez	NOUN
bam-10622	151	7	-	-	PUNCT
bam-10622	151	8	perez	perez	NOUN
bam-10622	151	9	he	he	PRON
bam-10622	151	10	,	,	PUNCT
bam-10622	151	11	gonzález	gonzález	PROPN
bam-10622	151	12	-	-	PUNCT
bam-10622	151	13	gonzález	gonzález	PROPN
bam-10622	151	14	g	g	PROPN
bam-10622	151	15	,	,	PUNCT
bam-10622	151	16	salinas	salinas	PROPN
bam-10622	151	17	-	-	PUNCT
bam-10622	151	18	martínez	martínez	PROPN
bam-10622	151	19	am	am	NOUN
bam-10622	151	20	,	,	PUNCT
bam-10622	151	21	montes	monte	NOUN
bam-10622	151	22	-	-	PUNCT
bam-10622	151	23	villarreal	villarreal	ADJ
bam-10622	151	24	j	j	PROPN
bam-10622	151	25	,	,	PUNCT
bam-10622	151	26	treviño	treviño	PROPN
bam-10622	151	27	-	-	PUNCT
bam-10622	151	28	ortiz	ortiz	PROPN
bam-10622	151	29	jh	jh	PROPN
bam-10622	151	30	,	,	PUNCT
bam-10622	151	31	rodríguez	rodríguez	NOUN
bam-10622	151	32	-	-	PUNCT
bam-10622	151	33	morán	morán	PROPN
bam-10622	151	34	m.	m.	NOUN
bam-10622	151	35	oral	oral	ADJ
bam-10622	151	36	magnesium	magnesium	NOUN
bam-10622	151	37	supplementation	supplementation	NOUN
bam-10622	151	38	improves	improve	VERB
bam-10622	151	39	insulin	insulin	NOUN
bam-10622	151	40	sensitivity	sensitivity	NOUN
bam-10622	151	41	in	in	ADP
bam-10622	151	42	non	non	ADJ
bam-10622	151	43	-	-	ADJ
bam-10622	151	44	diabetic	diabetic	ADJ
bam-10622	151	45	subjects	subject	NOUN
bam-10622	151	46	with	with	ADP
bam-10622	151	47	insulin	insulin	NOUN
bam-10622	151	48	resistance	resistance	NOUN
bam-10622	151	49	.	.	PUNCT
bam-10622	152	1	a	a	DET
bam-10622	152	2	double	double	ADJ
bam-10622	152	3	-	-	PUNCT
bam-10622	152	4	blind	blind	ADJ
bam-10622	152	5	placebo	placebo	NOUN
bam-10622	152	6	-	-	PUNCT
bam-10622	152	7	controlled	control	VERB
bam-10622	152	8	randomized	randomized	ADJ
bam-10622	152	9	trial	trial	NOUN
bam-10622	152	10	.	.	PUNCT
bam-10622	153	1	diabetes	diabetes	NOUN
bam-10622	153	2	metab	metab	NOUN
bam-10622	153	3	.	.	PUNCT
bam-10622	154	1	2004	2004	NUM
bam-10622	154	2	;	;	PUNCT
bam-10622	154	3	30(3	30(3	NUM
bam-10622	154	4	):	):	PUNCT
bam-10622	154	5	253	253	NUM
bam-10622	154	6	-	-	SYM
bam-10622	154	7	8	8	NUM
bam-10622	154	8	.	.	PUNCT
bam-10622	155	1	doi	doi	NOUN
bam-10622	155	2	:	:	PUNCT
bam-10622	155	3	10.1016	10.1016	NUM
bam-10622	155	4	/	/	SYM
bam-10622	155	5	s1262	s1262	PROPN
bam-10622	155	6	-	-	PUNCT
bam-10622	155	7	3636(07)70116	3636(07)70116	NUM
bam-10622	155	8	-	-	PUNCT
bam-10622	155	9	7	7	NUM
bam-10622	155	10	.	.	NOUN
bam-10622	155	11	17	17	NUM
bam-10622	155	12	.	.	PUNCT
bam-10622	156	1	lucia	lucia	PROPN
bam-10622	156	2	m	m	PROPN
bam-10622	156	3	,	,	PUNCT
bam-10622	156	4	isabela	isabela	PROPN
bam-10622	156	5	s	s	PROPN
bam-10622	156	6	,	,	PUNCT
bam-10622	156	7	minerva	minerva	PROPN
bam-10622	156	8	g.	g.	PROPN
bam-10622	156	9	changes	change	NOUN
bam-10622	156	10	of	of	ADP
bam-10622	156	11	serum	serum	NOUN
bam-10622	156	12	magnesium	magnesium	NOUN
bam-10622	156	13	level	level	NOUN
bam-10622	156	14	in	in	ADP
bam-10622	156	15	patients	patient	NOUN
bam-10622	156	16	with	with	ADP
bam-10622	156	17	rheumatoid	rheumatoid	NOUN
bam-10622	156	18	arthritis	arthritis	NOUN
bam-10622	156	19	stage	stage	NOUN
bam-10622	156	20	i	i	PROPN
bam-10622	156	21	-	-	PUNCT
bam-10622	156	22	ii	ii	PROPN
bam-10622	156	23	,	,	PUNCT
bam-10622	156	24	before	before	ADP
bam-10622	156	25	treatment	treatment	NOUN
bam-10622	156	26	.	.	PUNCT
bam-10622	157	1	med	med	ADJ
bam-10622	157	2	con	con	PROPN
bam-10622	157	3	.	.	PUNCT
bam-10622	157	4	2011	2011	NUM
bam-10622	157	5	;	;	PUNCT
bam-10622	157	6	6(2	6(2	NUM
bam-10622	157	7	):	):	PUNCT
bam-10622	157	8	9	9	NUM
bam-10622	157	9	-	-	SYM
bam-10622	157	10	16	16	NUM
bam-10622	157	11	.	.	PUNCT
bam-10622	158	1	doi	doi	NOUN
bam-10622	158	2	:	:	PUNCT
bam-10622	158	3	10.33311/	10.33311/	NUM
bam-10622	158	4	medcon	medcon	NOUN
bam-10622	158	5	.	.	PUNCT
bam-10622	159	1	2011.18.2.2	2011.18.2.2	NUM
bam-10622	159	2	18	18	NUM
bam-10622	159	3	.	.	PUNCT
bam-10622	160	1	arnett	arnett	PROPN
bam-10622	160	2	fc	fc	PROPN
bam-10622	160	3	,	,	PUNCT
bam-10622	160	4	edworthy	edworthy	PROPN
bam-10622	160	5	sm	sm	PROPN
bam-10622	160	6	,	,	PUNCT
bam-10622	160	7	bloch	bloch	PROPN
bam-10622	160	8	da	da	PROPN
bam-10622	160	9	,	,	PUNCT
bam-10622	160	10	mcshane	mcshane	PROPN
bam-10622	160	11	dj	dj	PROPN
bam-10622	160	12	,	,	PUNCT
bam-10622	160	13	fries	fries	PROPN
bam-10622	160	14	jf	jf	PROPN
bam-10622	160	15	,	,	PUNCT
bam-10622	160	16	cooper	cooper	PROPN
bam-10622	160	17	ns	ns	PROPN
bam-10622	160	18	,	,	PUNCT
bam-10622	160	19	healey	healey	PROPN
bam-10622	160	20	la	la	PROPN
bam-10622	160	21	,	,	PUNCT
bam-10622	160	22	kaplan	kaplan	PROPN
bam-10622	160	23	sr	sr	PROPN
bam-10622	160	24	,	,	PUNCT
bam-10622	160	25	liang	liang	PROPN
bam-10622	160	26	mh	mh	PROPN
bam-10622	160	27	,	,	PUNCT
bam-10622	160	28	luthra	luthra	PROPN
bam-10622	160	29	hs	hs	PROPN
bam-10622	160	30	,	,	PUNCT
bam-10622	160	31	medsger	medsger	NOUN
bam-10622	160	32	ta	ta	PROPN
bam-10622	160	33	,	,	PUNCT
bam-10622	160	34	mitchell	mitchell	PROPN
bam-10622	160	35	dm	dm	PROPN
bam-10622	160	36	,	,	PUNCT
bam-10622	160	37	neustadt	neustadt	NOUN
bam-10622	160	38	dh	dh	PROPN
bam-10622	160	39	,	,	PUNCT
bam-10622	160	40	pinals	pinal	NOUN
bam-10622	160	41	rs	r	VERB
bam-10622	160	42	,	,	PUNCT
bam-10622	160	43	schaller	schaller	NOUN
bam-10622	160	44	jg	jg	PROPN
bam-10622	160	45	,	,	PUNCT
bam-10622	160	46	sharp	sharp	PROPN
bam-10622	160	47	jt	jt	PROPN
bam-10622	160	48	,	,	PUNCT
bam-10622	160	49	wilder	wilder	ADJ
bam-10622	160	50	rl	rl	VERB
bam-10622	160	51	,	,	PUNCT
bam-10622	160	52	hunder	hunder	NOUN
bam-10622	160	53	gg	gg	PROPN
bam-10622	160	54	:	:	PUNCT
bam-10622	160	55	the	the	DET
bam-10622	160	56	american	american	ADJ
bam-10622	160	57	rheumatism	rheumatism	PROPN
bam-10622	160	58	association	association	PROPN
bam-10622	160	59	1987	1987	NUM
bam-10622	160	60	revised	revise	VERB
bam-10622	160	61	criteria	criterion	NOUN
bam-10622	160	62	for	for	ADP
bam-10622	160	63	the	the	DET
bam-10622	160	64	classification	classification	NOUN
bam-10622	160	65	of	of	ADP
bam-10622	160	66	rheumatoid	rheumatoid	NOUN
bam-10622	160	67	arthritis	arthritis	NOUN
bam-10622	160	68	.	.	PUNCT
bam-10622	161	1	arthritis	arthritis	NOUN
bam-10622	161	2	rheum	rheum	PROPN
bam-10622	161	3	1988	1988	NUM
bam-10622	161	4	,	,	PUNCT
bam-10622	161	5	31	31	NUM
bam-10622	161	6	:	:	SYM
bam-10622	161	7	315	315	NUM
bam-10622	161	8	-	-	SYM
bam-10622	161	9	24	24	NUM
bam-10622	161	10	.	.	PUNCT
bam-10622	162	1	doi	doi	NOUN
bam-10622	162	2	:	:	PUNCT
bam-10622	162	3	10.1002	10.1002	NUM
bam-10622	162	4	/	/	SYM
bam-10622	162	5	art.1780310302	art.1780310302	NOUN
bam-10622	162	6	.	.	PROPN
bam-10622	162	7	19	19	NUM
bam-10622	162	8	.	.	PUNCT
bam-10622	163	1	katz	katz	PROPN
bam-10622	163	2	a	a	PROPN
bam-10622	163	3	,	,	PUNCT
bam-10622	163	4	nambi	nambi	NOUN
bam-10622	163	5	ss	ss	PROPN
bam-10622	163	6	,	,	PUNCT
bam-10622	163	7	mather	mather	PROPN
bam-10622	163	8	k	k	PROPN
bam-10622	163	9	,	,	PUNCT
bam-10622	163	10	baron	baron	NOUN
bam-10622	163	11	ad	ad	NOUN
bam-10622	163	12	,	,	PUNCT
bam-10622	163	13	follmann	follmann	PROPN
bam-10622	163	14	da	da	PROPN
bam-10622	163	15	,	,	PUNCT
bam-10622	163	16	sullivan	sullivan	PROPN
bam-10622	163	17	g	g	PROPN
bam-10622	163	18	,	,	PUNCT
bam-10622	163	19	quon	quon	PROPN
bam-10622	163	20	mj	mj	PROPN
bam-10622	163	21	:	:	PUNCT
bam-10622	163	22	quantitative	quantitative	ADJ
bam-10622	163	23	insulin	insulin	NOUN
bam-10622	163	24	sensitivity	sensitivity	NOUN
bam-10622	163	25	check	check	NOUN
bam-10622	163	26	index	index	NOUN
bam-10622	163	27	:	:	PUNCT
bam-10622	163	28	a	a	DET
bam-10622	163	29	simple	simple	ADJ
bam-10622	163	30	,	,	PUNCT
bam-10622	163	31	accurate	accurate	ADJ
bam-10622	163	32	method	method	NOUN
bam-10622	163	33	for	for	ADP
bam-10622	163	34	assessing	assess	VERB
bam-10622	163	35	insulin	insulin	NOUN
bam-10622	163	36	sensitivity	sensitivity	NOUN
bam-10622	163	37	in	in	ADP
bam-10622	163	38	humans	human	NOUN
bam-10622	163	39	.	.	PUNCT
bam-10622	164	1	j	j	PROPN
bam-10622	164	2	clin	clin	PROPN
bam-10622	164	3	endocrinol	endocrinol	PROPN
bam-10622	164	4	metab	metab	PROPN
bam-10622	164	5	2000	2000	NUM
bam-10622	164	6	,	,	PUNCT
bam-10622	164	7	85:2402	85:2402	NOUN
bam-10622	164	8	-	-	SYM
bam-10622	164	9	2410	2410	NUM
bam-10622	164	10	.	.	PUNCT
bam-10622	165	1	doi	doi	NOUN
bam-10622	165	2	:	:	PUNCT
bam-10622	165	3	10.1210	10.1210	NUM
bam-10622	165	4	/	/	SYM
bam-10622	165	5	jcem.85	jcem.85	NOUN
bam-10622	165	6	.	.	PUNCT
bam-10622	166	1	7.6661	7.6661	NUM
bam-10622	166	2	.	.	PUNCT
bam-10622	167	1	20	20	NUM
bam-10622	167	2	.	.	PUNCT
bam-10622	167	3	matthews	matthews	PROPN
bam-10622	167	4	dr	dr	PROPN
bam-10622	167	5	,	,	PUNCT
bam-10622	167	6	hosker	hosker	NOUN
bam-10622	167	7	jp	jp	PROPN
bam-10622	167	8	,	,	PUNCT
bam-10622	167	9	rudenski	rudenski	NOUN
bam-10622	167	10	as	as	ADP
bam-10622	167	11	,	,	PUNCT
bam-10622	167	12	naylor	naylor	PROPN
bam-10622	167	13	ba	ba	PROPN
bam-10622	167	14	,	,	PUNCT
bam-10622	167	15	treacher	treacher	PROPN
bam-10622	167	16	df	df	PROPN
bam-10622	167	17	,	,	PUNCT
bam-10622	167	18	turner	turner	PROPN
bam-10622	167	19	rc	rc	PROPN
bam-10622	167	20	.	.	PUNCT
bam-10622	167	21	homeostasis	homeostasis	NOUN
bam-10622	167	22	model	model	NOUN
bam-10622	167	23	assessment	assessment	NOUN
bam-10622	167	24	:	:	PUNCT
bam-10622	167	25	insulin	insulin	NOUN
bam-10622	167	26	resistance	resistance	NOUN
bam-10622	167	27	and	and	CCONJ
bam-10622	167	28	betacell	betacell	ADJ
bam-10622	167	29	function	function	NOUN
bam-10622	167	30	from	from	ADP
bam-10622	167	31	fasting	fast	VERB
bam-10622	167	32	plasma	plasma	NOUN
bam-10622	167	33	glucose	glucose	NOUN
bam-10622	167	34	and	and	CCONJ
bam-10622	167	35	insulin	insulin	NOUN
bam-10622	167	36	concentrations	concentration	NOUN
bam-10622	167	37	in	in	ADP
bam-10622	167	38	man	man	NOUN
bam-10622	167	39	.	.	PUNCT
bam-10622	168	1	diabetologia	diabetologia	NOUN
bam-10622	168	2	1985	1985	NUM
bam-10622	168	3	;	;	PUNCT
bam-10622	168	4	28	28	NUM
bam-10622	168	5	:	:	SYM
bam-10622	168	6	412e9	412e9	NUM
bam-10622	168	7	.	.	PUNCT
bam-10622	169	1	doi	doi	NOUN
bam-10622	169	2	:	:	PUNCT
bam-10622	169	3	10.1007	10.1007	NUM
bam-10622	169	4	/	/	SYM
bam-10622	169	5	bf00280883	bf00280883	NOUN
bam-10622	169	6	.	.	PUNCT
bam-10622	170	1	21	21	NUM
bam-10622	170	2	.	.	PUNCT
bam-10622	170	3	geloneze	geloneze	PROPN
bam-10622	170	4	b	b	PROPN
bam-10622	170	5	,	,	PUNCT
bam-10622	170	6	repetto	repetto	PROPN
bam-10622	170	7	em	em	PRON
bam-10622	170	8	,	,	PUNCT
bam-10622	170	9	geloneze	geloneze	VERB
bam-10622	170	10	sr	sr	PROPN
bam-10622	170	11	,	,	PUNCT
bam-10622	170	12	tambascia	tambascia	PROPN
bam-10622	170	13	ma	ma	PROPN
bam-10622	170	14	,	,	PUNCT
bam-10622	170	15	ermetice	ermetice	PROPN
bam-10622	170	16	mn	mn	PROPN
bam-10622	170	17	.	.	PUNCT
bam-10622	171	1	the	the	DET
bam-10622	171	2	threshold	threshold	NOUN
bam-10622	171	3	value	value	NOUN
bam-10622	171	4	for	for	ADP
bam-10622	171	5	insulin	insulin	NOUN
bam-10622	171	6	resistance	resistance	NOUN
bam-10622	171	7	(	(	PUNCT
bam-10622	171	8	homa	homa	NOUN
bam-10622	171	9	-	-	PUNCT
bam-10622	171	10	ir	ir	NOUN
bam-10622	171	11	)	)	PUNCT
bam-10622	171	12	in	in	ADP
bam-10622	171	13	an	an	DET
bam-10622	171	14	admixtured	admixture	VERB
bam-10622	171	15	population	population	NOUN
bam-10622	171	16	ir	ir	NOUN
bam-10622	171	17	in	in	ADP
bam-10622	171	18	the	the	DET
bam-10622	171	19	brazilian	brazilian	ADJ
bam-10622	171	20	metabolic	metabolic	PROPN
bam-10622	171	21	syndrome	syndrome	PROPN
bam-10622	171	22	study	study	NOUN
bam-10622	171	23	.	.	PUNCT
bam-10622	172	1	diabetes	diabetes	NOUN
bam-10622	172	2	res	re	VERB
bam-10622	172	3	clin	clin	PROPN
bam-10622	172	4	pract	pract	PROPN
bam-10622	172	5	.	.	PUNCT
bam-10622	173	1	2006	2006	NUM
bam-10622	173	2	;	;	PUNCT
bam-10622	173	3	72(2):219	72(2):219	NOUN
bam-10622	173	4	-	-	SYM
bam-10622	173	5	220	220	NUM
bam-10622	173	6	.	.	PUNCT
bam-10622	174	1	doi	doi	NOUN
bam-10622	174	2	:	:	PUNCT
bam-10622	174	3	10.1016	10.1016	NUM
bam-10622	174	4	/	/	SYM
bam-10622	174	5	j.	j.	PROPN
bam-10622	174	6	diabres.2005.10.017	diabres.2005.10.017	PROPN
bam-10622	174	7	.	.	PUNCT
bam-10622	175	1	epub	epub	PROPN
bam-10622	175	2	2005	2005	NUM
bam-10622	175	3	nov	nov	PROPN
bam-10622	175	4	28	28	NUM
bam-10622	175	5	.	.	PUNCT
bam-10622	176	1	22	22	NUM
bam-10622	176	2	.	.	PUNCT
bam-10622	176	3	wasko	wasko	PROPN
bam-10622	176	4	mc	mc	PROPN
bam-10622	176	5	,	,	PUNCT
bam-10622	176	6	kay	kay	PROPN
bam-10622	176	7	j	j	PROPN
bam-10622	176	8	,	,	PUNCT
bam-10622	176	9	hsia	hsia	PROPN
bam-10622	176	10	ec	ec	PROPN
bam-10622	176	11	,	,	PUNCT
bam-10622	176	12	rahman	rahman	PROPN
bam-10622	176	13	mu	mu	PROPN
bam-10622	176	14	.	.	PROPN
bam-10622	177	1	diabetes	diabete	NOUN
bam-10622	177	2	mellitus	mellitus	NOUN
bam-10622	177	3	and	and	CCONJ
bam-10622	177	4	insulin	insulin	NOUN
bam-10622	177	5	resistance	resistance	NOUN
bam-10622	177	6	in	in	ADP
bam-10622	177	7	patients	patient	NOUN
bam-10622	177	8	with	with	ADP
bam-10622	177	9	rheumatoid	rheumatoid	NOUN
bam-10622	177	10	arthritis	arthritis	NOUN
bam-10622	177	11	:	:	PUNCT
bam-10622	177	12	risk	risk	NOUN
bam-10622	177	13	reduction	reduction	NOUN
bam-10622	177	14	in	in	ADP
bam-10622	177	15	a	a	DET
bam-10622	177	16	chronic	chronic	ADJ
bam-10622	177	17	inflammatory	inflammatory	ADJ
bam-10622	177	18	disease	disease	NOUN
bam-10622	177	19	.	.	PUNCT
bam-10622	178	1	arthritis	arthritis	NOUN
bam-10622	178	2	care	care	PROPN
bam-10622	178	3	&	&	CCONJ
bam-10622	178	4	research	research	PROPN
bam-10622	178	5	2011	2011	NUM
bam-10622	178	6	;	;	PUNCT
bam-10622	178	7	63(4	63(4	NUM
bam-10622	178	8	):	):	PUNCT
bam-10622	178	9	512	512	NUM
bam-10622	178	10	-	-	SYM
bam-10622	178	11	21	21	NUM
bam-10622	178	12	.	.	PUNCT
bam-10622	179	1	doi	doi	NOUN
bam-10622	179	2	:	:	PUNCT
bam-10622	179	3	10.1002	10.1002	NUM
bam-10622	179	4	/	/	SYM
bam-10622	179	5	acr	acr	PROPN
bam-10622	179	6	.	.	PUNCT
bam-10622	179	7	20414	20414	NUM
bam-10622	179	8	.	.	PUNCT
bam-10622	180	1	23	23	NUM
bam-10622	180	2	.	.	PUNCT
bam-10622	181	1	hadjistavri	hadjistavri	PROPN
bam-10622	181	2	ls	ls	PROPN
bam-10622	181	3	,	,	PUNCT
bam-10622	181	4	sarafidis	sarafidis	PROPN
bam-10622	181	5	pa	pa	PROPN
bam-10622	181	6	,	,	PUNCT
bam-10622	181	7	georgianos	georgianos	NOUN
bam-10622	181	8	pi	pi	NOUN
bam-10622	181	9	,	,	PUNCT
bam-10622	181	10	tziolas	tziolas	PROPN
bam-10622	181	11	i	i	PRON
bam-10622	181	12	m	m	PROPN
bam-10622	181	13	,	,	PUNCT
bam-10622	181	14	aroditis	aroditis	ADJ
bam-10622	181	15	cp	cp	NOUN
bam-10622	181	16	,	,	PUNCT
bam-10622	181	17	hitoglou	hitoglou	PROPN
bam-10622	181	18	-	-	PUNCT
bam-10622	181	19	makedou	makedou	PROPN
bam-10622	181	20	a	a	PROPN
bam-10622	181	21	,	,	PUNCT
bam-10622	181	22	zebekakis	zebekakis	PROPN
bam-10622	181	23	pe	pe	PROPN
bam-10622	181	24	,	,	PUNCT
bam-10622	181	25	pikilidou	pikilidou	PROPN
bam-10622	181	26	mi	mi	PROPN
bam-10622	181	27	,	,	PUNCT
bam-10622	181	28	lasaridis	lasaridi	VERB
bam-10622	181	29	an	an	DET
bam-10622	181	30	.	.	PUNCT
bam-10622	181	31	beneficial	beneficial	ADJ
bam-10622	181	32	effects	effect	NOUN
bam-10622	181	33	of	of	ADP
bam-10622	181	34	oral	oral	ADJ
bam-10622	181	35	magnesium	magnesium	NOUN
bam-10622	181	36	supplementation	supplementation	NOUN
bam-10622	181	37	on	on	ADP
bam-10622	181	38	insulin	insulin	NOUN
bam-10622	181	39	sensitivity	sensitivity	NOUN
bam-10622	181	40	and	and	CCONJ
bam-10622	181	41	serum	serum	NOUN
bam-10622	181	42	lipid	lipid	NOUN
bam-10622	181	43	profile	profile	NOUN
bam-10622	181	44	.	.	PUNCT
bam-10622	182	1	med	med	PROPN
bam-10622	182	2	sci	sci	PROPN
bam-10622	182	3	monit	monit	PROPN
bam-10622	182	4	.	.	PUNCT
bam-10622	183	1	2010	2010	NUM
bam-10622	184	1	jun;16(6):cr307	jun;16(6):cr307	PROPN
bam-10622	184	2	-	-	PROPN
bam-10622	184	3	312	312	NUM
bam-10622	184	4	.	.	NUM
bam-10622	184	5	24	24	NUM
bam-10622	184	6	.	.	PUNCT
bam-10622	185	1	cahill	cahill	PROPN
bam-10622	185	2	f	f	PROPN
bam-10622	185	3	,	,	PUNCT
bam-10622	185	4	shahidi	shahidi	PROPN
bam-10622	185	5	m	m	PROPN
bam-10622	185	6	,	,	PUNCT
bam-10622	185	7	shea	shea	PROPN
bam-10622	185	8	j	j	PROPN
bam-10622	185	9	,	,	PUNCT
bam-10622	185	10	wadden	wadden	PROPN
bam-10622	185	11	d	d	PROPN
bam-10622	185	12	,	,	PUNCT
bam-10622	185	13	gulliver	gulliver	VERB
bam-10622	185	14	w	w	PROPN
bam-10622	185	15	,	,	PUNCT
bam-10622	185	16	randell	randell	PROPN
bam-10622	185	17	e	e	PROPN
bam-10622	185	18	,	,	PUNCT
bam-10622	185	19	vasdev	vasdev	PROPN
bam-10622	185	20	s	s	PROPN
bam-10622	185	21	,	,	PUNCT
bam-10622	185	22	sun	sun	PROPN
bam-10622	185	23	g.	g.	PROPN
bam-10622	185	24	high	high	ADJ
bam-10622	185	25	dietary	dietary	ADJ
bam-10622	185	26	magnesium	magnesium	NOUN
bam-10622	185	27	intake	intake	NOUN
bam-10622	185	28	is	be	AUX
bam-10622	185	29	associated	associate	VERB
bam-10622	185	30	with	with	ADP
bam-10622	185	31	low	low	ADJ
bam-10622	185	32	insulin	insulin	NOUN
bam-10622	185	33	resistance	resistance	NOUN
bam-10622	185	34	in	in	ADP
bam-10622	185	35	the	the	DET
bam-10622	185	36	newfoundland	newfoundland	PROPN
bam-10622	185	37	population	population	NOUN
bam-10622	185	38	.	.	PUNCT
bam-10622	186	1	plos	plos	PROPN
bam-10622	186	2	one	one	NUM
bam-10622	186	3	.	.	PUNCT
bam-10622	187	1	2013;8(3):e58278	2013;8(3):e58278	NOUN
bam-10622	187	2	.	.	PUNCT
bam-10622	188	1	doi	doi	NOUN
bam-10622	188	2	:	:	PUNCT
bam-10622	188	3	10.1371/	10.1371/	NUM
bam-10622	188	4	journal.pone.0058278	journal.pone.0058278	PROPN
bam-10622	188	5	.	.	PUNCT
bam-10622	189	1	epub	epub	PROPN
bam-10622	189	2	2013	2013	NUM
bam-10622	189	3	mar	mar	PROPN
bam-10622	189	4	5	5	NUM
bam-10622	189	5	.	.	PROPN
bam-10622	189	6	25	25	NUM
bam-10622	189	7	.	.	PUNCT
bam-10622	190	1	villegas	villegas	PROPN
bam-10622	190	2	r	r	PROPN
bam-10622	190	3	,	,	PUNCT
bam-10622	190	4	gao	gao	PROPN
bam-10622	190	5	yt	yt	PROPN
bam-10622	190	6	,	,	PUNCT
bam-10622	190	7	dai	dai	PROPN
bam-10622	190	8	q	q	PROPN
bam-10622	190	9	,	,	PUNCT
bam-10622	190	10	yang	yang	PROPN
bam-10622	190	11	g	g	PROPN
bam-10622	190	12	,	,	PUNCT
bam-10622	190	13	cai	cai	PROPN
bam-10622	190	14	h	h	PROPN
bam-10622	190	15	,	,	PUNCT
bam-10622	190	16	li	li	PROPN
bam-10622	190	17	h	h	PROPN
bam-10622	190	18	,	,	PUNCT
bam-10622	190	19	zheng	zheng	PROPN
bam-10622	190	20	w	w	PROPN
bam-10622	190	21	,	,	PUNCT
bam-10622	190	22	shu	shu	PROPN
bam-10622	190	23	xo	xo	PROPN
bam-10622	190	24	.	.	PUNCT
bam-10622	191	1	dietary	dietary	ADJ
bam-10622	191	2	calcium	calcium	NOUN
bam-10622	191	3	and	and	CCONJ
bam-10622	191	4	magnesium	magnesium	NOUN
bam-10622	191	5	intakes	intake	NOUN
bam-10622	191	6	and	and	CCONJ
bam-10622	191	7	the	the	DET
bam-10622	191	8	risk	risk	NOUN
bam-10622	191	9	of	of	ADP
bam-10622	191	10	type	type	NOUN
bam-10622	191	11	2	2	NUM
bam-10622	191	12	diabetes	diabete	NOUN
bam-10622	191	13	:	:	PUNCT
bam-10622	191	14	the	the	DET
bam-10622	191	15	shanghai	shanghai	PROPN
bam-10622	191	16	women	woman	NOUN
bam-10622	191	17	's	's	PART
bam-10622	191	18	health	health	NOUN
bam-10622	191	19	study	study	NOUN
bam-10622	191	20	.	.	PUNCT
bam-10622	192	1	am	be	AUX
bam-10622	192	2	j	j	PROPN
bam-10622	192	3	clin	clin	PROPN
bam-10622	192	4	nutr	nutr	PROPN
bam-10622	192	5	.	.	PROPN
bam-10622	192	6	2009	2009	NUM
bam-10622	192	7	apr;89(4):1059	apr;89(4):1059	PROPN
bam-10622	192	8	-	-	SYM
bam-10622	192	9	67	67	NUM
bam-10622	192	10	.	.	PUNCT
bam-10622	193	1	doi	doi	NOUN
bam-10622	193	2	:	:	PUNCT
bam-10622	193	3	10.3945	10.3945	NUM
bam-10622	193	4	/	/	SYM
bam-10622	193	5	ajcn.2008.27182	ajcn.2008.27182	NOUN
bam-10622	193	6	.	.	PUNCT
bam-10622	194	1	epub	epub	PROPN
bam-10622	194	2	2009	2009	NUM
bam-10622	194	3	feb	feb	NOUN
bam-10622	194	4	18	18	NUM
bam-10622	194	5	.	.	NOUN
bam-10622	194	6	26	26	NUM
bam-10622	194	7	.	.	PUNCT
bam-10622	195	1	lima	lima	PROPN
bam-10622	195	2	de	de	PROPN
bam-10622	195	3	souza	souza	PROPN
bam-10622	195	4	e	e	PROPN
bam-10622	195	5	silva	silva	PROPN
bam-10622	195	6	mde	mde	PROPN
bam-10622	195	7	l	l	PROPN
bam-10622	195	8	,	,	PUNCT
bam-10622	195	9	cruz	cruz	PROPN
bam-10622	195	10	t	t	PROPN
bam-10622	195	11	,	,	PUNCT
bam-10622	195	12	rodrigues	rodrigues	PROPN
bam-10622	195	13	le	le	PROPN
bam-10622	195	14	,	,	PUNCT
bam-10622	195	15	ladeia	ladeia	PROPN
bam-10622	195	16	am	am	PROPN
bam-10622	195	17	,	,	PUNCT
bam-10622	195	18	bomfim	bomfim	PROPN
bam-10622	195	19	o	o	NOUN
bam-10622	195	20	,	,	PUNCT
bam-10622	195	21	olivieri	olivieri	PROPN
bam-10622	195	22	l	l	PROPN
bam-10622	195	23	,	,	PUNCT
bam-10622	195	24	melo	melo	PROPN
bam-10622	195	25	j	j	PROPN
bam-10622	195	26	,	,	PUNCT
bam-10622	195	27	correia	correia	PROPN
bam-10622	195	28	r	r	PROPN
bam-10622	195	29	,	,	PUNCT
bam-10622	195	30	porto	porto	PROPN
bam-10622	195	31	m	m	PROPN
bam-10622	195	32	,	,	PUNCT
bam-10622	195	33	cedro	cedro	PROPN
bam-10622	195	34	a.	a.	NOUN
bam-10622	195	35	magnesium	magnesium	NOUN
bam-10622	195	36	replacement	replacement	NOUN
bam-10622	195	37	does	do	AUX
bam-10622	195	38	not	not	PART
bam-10622	195	39	improve	improve	VERB
bam-10622	195	40	insulin	insulin	NOUN
bam-10622	195	41	resistance	resistance	NOUN
bam-10622	195	42	in	in	ADP
bam-10622	195	43	patients	patient	NOUN
bam-10622	195	44	with	with	ADP
bam-10622	195	45	metabolic	metabolic	NOUN
bam-10622	195	46	syndrome	syndrome	NOUN
bam-10622	195	47	:	:	PUNCT
bam-10622	195	48	a	a	DET
bam-10622	195	49	12	12	NUM
bam-10622	195	50	-	-	PUNCT
bam-10622	195	51	week	week	NOUN
bam-10622	195	52	randomized	randomize	VERB
bam-10622	195	53	double	double	ADJ
bam-10622	195	54	-	-	PUNCT
bam-10622	195	55	blind	blind	ADJ
bam-10622	195	56	study	study	NOUN
bam-10622	195	57	.	.	PUNCT
bam-10622	196	1	j	j	PROPN
bam-10622	196	2	clin	clin	PROPN
bam-10622	196	3	med	med	PROPN
bam-10622	196	4	res	re	NOUN
bam-10622	196	5	.	.	PUNCT
bam-10622	196	6	2014	2014	NUM
bam-10622	196	7	dec;6(6):456	dec;6(6):456	PROPN
bam-10622	196	8	-	-	PUNCT
bam-10622	196	9	62	62	NUM
bam-10622	196	10	.	.	PUNCT
bam-10622	197	1	doi	doi	NOUN
bam-10622	197	2	:	:	PUNCT
bam-10622	197	3	10.14740	10.14740	NUM
bam-10622	197	4	/	/	SYM
bam-10622	197	5	jocmr	jocmr	ADJ
bam-10622	197	6	1580w	1580w	NUM
bam-10622	197	7	.	.	PUNCT
bam-10622	198	1	epub	epub	NOUN
bam-10622	198	2	2014	2014	NUM
bam-10622	198	3	sep	sep	NOUN
bam-10622	198	4	9	9	NUM
bam-10622	198	5	.	.	X
bam-10622	198	6	27	27	NUM
bam-10622	198	7	.	.	PUNCT
bam-10622	199	1	lee	lee	PROPN
bam-10622	199	2	s	s	PROPN
bam-10622	199	3	,	,	PUNCT
bam-10622	199	4	park	park	PROPN
bam-10622	199	5	hk	hk	PROPN
bam-10622	199	6	,	,	PUNCT
bam-10622	199	7	son	son	NOUN
bam-10622	199	8	sp	sp	PROPN
bam-10622	199	9	,	,	PUNCT
bam-10622	199	10	lee	lee	PROPN
bam-10622	199	11	cw	cw	PROPN
bam-10622	199	12	,	,	PUNCT
bam-10622	199	13	kim	kim	PROPN
bam-10622	199	14	ij	ij	PROPN
bam-10622	199	15	,	,	PUNCT
bam-10622	199	16	kim	kim	PROPN
bam-10622	199	17	hj	hj	PROPN
bam-10622	199	18	.	.	PUNCT
bam-10622	199	19	effects	effect	NOUN
bam-10622	199	20	of	of	ADP
bam-10622	199	21	oral	oral	ADJ
bam-10622	199	22	magnesium	magnesium	NOUN
bam-10622	199	23	supplementation	supplementation	NOUN
bam-10622	199	24	on	on	ADP
bam-10622	199	25	insulin	insulin	NOUN
bam-10622	199	26	sensitivity	sensitivity	NOUN
bam-10622	199	27	and	and	CCONJ
bam-10622	199	28	blood	blood	NOUN
bam-10622	199	29	pressure	pressure	NOUN
bam-10622	199	30	in	in	ADP
bam-10622	199	31	normo	normo	NOUN
bam-10622	199	32	-	-	PUNCT
bam-10622	199	33	magnesemic	magnesemic	ADJ
bam-10622	199	34	nondiabetic	nondiabetic	ADJ
bam-10622	199	35	overweight	overweight	ADJ
bam-10622	199	36	korean	korean	ADJ
bam-10622	199	37	adults	adult	NOUN
bam-10622	199	38	.	.	PUNCT
bam-10622	200	1	nutr	nutr	PROPN
bam-10622	200	2	metab	metab	PROPN
bam-10622	200	3	cardiovasc	cardiovasc	PROPN
bam-10622	200	4	dis	dis	PROPN
bam-10622	200	5	.	.	PUNCT
bam-10622	200	6	2009	2009	NUM
bam-10622	200	7	magnesium	magnesium	NOUN
bam-10622	200	8	supplementation	supplementation	NOUN
bam-10622	200	9	in	in	ADP
bam-10622	200	10	rheumatoid	rheumatoid	NOUN
bam-10622	200	11	arthritis	arthritis	NOUN
bam-10622	200	12	eur	eur	PROPN
bam-10622	200	13	j	j	PROPN
bam-10622	200	14	transl	transl	PROPN
bam-10622	200	15	myol	myol	ADV
bam-10622	200	16	32	32	NUM
bam-10622	200	17	(	(	PUNCT
bam-10622	200	18	3	3	NUM
bam-10622	200	19	):	):	PUNCT
bam-10622	200	20	10622	10622	NUM
bam-10622	200	21	,	,	PUNCT
bam-10622	200	22	2022	2022	NUM
bam-10622	200	23	doi	doi	NOUN
bam-10622	200	24	:	:	PUNCT
bam-10622	200	25	10.4081	10.4081	NUM
bam-10622	200	26	/	/	SYM
bam-10622	200	27	ejtm.2022.10622	ejtm.2022.10622	NUM
bam-10622	200	28	7	7	NUM
bam-10622	200	29	dec;19(11):781	dec;19(11):781	NOUN
bam-10622	200	30	-	-	PUNCT
bam-10622	200	31	8	8	NUM
bam-10622	200	32	.	.	PUNCT
bam-10622	201	1	doi	doi	NOUN
bam-10622	201	2	:	:	PUNCT
bam-10622	201	3	10.1016	10.1016	NUM
bam-10622	201	4	/	/	SYM
bam-10622	201	5	j.numecd.2009	j.numecd.2009	PROPN
bam-10622	201	6	.	.	PUNCT
bam-10622	202	1	01.002	01.002	NUM
bam-10622	202	2	.	.	PUNCT
bam-10622	203	1	epub	epub	NOUN
bam-10622	203	2	2009	2009	NUM
bam-10622	203	3	apr	apr	NOUN
bam-10622	203	4	8	8	NUM
bam-10622	203	5	.	.	NOUN
bam-10622	203	6	28	28	NUM
bam-10622	203	7	.	.	PUNCT
bam-10622	204	1	balon	balon	PROPN
bam-10622	204	2	tw	tw	PROPN
bam-10622	204	3	,	,	PUNCT
bam-10622	204	4	gu	gu	NOUN
bam-10622	204	5	jl	jl	PROPN
bam-10622	204	6	,	,	PUNCT
bam-10622	204	7	tokuyama	tokuyama	NOUN
bam-10622	204	8	y	y	PROPN
bam-10622	204	9	,	,	PUNCT
bam-10622	204	10	jasman	jasman	PROPN
bam-10622	204	11	ap	ap	PROPN
bam-10622	204	12	,	,	PUNCT
bam-10622	204	13	nadler	nadler	PROPN
bam-10622	204	14	jl	jl	PROPN
bam-10622	204	15	.	.	PUNCT
bam-10622	204	16	magnesium	magnesium	NOUN
bam-10622	204	17	supplementation	supplementation	NOUN
bam-10622	204	18	reduces	reduce	VERB
bam-10622	204	19	development	development	NOUN
bam-10622	204	20	of	of	ADP
bam-10622	204	21	diabetes	diabetes	NOUN
bam-10622	204	22	in	in	ADP
bam-10622	204	23	a	a	DET
bam-10622	204	24	rat	rat	NOUN
bam-10622	204	25	model	model	NOUN
bam-10622	204	26	of	of	ADP
bam-10622	204	27	spontaneous	spontaneous	ADJ
bam-10622	204	28	niddm	niddm	NOUN
bam-10622	204	29	.	.	PUNCT
bam-10622	205	1	am	be	AUX
bam-10622	205	2	j	j	PROPN
bam-10622	205	3	physiol	physiol	PROPN
bam-10622	205	4	1995	1995	NUM
bam-10622	205	5	;	;	PUNCT
bam-10622	205	6	269	269	NUM
bam-10622	205	7	:	:	PUNCT
bam-10622	205	8	e745–52	e745–52	ADJ
bam-10622	205	9	.	.	PROPN
bam-10622	205	10	doi	doi	NOUN
bam-10622	205	11	:	:	PUNCT
bam-10622	205	12	10.1152	10.1152	NUM
bam-10622	205	13	/	/	SYM
bam-10622	205	14	ajpendo.1995.269.4	ajpendo.1995.269.4	PROPN
bam-10622	205	15	.	.	PUNCT
bam-10622	206	1	e745	e745	PROPN
bam-10622	206	2	.	.	PROPN
bam-10622	206	3	29	29	NUM
bam-10622	206	4	.	.	PUNCT
bam-10622	207	1	wasko	wasko	PROPN
bam-10622	207	2	mc	mc	PROPN
bam-10622	207	3	.	.	PROPN
bam-10622	208	1	rheumatoid	rheumatoid	VERB
bam-10622	208	2	arthritis	arthritis	NOUN
bam-10622	208	3	and	and	CCONJ
bam-10622	208	4	cardiovascular	cardiovascular	ADJ
bam-10622	208	5	disease	disease	NOUN
bam-10622	208	6	.	.	PUNCT
bam-10622	209	1	curr	curr	PROPN
bam-10622	209	2	rheumatol	rheumatol	PROPN
bam-10622	209	3	rep	rep	PROPN
bam-10622	209	4	.	.	PROPN
bam-10622	209	5	2008	2008	NUM
bam-10622	209	6	;	;	PUNCT
bam-10622	210	1	10	10	NUM
bam-10622	210	2	:	:	SYM
bam-10622	210	3	390y397	390y397	NUM
bam-10622	210	4	.	.	PUNCT
bam-10622	210	5	doi	doi	NOUN
bam-10622	210	6	:	:	PUNCT
bam-10622	210	7	10.1007	10.1007	NUM
bam-10622	210	8	/	/	SYM
bam-10622	210	9	s11926	s11926	NOUN
bam-10622	210	10	-	-	PUNCT
bam-10622	210	11	0080063	0080063	NUM
bam-10622	210	12	-	-	SYM
bam-10622	210	13	0	0	NUM
bam-10622	210	14	.	.	NOUN
bam-10622	210	15	30	30	NUM
bam-10622	210	16	.	.	PUNCT
bam-10622	211	1	giles	giles	PROPN
bam-10622	211	2	jt	jt	PROPN
bam-10622	211	3	,	,	PUNCT
bam-10622	211	4	bartlett	bartlett	PROPN
bam-10622	211	5	sj	sj	PROPN
bam-10622	211	6	,	,	PUNCT
bam-10622	211	7	andersen	andersen	PROPN
bam-10622	211	8	re	re	PROPN
bam-10622	211	9	,	,	PUNCT
bam-10622	211	10	fontaine	fontaine	PROPN
bam-10622	211	11	kr	kr	PROPN
bam-10622	211	12	,	,	PUNCT
bam-10622	211	13	bathon	bathon	PROPN
bam-10622	211	14	jm	jm	PROPN
bam-10622	211	15	.	.	PROPN
bam-10622	211	16	association	association	PROPN
bam-10622	211	17	of	of	ADP
bam-10622	211	18	body	body	NOUN
bam-10622	211	19	composition	composition	NOUN
bam-10622	211	20	with	with	ADP
bam-10622	211	21	disability	disability	NOUN
bam-10622	211	22	in	in	ADP
bam-10622	211	23	rheumatoid	rheumatoid	NOUN
bam-10622	211	24	arthritis	arthritis	NOUN
bam-10622	211	25	:	:	PUNCT
bam-10622	211	26	impact	impact	NOUN
bam-10622	211	27	of	of	ADP
bam-10622	211	28	appendicular	appendicular	ADJ
bam-10622	211	29	fat	fat	ADJ
bam-10622	211	30	and	and	CCONJ
bam-10622	211	31	lean	lean	ADJ
bam-10622	211	32	tissue	tissue	NOUN
bam-10622	211	33	mass	mass	NOUN
bam-10622	211	34	.	.	PUNCT
bam-10622	212	1	arthritis	arthritis	NOUN
bam-10622	212	2	rheum	rheum	NOUN
bam-10622	212	3	.	.	PUNCT
bam-10622	213	1	2008	2008	NUM
bam-10622	213	2	oct	oct	NOUN
bam-10622	213	3	15;59(10):1407	15;59(10):1407	NUM
bam-10622	213	4	-	-	SYM
bam-10622	213	5	15	15	NUM
bam-10622	213	6	.	.	PUNCT
bam-10622	214	1	doi	doi	NOUN
bam-10622	214	2	:	:	PUNCT
bam-10622	214	3	10.1002	10.1002	NUM
bam-10622	214	4	/	/	SYM
bam-10622	214	5	art.24109	art.24109	NUM
bam-10622	214	6	.	.	PROPN
bam-10622	214	7	31	31	NUM
bam-10622	214	8	.	.	PUNCT
bam-10622	215	1	larsson	larsson	PROPN
bam-10622	215	2	sc	sc	PROPN
bam-10622	215	3	,	,	PUNCT
bam-10622	215	4	wolk	wolk	NOUN
bam-10622	215	5	a.	a.	NOUN
bam-10622	215	6	magnesium	magnesium	PROPN
bam-10622	215	7	intake	intake	NOUN
bam-10622	215	8	and	and	CCONJ
bam-10622	215	9	risk	risk	NOUN
bam-10622	215	10	of	of	ADP
bam-10622	215	11	type	type	NOUN
bam-10622	215	12	2	2	NUM
bam-10622	215	13	diabetes	diabetes	NOUN
bam-10622	215	14	:	:	PUNCT
bam-10622	215	15	a	a	DET
bam-10622	215	16	meta	meta	ADJ
bam-10622	215	17	-	-	PUNCT
bam-10622	215	18	analysis	analysis	NOUN
bam-10622	215	19	.	.	PUNCT
bam-10622	216	1	j	j	PROPN
bam-10622	216	2	intern	intern	NOUN
bam-10622	216	3	med	me	VERB
bam-10622	216	4	2007	2007	NUM
bam-10622	216	5	;	;	PUNCT
bam-10622	216	6	262	262	NUM
bam-10622	216	7	:	:	SYM
bam-10622	216	8	208e14	208e14	X
bam-10622	216	9	.	.	PUNCT
bam-10622	216	10	doi	doi	NOUN
bam-10622	216	11	:	:	PUNCT
bam-10622	216	12	10.1111	10.1111	NUM
bam-10622	216	13	/	/	SYM
bam-10622	216	14	j.13652796.2007.01840.x	j.13652796.2007.01840.x	NOUN
bam-10622	216	15	.	.	PUNCT
bam-10622	217	1	32	32	NUM
bam-10622	217	2	.	.	PUNCT
bam-10622	218	1	guerrero	guerrero	PROPN
bam-10622	218	2	-	-	PUNCT
bam-10622	218	3	romero	romero	PROPN
bam-10622	218	4	f	f	PROPN
bam-10622	218	5	,	,	PUNCT
bam-10622	218	6	rodríguez	rodríguez	NOUN
bam-10622	218	7	-	-	PUNCT
bam-10622	218	8	morán	morán	PROPN
bam-10622	218	9	m.	m.	NOUN
bam-10622	218	10	complementary	complementary	ADJ
bam-10622	218	11	therapies	therapy	NOUN
bam-10622	218	12	for	for	ADP
bam-10622	218	13	diabetes	diabetes	NOUN
bam-10622	218	14	:	:	PUNCT
bam-10622	218	15	the	the	DET
bam-10622	218	16	case	case	NOUN
bam-10622	218	17	for	for	ADP
bam-10622	218	18	chromium	chromium	NOUN
bam-10622	218	19	,	,	PUNCT
bam-10622	218	20	magnesium	magnesium	NOUN
bam-10622	218	21	,	,	PUNCT
bam-10622	218	22	and	and	CCONJ
bam-10622	218	23	antioxidants	antioxidant	NOUN
bam-10622	218	24	.	.	PUNCT
bam-10622	219	1	arch	arch	ADJ
bam-10622	219	2	med	med	ADJ
bam-10622	219	3	res	re	NOUN
bam-10622	219	4	.	.	PUNCT
bam-10622	220	1	2005	2005	NUM
bam-10622	220	2	may	may	PROPN
bam-10622	220	3	-	-	PUNCT
bam-10622	220	4	jun;36(3):250	jun;36(3):250	VERB
bam-10622	220	5	-	-	PUNCT
bam-10622	220	6	7	7	PROPN
bam-10622	220	7	.	.	PUNCT
bam-10622	220	8	doi	doi	NOUN
bam-10622	220	9	:	:	PUNCT
bam-10622	220	10	10.1016	10.1016	NUM
bam-10622	220	11	/	/	SYM
bam-10622	220	12	j.arcmed.2005.01.004	j.arcmed.2005.01.004	PROPN
bam-10622	220	13	.	.	PUNCT
bam-10622	221	1	33	33	NUM
bam-10622	221	2	.	.	PUNCT
bam-10622	222	1	barbagallo	barbagallo	PROPN
bam-10622	222	2	m	m	PROPN
bam-10622	222	3	,	,	PUNCT
bam-10622	222	4	dominguez	dominguez	PROPN
bam-10622	222	5	lj	lj	PROPN
bam-10622	222	6	.	.	PUNCT
bam-10622	222	7	magnesium	magnesium	NOUN
bam-10622	222	8	metabolism	metabolism	NOUN
bam-10622	222	9	in	in	ADP
bam-10622	222	10	type	type	NOUN
bam-10622	222	11	2	2	NUM
bam-10622	222	12	diabetes	diabetes	NOUN
bam-10622	222	13	mellitus	mellitus	NOUN
bam-10622	222	14	,	,	PUNCT
bam-10622	222	15	metabolic	metabolic	NOUN
bam-10622	222	16	syndrome	syndrome	NOUN
bam-10622	222	17	and	and	CCONJ
bam-10622	222	18	insulin	insulin	NOUN
bam-10622	222	19	resistance	resistance	NOUN
bam-10622	222	20	.	.	PUNCT
bam-10622	223	1	arch	arch	ADJ
bam-10622	223	2	biochem	biochem	PROPN
bam-10622	223	3	biophys	biophy	NOUN
bam-10622	223	4	.	.	PUNCT
bam-10622	224	1	2007	2007	NUM
bam-10622	224	2	;	;	PUNCT
bam-10622	224	3	458(1	458(1	NUM
bam-10622	224	4	):	):	PUNCT
bam-10622	224	5	4047	4047	NUM
bam-10622	224	6	.	.	PUNCT
bam-10622	225	1	doi	doi	NOUN
bam-10622	225	2	:	:	PUNCT
bam-10622	225	3	10.1016	10.1016	NUM
bam-10622	225	4	/	/	SYM
bam-10622	225	5	j.abb.2006.05.007	j.abb.2006.05.007	NOUN
bam-10622	225	6	.	.	PUNCT
bam-10622	226	1	epub	epub	PROPN
bam-10622	226	2	2006	2006	NUM
bam-10622	226	3	jun	jun	PROPN
bam-10622	226	4	12	12	NUM
bam-10622	226	5	.	.	PUNCT
bam-10622	227	1	34	34	NUM
bam-10622	227	2	.	.	PUNCT
bam-10622	228	1	dong	dong	PROPN
bam-10622	228	2	jy	jy	PROPN
bam-10622	228	3	,	,	PUNCT
bam-10622	228	4	xun	xun	PROPN
bam-10622	229	1	p	p	PROPN
bam-10622	229	2	,	,	PUNCT
bam-10622	229	3	he	he	PRON
bam-10622	229	4	k	k	NOUN
bam-10622	229	5	,	,	PUNCT
bam-10622	229	6	qin	qin	PROPN
bam-10622	229	7	lq	lq	PROPN
bam-10622	229	8	.	.	PROPN
bam-10622	229	9	magnesium	magnesium	NOUN
bam-10622	229	10	intake	intake	NOUN
bam-10622	229	11	and	and	CCONJ
bam-10622	229	12	risk	risk	NOUN
bam-10622	229	13	of	of	ADP
bam-10622	229	14	type	type	NOUN
bam-10622	229	15	2	2	NUM
bam-10622	229	16	diabetes	diabetes	NOUN
bam-10622	229	17	:	:	PUNCT
bam-10622	229	18	meta	meta	ADJ
bam-10622	229	19	-	-	PUNCT
bam-10622	229	20	analysis	analysis	NOUN
bam-10622	229	21	of	of	ADP
bam-10622	229	22	prospective	prospective	ADJ
bam-10622	229	23	cohort	cohort	NOUN
bam-10622	229	24	studies	study	NOUN
bam-10622	229	25	.	.	PUNCT
bam-10622	230	1	diabetes	diabetes	NOUN
bam-10622	230	2	care	care	NOUN
bam-10622	230	3	.	.	PUNCT
bam-10622	231	1	2011	2011	NUM
bam-10622	231	2	;	;	PUNCT
bam-10622	231	3	34(9	34(9	NUM
bam-10622	231	4	):	):	PUNCT
bam-10622	231	5	2116	2116	NUM
bam-10622	231	6	-	-	SYM
bam-10622	231	7	22	22	NUM
bam-10622	231	8	.	.	PUNCT
bam-10622	232	1	doi	doi	NOUN
bam-10622	232	2	:	:	PUNCT
bam-10622	232	3	10.2337	10.2337	NUM
bam-10622	232	4	/	/	SYM
bam-10622	232	5	dc11	dc11	PROPN
bam-10622	232	6	-	-	PUNCT
bam-10622	232	7	0518	0518	NUM
bam-10622	232	8	.	.	PUNCT
bam-10622	233	1	disclaimer	disclaimer	PROPN
bam-10622	233	2	all	all	DET
bam-10622	233	3	claims	claim	NOUN
bam-10622	233	4	expressed	express	VERB
bam-10622	233	5	in	in	ADP
bam-10622	233	6	this	this	DET
bam-10622	233	7	article	article	NOUN
bam-10622	233	8	are	be	AUX
bam-10622	233	9	solely	solely	ADV
bam-10622	233	10	those	those	PRON
bam-10622	233	11	of	of	ADP
bam-10622	233	12	the	the	DET
bam-10622	233	13	authors	author	NOUN
bam-10622	233	14	and	and	CCONJ
bam-10622	233	15	do	do	AUX
bam-10622	233	16	not	not	PART
bam-10622	233	17	necessarily	necessarily	ADV
bam-10622	233	18	represent	represent	VERB
bam-10622	233	19	those	those	PRON
bam-10622	233	20	of	of	ADP
bam-10622	233	21	their	their	PRON
bam-10622	233	22	affiliated	affiliated	ADJ
bam-10622	233	23	organizations	organization	NOUN
bam-10622	233	24	,	,	PUNCT
bam-10622	233	25	or	or	CCONJ
bam-10622	233	26	those	those	PRON
bam-10622	233	27	of	of	ADP
bam-10622	233	28	the	the	DET
bam-10622	233	29	publisher	publisher	NOUN
bam-10622	233	30	,	,	PUNCT
bam-10622	233	31	the	the	DET
bam-10622	233	32	editors	editor	NOUN
bam-10622	233	33	and	and	CCONJ
bam-10622	233	34	the	the	DET
bam-10622	233	35	reviewers	reviewer	NOUN
bam-10622	233	36	.	.	PUNCT
bam-10622	234	1	any	any	DET
bam-10622	234	2	product	product	NOUN
bam-10622	234	3	that	that	PRON
bam-10622	234	4	may	may	AUX
bam-10622	234	5	be	be	AUX
bam-10622	234	6	evaluated	evaluate	VERB
bam-10622	234	7	in	in	ADP
bam-10622	234	8	this	this	DET
bam-10622	234	9	article	article	NOUN
bam-10622	234	10	or	or	CCONJ
bam-10622	234	11	claim	claim	NOUN
bam-10622	234	12	that	that	PRON
bam-10622	234	13	may	may	AUX
bam-10622	234	14	be	be	AUX
bam-10622	234	15	made	make	VERB
bam-10622	234	16	by	by	ADP
bam-10622	234	17	its	its	PRON
bam-10622	234	18	manufacturer	manufacturer	NOUN
bam-10622	234	19	is	be	AUX
bam-10622	234	20	not	not	PART
bam-10622	234	21	guaranteed	guarantee	VERB
bam-10622	234	22	or	or	CCONJ
bam-10622	234	23	endorsed	endorse	VERB
bam-10622	234	24	by	by	ADP
bam-10622	234	25	the	the	DET
bam-10622	234	26	publisher	publisher	NOUN
bam-10622	234	27	.	.	PUNCT
bam-10622	235	1	submission	submission	NOUN
bam-10622	235	2	:	:	PUNCT
bam-10622	235	3	may	may	AUX
bam-10622	235	4	15	15	NUM
bam-10622	235	5	,	,	PUNCT
bam-10622	235	6	2022	2022	NUM
bam-10622	235	7	revision	revision	NOUN
bam-10622	235	8	received	receive	VERB
bam-10622	235	9	:	:	PUNCT
bam-10622	235	10	may	may	AUX
bam-10622	235	11	26	26	NUM
bam-10622	235	12	,	,	PUNCT
bam-10622	235	13	2022	2022	NUM
bam-10622	235	14	accepted	accept	VERB
bam-10622	235	15	for	for	ADP
bam-10622	235	16	publication	publication	NOUN
bam-10622	235	17	:	:	PUNCT
bam-10622	235	18	may	may	AUX
bam-10622	235	19	26	26	NUM
bam-10622	235	20	,	,	PUNCT
bam-10622	235	21	2022	2022	NUM
bam-10622	235	22	results	result	VERB